TradingFloor Mobile
2025-11-10 / ALL-MARKETS
Full desktop terminal available Open Full Site ↗
Guest Preview Active
Create an account after 12s to keep the mobile market desk live.
Create Account Login
TFAI Command Terminal

Full Market Intelligence

AI-powered RNS digestion, live interactive charts, insider flow and broker targets — all in your pocket.

Create Free Account
Market AI 536 headlines · 30 AI picks today Tap a ticker to open AI chart · Ask AI above -- AI
Find by ticker, company name or close match. Tap + to add alerts.
Loading market intelligence…
Quant BTC Blending

Crypto Dream Desk

BTC structure, AI forecast, macro event odds and listed crypto-beta names blended into one mobile cockpit.

BTC logo
Loading BTC quant blending from the main site engine...
Open full quant desk

Live RNS Feed

49 types
All Market News Today All digested RNS titles 536
JCGI logo
All News 15:48
JCGI

Holding(s) in Company

JPMorgan China Growth & Income PLC

TR1 Buy
['City of London Investment Management Company Limited', '19.130000', '18.020000']
BAG logo
All News 15:45
BAG

Director/PDMR Shareholding

A.G.Barr PLC

<mark style="background-coloryellow">Purchase</mark> of shares in relation to the A.G. BARR All Employee Share Ownership Plan (AESOP) dividend reinvestment
SST logo
All News 15:42
SST

Holding(s) in Company

The Scottish Oriental Smaller Companies Trust plc

TR1 Buy
['City of London Investment Management Company Limited', '13.050000', '12.090000']
WIZZ logo
All News 15:39
WIZZ

Holding(s) in Company

Wizz Air Holdings PLC

<mark style="background-coloryellow">TR1</mark> Buy
['Barclays PLC', '0.030000', 'Below minimum threshold ']
BAG logo
All News 15:39
BAG

Director/PDMR Shareholding

A.G.Barr PLC

<mark style="background-coloryellow">Purchase</mark> of shares in relation to the A.G. BARR All Employee Share Ownership Plan (AESOP). The AESOP is an all-employee trust arrangement approved by HM Revenue and Customs, under which employees are able to buy ordinary shares in the Company of 4⅙p each, using deductions from salary in each pay period, and receive allocations of matching free ordinary shares.
IGET logo
All News 15:35
IGET

Issue of Equity

Invesco Perpetual Select Trust plc - Global Equity Income Share Portfolio

NFG logo
All News 15:31
NFG

Holding(s) in Company

Next 15 Group PLC

TR1 Buy
['Liontrust Investment Partners LLP', '9.855000', '10.977700']
RR. logo
All News 15:31
RR.

Director/PDMR Shareholding

RR.

Rolls-Royce Holdings plc (the Company) announces that the following person(s) discharging managerial responsibilities <mark style="background-color:yellow">purchase</mark>d ordinary shares of 20p each in the Company by way of a monthly share purchase plan.
AWE logo
All News 15:02
AWE

Holding(s) in Company

Alphawave IP Group PLC

<mark style="background-coloryellow">TR1</mark> Buy
['JPMorgan Chase & Co.', 'Below minimum threshold', '1.344761']
TIDE logo
All News 14:15
TIDE

Contract Renewal with Major Global Retailer

Crimson Tide plc

**Summary**
Crimson Tide PLC, the provider of the mpro5 process management app, has secured a three-year contract extension worth £3.88 million with one of the world’s largest retailers. This renewal strengthens the company’s long-standing relationship with the retailer, which already uses mpro5 across 3,000+ locations in the UK and Ireland, with potential for further international expansion. The platform has become integral to the retailer’s in-store operations, consolidating multiple systems and driving efficiency. The agreement highlights mpro5’s role as a mission-critical tool for large enterprises and aligns with the retailer’s digital transformation strategy. CEO Jon Clarke emphasized the renewal’s significance, noting it reflects the company’s successful customer retention and growth strategy, with four of its top five revenue customers renewing contracts this financial year. This positions Crimson Tide for future growth.
NewContract
WKP logo
All News 14:09
WKP

Holding(s) in Company

Workspace Group PLC

TR1 Buy
['Jefferies Financial Group Inc', '0.996000', '1.563000']
IPF logo
All News 14:01
IPF

Form 8.3

International Personal Finance PLC

GNC logo
All News 14:01
GNC

Holding(s) in Company

Greencore Group

TR1 Buy
['UBS Group AG-Investment Bank & Global Wealth Management', '3.980700', '0.000000']
BGEU logo
All News 13:56
BGEU

Holding(s) in Company

Baillie Gifford European Growth Trust PLC

TR1 Buy
['Allspring Global Investments Holdings.', '21.031000', '20.633000']
MAB logo
All News 13:01
MAB

Director/PDMR Shareholding

Mitchells & Butlers PLC

<mark style="background-coloryellow">Purchase</mark> of partnership shares by the SIP Trustee (notified on 10 November 2025)
GAMA logo
All News 13:01
GAMA

Holding(s) in Company

Gamma Communications PLC

TR1 Buy
['Allianz Global Investors GmbH', '10.800000', '11.010000']
PCGH logo
All News 12:47
PCGH

Holding(s) in Company

Polar Capital Global Healthcare Trust plc

TR1 Buy
['Rathbones Investment Management Ltd', '13.978800', '14.003100']
DGE logo
All News 12:21
DGE

Director/PDMR Shareholding

Diageo PLC

Share <mark style="background-coloryellow">purchase</mark> under an arrangement with the Company
AMS logo
All News 11:39
AMS

Holding(s) in Company

Advanced Medical Solutions Group plc

TR1 Buy
['Richard Griffiths and controlled holdings', '0.53', '0.37']
APN logo
All News 10:51
APN

Holding(s) in Company

Applied Nutrition Plc

TR1 Buy
['UBS Group AG-Investment Bank & Global Wealth Management', '0.000000', '5.016711']
JUP logo
All News 10:16
JUP

Holding(s) in Company

Jupiter Fund Management Plc

TR1 Buy
['SILCHESTER INTERNATIONAL INVESTORS LLP', '15.970000', '16.997000']
EWI logo
All News 09:39
EWI

Holding(s) in Company

Edinburgh Worldwide Investment Trust plc

TR1 Buy
['Saba Capital Management, L.P.', '25.051939', '24.887687']
MSLH logo
All News 09:31
MSLH

Director/PDMR Shareholding

Marshalls PLC

<mark style="background-coloryellow">Purchase</mark> of shares under the Marshalls plc Employee Share Purchase Plan 2015
MSLH logo
All News 09:30
MSLH

Director/PDMR Shareholding

Marshalls PLC

<mark style="background-coloryellow">Purchase</mark> of shares under the Marshalls plc Employee Share Purchase Plan 2015
MSLH logo
All News 09:28
MSLH

Director/PDMR Shareholding

Marshalls PLC

<mark style="background-coloryellow">Purchase</mark> of shares under the Marshalls plc Employee Share Purchase Plan 2015
THRG logo
All News 09:19
THRG

Holding(s) in Company

Throgmorton Trust Plc

TR1 Buy
['Jefferies Financial Group Inc', '1.218000', '2.011000']
DOM logo
All News 09:01
DOM

Holding(s) in Company

Domino’s Pizza Group PLC

TR1 Buy
['The Capital Group Companies, Inc.', '9.730380', '10.615023']
PTSB logo
All News 09:01
PTSB

Holding(s) in Company

Permanent TSB Group Holdings PLC

TR1 Buy
['The Goldman Sachs Group, Inc.', '3.68', '3.73']
WIZZ logo
All News 08:47
WIZZ

Holding(s) in Company

Wizz Air Holdings PLC

<mark style="background-coloryellow">TR1</mark> Buy
['Barclays PLC', 'Below minimum threshold', '0.030000']
ECEL logo
All News 08:31
ECEL

Director/PDMR Shareholding

Eurocell PLC

Eurocell plc announces that, pursuant to the Non-executive Directors Share <mark style="background-color:yellow">Purchase</mark> Plan which was announced on 3 February 2023, five directors have purchased shares in the Company on 7 November 2025. As previously announced, following these trades, Will Trumans membership of the scheme has now ceased.
0RPR logo
All News 06:28
0RPR

Share buyback programme - week 45

Ringkjoebing Landbobank A/S

**Summary of Ringkjøbing Landbobank A/S Share Buyback Programme - Week 45 (10 November 2025)**
Ringkjøbing Landbobank A/S announced the progress of its share buyback programme for Week 45, part of a larger initiative running from 2 June 2025 to 30 January 2026. The programme aims to repurchase up to DKK 1,000 million worth of shares, with a maximum of 1,600,000 shares, in compliance with EU regulations (Regulation No. 596/2014 and Delegated Regulation No. 2016/1052).
**Key Highlights**
1. **Total Shares Bought Back (Week 45)** 20,500 shares.
2. **Average Purchase Price (Week 45)** DKK 1,456.89.
3. **Total Programme Expenditure (Week 45):** DKK 707,975,445.
4. **Cumulative Shares Bought Back (Since Programme Start):** 910,877 shares (3.59% of share capital).
5. **Cumulative Programme Expenditure** DKK 1,207,964,151.
**Transactions Breakdown (Week 45)**
**3 November 2025:** 3500 shares at DKK 1472.79.
**4 November 2025:** 3500 shares at DKK 1470.64.
**5 November 2025:** 3500 shares at DKK 1466.14.
**6 November 2025:** 3500 shares at DKK 1456.89.
**7 November 2025:** 5000 shares at DKK 1428.41.
The bank now holds 910,877 of its own shares, excluding trading portfolio and customer investments. Detailed transaction data is attached to the corporate announcement for transparency.
**CEO Statement**
John Fisker, CEO, confirmed adherence to regulatory requirements and provided detailed transaction records for stakeholder review.
This update reflects the bank’s ongoing commitment to its share buyback strategy, with Week 45 transactions contributing to the programme’s overall progress.
BuyBack
0A3D logo
All News 06:11
0A3D

Net Asset Value

iShares VII Public Limited Company - iShares Core S&P 500 UCITS ETF

SYM logo
All News 06:01
SYM

New product launch, South Korea

Symphony Environmental Technologies plc

**Summary**
Symphony Environmental Technologies Plc, a global leader in sustainable plastic and rubber technologies, announced that its exclusive South Korean distributor, CPST, in collaboration with PetRize Inc., won the Grand Prize (Early Startup Division) at the Gyeonggi Province Pet Startup Competition for the **Wanspapa biodegradable Dog Waste Bag**. This product incorporates Symphonys **d2w® biodegradable masterbatch**, offering a sustainable solution for pet owners without compromising performance. Key advantages of Wanspapa include ASTM D6954-24 open-air biodegradability (leaving no microplastics), easy-open design, tear strength, reduced odor, lower CO₂ emissions, and South Korean manufacturing for quality assurance.
PetRize Inc., a startup with ambitious international expansion plans, aims to target major retail chains in Korea, North America, Canada, and Australia. Symphony’s CEO, Michael Laurier, praised the achievement, highlighting the success of their technology and CPST’s efforts. This milestone underscores the commercial and environmental value of Symphony’s d2w technology in the global pet market.
The announcement is non-regulatory and does not significantly impact Symphony’s performance expectations. Symphony continues to innovate with its d2p and NbR brands, offering diverse plastic technologies globally, with products available in nearly 100 countries.
**Key Points**
**Product** Wanspapa biodegradable Dog Waste Bag using Symphony’s d2w technology.
**Award** Grand Prize at Korean Pet Startup Competition.
**Advantages:** Biodegradabilityconveniencereliabilitysustainabilityand quality.
**Expansion** PetRize targets international markets, including North America, Canada, and Australia.
**Impact** Demonstrates Symphony’s technology’s commercial and environmental value.
Launch
EYE logo
All News 06:01
EYE

Multi-year contract with North American retailer

Eagle Eye Solutions Group plc

**Summary**
Eagle Eye Solutions Group PLC, a leading SaaS and AI technology company, has secured a five-year contract with one of North Americas largest independent food retailers. The retailer, operating over 450 stores across Texas and Mexico under five brands, will utilize Eagle Eyes AIR platform for promotional capabilities within its eCommerce business. The contract, expected to go live in the first half of 2026, marks a significant opportunity for Eagle Eye to deepen its relationship with the retailer and expand its presence in the North American market.
This win underscores Eagle Eyes strategic focus on North America, the worlds largest loyalty and promotions market, and reflects early success from initiatives aimed at growing the sales pipeline and improving conversion rates. Tim Mason, Eagle Eyes CEO, emphasized the companys commitment to accelerating growth in the region through enhanced personalization and customer experience.
Eagle Eyes technology, recognized by industry leaders like Gartner and Forrester, powers over 1 billion personalized offers weekly and manages 700 million loyalty member wallets globally. The company’s growing client base includes major retailers such as Loblaws, Tesco, and Carrefour. This contract reinforces Eagle Eyes position as a key player in real-time, omnichannel, and personalized marketing solutions.
NewContract
ELCO logo
All News 06:01
ELCO

Industry Award Wins

Eleco PLC

**Summary**
Eleco plc (AIMELCO), a specialist software provider for the built environment, has been honored with two prestigious awards at the Construction Computing Awards 2025: *Company of the Year* and *Project Management Software of the Year* for the twelfth consecutive year. Jonathan Hunter, CEO of Eleco plc, expressed gratitude for the recognition, attributing the success to the company’s talented teams and their dedication to meeting customer needs in a competitive and fast-evolving industry. Eleco operates internationally through brands like Elecosoft, BestOutcome, and PEMAC, offering software solutions across the building lifecycle, from planning and design to asset and facilities management. The announcement was distributed via RNS Reach, a non-regulatory press release service of the London Stock Exchange.
Awards
GPE logo
All News 06:01
GPE

GPE gets planning approval for Whittington House

GREAT PORTLAND ESTATES PLC

**Summary**
Great Portland Estates PLC (GPE) has secured planning approval from Camden Council for the refurbishment of Whittington House, a 74,500 sq ft HQ building in Londons West End (WC1). The project, expected to complete in Q1 2027, will transform the building into a sustainable, Grade A workspace with eight floors of offices, a new rooftop terrace, and a pavilion. Located near Tottenham Court Road Elizabeth Line station, the development is part of a larger 220,000 sq ft cluster of prime office space, including the Gable Building, Courtyard Building, and 31/34 Alfred Place. Trevor Phyo, GPEs Senior Development Manager, highlighted the projects significance in preserving architectural heritage while creating a modern workplace. This approval strengthens GPEs HQ portfolio and underscores its commitment to delivering exceptional spaces in prime London locations.
Approvals
AVG logo
All News 06:01
AVG

Adaptix receives FDA 510(K) clearance

Avingtrans Plc

**Summary**
Avingtrans plc, a UK-based company specializing in critical components and systems for energy, medical, and industrial sectors, announced that its subsidiary Adaptix Limited has received FDA 510(k) clearance for its orthopaedic 3D imaging product, the Adaptix Ortho350. This compact, mobile, low-dose Digital Tomosynthesis (DT) system is designed for point-of-care use, offering fast, affordable, and high-quality 3D X-ray imaging for upper and lower extremity diagnostics. The clearance enables Adaptix to enter the U.S. human healthcare imaging market, marking a significant milestone in its mission to revolutionize radiology. The Ortho350 delivers superior image clarity compared to 2D X-ray systems while reducing radiation exposure, improving diagnostic accuracy, and enhancing patient outcomes. Adaptix has already commercialized similar technology in veterinary and industrial markets, and this FDA approval validates the technologys commercial potential. Company executives expressed excitement about the strong interest from healthcare providers and the systems potential impact on primary care, intensive care, and emergency departments.
FDA
WKP logo
All News 06:01
WKP

Holding(s) in Company

Workspace Group PLC

TR1 Buy
['Saba Capital Management, L.P.', '0.162330', '0.162330']
SEEN logo
All News 06:01
SEEN

Director dealing

SEEEN PLC

<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares into SIPP
INSG logo
All News 06:01
INSG

New contract with global advisory firm

Insig Ai PLC

**Summary**
Insig AI Plc (AIMINSG), a leader in AI-led analytics and machine-learning solutions, has secured a new contract with a global advisory firm operating in over 70 countries. This agreement marks Insig AIs entry into the global advisory sector, a market with significant growth potential. The contract is based on a monthly subscription model, with expected value increases in 2026 as the solution is implemented across the clients business.
The client will utilize Insig AIs Generative Intelligence Engine (GIE) to automate the benchmarking of corporate reporting disclosures against international standards. GIE streamlines the process by converting documents into structured data, performing targeted analyses, and delivering auditable insights and recommendations. This automation enhances speed, reduces manual effort, and improves consistency in reporting.
Insig AI CEO Richard Bernstein highlighted the significance of this agreement, emphasizing its demonstration of the platforms commercial relevance and ability to support large, multinational clients. The deal is seen as a foundation for future recurring revenue growth in the advisory sector.
**Key Points**
Insig AI secures a new contract with a global advisory firm.
Entry into the global advisory sector, a new market vertical with growth potential.
Monthly subscription model with anticipated value increase in 2026.
Client will use Insig AIs Generative Intelligence Engine (GIE) for automated benchmarking of corporate reporting disclosures.
GIE enhances speed, reduces manual effort, and improves consistency in reporting.
Agreement demonstrates Insig AIs platform relevance and ability to support large clients.
Foundation for future recurring revenue growth in the advisory sector.
NewContract
APN logo
All News 06:01
APN

Final Results

Applied Nutrition Plc

**Summary of Applied Nutrition PLCs Final Results for FY25**
Applied Nutrition PLC, a leading sports nutrition, health, and wellness brand, announced its final results for the fiscal year ended July 31, 2025 (FY25), highlighting significant growth and strategic achievements.
**Financial Highlights**
**Revenue Growth** FY25 revenue increased by 24.2% to £107.1 million, surpassing IPO guidance and market expectations.
**EBITDA and Profit** Adjusted EBITDA rose by 18.8% to £30.9 million, and unadjusted operating profit grew by 18.6% to £28.1 million.
**Cash Flow** Strong free cash flow conversion of 72.4% and net cash of £18.5 million at the period end.
**Operational and Strategic Achievements**
**Global Expansion** Deepened relationships with existing customers and expanded into new geographies, including Latin America and Asia.
**Product Innovation** Launched new products like Vimto-flavored gels, hydration products, and Sparkling Collagen Protein Water.
**Capacity Increase** Completed a factory extension in August 2024, increasing revenue capacity to approximately £200 million.
**Current Trading and Outlook**
**Continued Momentum** Strong sales growth in Q4 FY25 continued into Q1 FY26, with positive market share trends.
**Investment in Growth** Plans to invest in additional capacity and capabilities to support continued growth.
**Prudent Outlook** Despite a strong Q1 FY26, the Board maintains current market expectations for FY26 due to the early stage of the financial year.
**CEO Commentary**
Thomas Ryder, CEO, emphasized over-delivering on IPO targets, strengthening customer relationships, and expanding globally. The company aims to become the worlds most trusted and innovative sports nutrition brand.
**Key Financial Metrics**
**Revenue** £107.1 million (FY24: £86.2 million)
**Adjusted EBITDA** £30.9 million (FY24: £26.0 million)
**Operating Profit** £28.1 million (FY24: £23.7 million)
**Free Cash Flow** £16.5 million (FY24: £7.1 million)
**Strategic Focus**
**B2B Model** Leveraging a low-risk, cost-effective B2B strategy with complementary D2C growth.
**Innovation** Continuous product development to meet consumer trends and expand market share.
**Global Presence** Expanding into new markets and strengthening distributor relationships.
**Future Investments**
**Production Expansion** Investing £2.0-£2.5 million to increase capacity to £300 million in revenue.
**New Distribution Facility** Planning a new global distribution facility and head office, expected to cost £3.5-£4.0 million.
**Conclusion**
Applied Nutrition PLC demonstrated robust financial and operational performance in FY25, exceeding expectations and positioning itself for continued growth in FY26. The company remains focused on innovation, global expansion, and strengthening its market position in the sports nutrition and wellness sector.
Here is the HTML table code comparing the financials and debt year on year for Applied Nutrition PLC:
MetricFY25 (£m)FY24 (£m)Change
Revenue107.186.224.2%
Gross Profit49.341.319.4%
Adjusted EBITDA30.926.018.8%
Adjusted Profit Before Tax30.225.717.5%
Free Cash Flow16.57.1132.4%
Net Cash18.518.7(1.1%)
Lease Liabilities (Current)0.60.3100.0%
Lease Liabilities (Non-Current)2.41.560.0%
Total Lease Liabilities3.01.866.7%
**Notes:** * The table compares key financial metrics and debt (lease liabilities) for Applied Nutrition PLC between FY25 and FY24. * Net Cash is calculated as Cash and Cash Equivalents minus Total Lease Liabilities. * The percentage change is calculated as ((FY25 - FY24) / FY24) * 100. * This table provides a snapshot of the company's financial performance and debt position, highlighting areas of growth and potential concerns.
RHIM logo
All News 06:01
RHIM

Trading Update

RHI Magnesita NV

<mark style="background-coloryellow"></mark>
CMCL logo
All News 06:01
CMCL

3rd Quarter Results

Caledonia Mining Corporation Plc

**Summary of Caledonia Mining Corporation Plcs 3rd Quarter 2025 Results**
Caledonia Mining Corporation Plc reported strong financial and operational results for the third quarter of 2025, driven by higher gold prices and increased sales. Key highlights include
1. **Financial Performance**
**Revenue**Increased by 52% to $71.4 million compared to Q3 2024, due to a 40% rise in the average realized gold price and an 8.7% increase in ounces sold.
**Gross Profit**Rose to $36.9 million, up from $19.3 million in Q3 2024.
**EBITDA**Surged by 162% to $33.5 million.
**Profit After Tax**Jumped 467% to $18.7 million.
**Free Cash Flow**Turned positive at $5.9 million, compared to a negative $2.4 million in Q3 2024.
2. **Operational Highlights**
**Gold Production**19,106 ounces from the Blanket Mine, with an additional 437 ounces from the Bilboes oxide mine.
**Gold Sales**20,355 ounces from Blanket, with 2,861 ounces of bullion on hand sold at the start of Q4.
**On-Mine Cost**$1,228/oz sold, with an all-in sustaining cost (AISC) of $1,937/oz sold.
**Ore Production**Increased tonnes broken and hoisted, with 229.5 thousand tonnes and 208.7 thousand tonnes, respectively.
3. **Safety and Sustainability**
Reported a fatality at Blanket Mine due to a secondary blasting accident, leading to a comprehensive review of safety procedures and training.
Group Lost Time Injury Frequency Rate (LTIFR) and Total Injury Frequency Rate (TIFR) showed slight increases, with ongoing efforts to improve safety.
4. **Exploration and Development**
Continued deep exploration drilling at Blanket, targeting down-dip continuations of mineralized zones, with encouraging results.
Surface trenching at Blanket identified anomalous gold values, leading to a 5,000-metre reverse circulation drilling program.
Motapa project exploration progressed, with 17,787 metres of reverse circulation drilling and 1,763.4 metres of diamond drilling completed.
5. **Capital Expenditure and Liquidity**
Total liquidity stood at $44.3 million, supporting ongoing capital projects.
Sustaining capital expenditure totaled $5.174 million, with non-sustaining capex at $1.585 million.
Completion of the new tailings storage facility (TSF) and ongoing mine development to access new areas.
6. **Corporate Developments**
Appointed Mr. July Ndlovu as an independent non-executive director.
Approved a quarterly dividend of 14 cents per share, payable on December 5, 2025.
Bilboes feasibility study expected to be released imminently.
7. **Guidance**
Maintained 2025 gold production guidance at 75,500 to 79,500 ounces.
Revised on-mine cost guidance to $1,150 to $1,250/oz sold and AISC to $1,850 to $1,950/oz sold, reflecting higher costs and royalties.
**CEO Commentary**
Mark Learmonth, CEO, emphasized the companys focus on stable production, disciplined capital investment, and modernization of operations at Blanket. Despite the tragic fatality, the company remains committed to safety and long-term growth, with strategic investments to strengthen its foundations.
**Conclusion**
Caledonia Mining Corporation Plc demonstrated robust performance in Q3 2025, with significant improvements in revenue, profitability, and cash flow, supported by strong gold prices and operational efficiency. The company continues to invest in exploration and development to sustain long-term growth while addressing safety concerns.
Here is the HTML table code comparing the financials and debt year on year for Caledonia Mining Corporation Plc: 25.9%
MetricQ3 2025Q3 2024% Change9-Months 20259-Months 2024% Change
Revenue (US$ 000)71,44046,86852.4%192,927135,50342.4%
EBITDA (US$ 000)33,49112,756162.6%95,50242,269
Profit after tax (US$ 000)18,6543,284468.0%53,41215,538243.8%
Free cash-flow (US$ 000)5,911(2,406)345.7%48,3289,767394.8%
Total liquidity (US$ 000)44,31838,000 (approx.)16.6%44,31838,000 (approx.)16.6%
Debt (Loans and borrowings, US$ 000)1,313 (non-current) + 1,281 (current)1,500 (non-current) + 1,174 (current)-12.5% (total)1,313 (non-current) + 1,281 (current)1,500 (non-current) + 1,174 (current)-12.5% (total)

Notes:

  • Total liquidity for Q3 2024 is approximated based on the available data.
  • Debt is represented by loans and borrowings, both non-current and current.
This table provides a comparison of key financials and debt metrics for Caledonia Mining Corporation Plc between Q3 2025 and Q3 2024, as well as for the 9-month periods ending September 30, 2025, and 2024. The data is extracted from the provided text.
CNSL logo
All News 06:01
CNSL

Half-year Report

Cambridge Nutritional Sciences plc

**Summary of Cambridge Nutritional Sciences PLC Half-Year Report (H1 2025)**
**Financial Highlights**
**Revenue Decline** Revenue decreased to £3.9 million (H1 2024: £4.1 million), primarily due to slower orders in key regions like mainland Europe, Africa/Middle East, and the Americas.
**Gross Margin Improvement** Gross margin increased to 67.7% (H1 2024: 65.4%), driven by production efficiencies and product mix optimization.
**Adjusted EBITDA** Remained positive at £0.1 million (H1 2024: £0.2 million), despite lower sales.
**Loss Before Tax** Increased to £0.4 million (H1 2024: £0.2 million) due to lower revenue and higher operational costs.
**Cash Position** Cash balance decreased to £3.6 million (H1 2024: £4.5 million) due to working capital outflows, capital expenditures, and financing activities.
**Operational Highlights**
**Sales Restructuring** The sales and marketing teams were restructured to focus on long-term growth, separating customer service, acquisition, and success functions from sales.
**Product Performance** FoodPrint® sales declined by 7% to £2.4 million, while Food Detective® sales dropped by 23% to £0.6 million. CNS Lab sales grew by 9% to £0.9 million.
**Regional Growth** Strong growth in the UK (6%) and India (33%), offset by declines in Europe, Americas, and Africa/Middle East.
**New Product Launch** Introduced Gut Detective®, a comprehensive stool biomarker panel for gut health, targeting UK practitioners.
**Outlook**
**Full-Year Sales** Expected to be lower than the previous year due to longer sales cycles and slower commercialization in key regions.
**Strategic Focus** Emphasis on converting pipeline opportunities into orders, particularly in the USA and Europe.
**Cost Management** Aim to remain profitable at the adjusted EBITDA level through careful cost management.
**Cash Investment** Continued investment in strategic initiatives like IVDR development and new products, despite a decline in cash position.
**Management Commentary**
**Challenges** Carolyn Rand, Chair, acknowledged a frustrating first half due to underperformance in key regions, despite strong growth in the UK and India.
**Optimism** Confidence in long-term growth prospects as the restructured sales team begins to deliver, supported by improved gross margins and operational efficiencies.
**Investor Engagement**
A live investor presentation was held on 10 November 2025, led by CEO James Cooper and CFO Ajay Patel, to discuss the interim results.
**Conclusion**
Cambridge Nutritional Sciences PLC faces short-term challenges with revenue declines in key regions but remains focused on long-term growth through sales restructuring, operational efficiencies, and strategic investments. The company is well-funded to execute its strategy and expects to return to growth with a healthy gross margin.
Here is the HTML table code comparing the financials and debt year on year for Cambridge Nutritional Sciences PLC: tr>
MetricH1 2025H1 2024Change
Revenue (£'000)3,8634,134(6.6%)
Gross Margin (%)67.7%65.4%+2.3%
Adjusted EBITDA (£'000)102227(55.1%)
Loss Before Tax (£'000)(397)(196)-102.6%
Cash Balance (£'000)3,5944,520(20.5%)
Total Debt (£'000)1633,964(95.9%)

Regional Revenue Breakdown

RegionH1 2025 (£'000)H1 2024 (£'000)Change (%)
UK894840+6%
Rest of Europe707952(25.7%)
Americas737805(8.4%)
India402302+33.1%
Asia796826(3.6%)
Africa and Middle East327408(19.8%)

Product Revenue Breakdown

ProductH1 2025 (£'000)H1 2024 (£'000)Change (%)
FoodPrint®2,3802,564(7%)
Food Detective®554717(22.7%)
CNS Laboratory Service910842+8.1%
Food ELISA/Other1911+72.7%
**Notes:** * Total Debt is calculated as the sum of Short-term borrowings, Lease liabilities, and Long-term borrowings (if any). * The percentage changes are calculated based on the absolute values. * The tables provide a clear comparison of the company's financials and debt position year on year, as well as a breakdown of revenue by region and product.
KNOS logo
All News 06:01
KNOS

Interim results

Kainos Group PLC

**Summary of Kainos Group plc Interim Results for H1 2026**
**Overview**
Kainos Group plc, a UK-based IT provider specializing in Digital Services, Workday Services, and Workday Products, reported strong interim results for the six months ended 30 September 2025. The company highlighted robust sales performance, revenue growth, and strategic advancements despite challenges like cost increases and investment in partnerships.
**Financial Highlights**
**Revenue**Increased by 7% to £196.1 million (H1 2025: £183.1 million), driven by organic growth and currency benefits.
**Adjusted Pre-Tax Profit**Declined by 16% to £32.0 million (H1 2025: £38.2 million) due to increased investment in the Workday partnership, National Insurance costs, and short-term use of contractors.
**Bookings**Surged by 27% to £227.9 million (H1 2025: £179.5 million), reflecting strong sales across all divisions.
**Contracted Backlog**Grew by 12% to £396.9 million (H1 2025: £354.1 million).
**Cash**Decreased by 30% to £105.5 million (H1 2025: £151.6 million) due to restructuring costs, working capital increases, and shareholder returns.
**Interim Dividend**Increased by 5% to 9.8p per share (H1 2025: 9.3p).
**Operational Highlights**
1. **Workday Products**
Revenue grew by 14% to £39.2 millionwith ARR up 19% to £77.5 million.
Achieved $100 million ARR milestone in July 2025, a significant SaaS industry benchmark.
Launched "Pay Transparency Analyzer powered by Kainos" in partnership with Workday, targeting EU compliance requirements.
2. **Digital Services**
Revenue increased by 6% to £103.5 million, driven by healthcare sector growth (33%) and North American expansion (152% revenue growth).
Secured major contracts in the UK public sector, including a £73 million deal with the DVSA.
3. **Workday Services**
Revenue grew by 4% to £53.4 million, with strong performance in North America and emerging markets like Australia and Latin America.
Bookings increased by 35% to £54.0 million.
4. **International Growth**
International revenue rose by 13% to £84.9 million, accounting for 43% of Group revenue.
5. **Customer Satisfaction**
Net Promoter Score (NPS) improved to 70 (H1 2025: 58), reflecting high customer satisfaction.
6. **Employee Engagement**
Employee retention remained strong at 92%, with engagement levels at 75%.
Recognized as one of the "50 Best Places to Work in the UK" by Glassdoor.
7. **AI Initiatives**
AI-related revenue grew by 6% to £15.3 million.
Launched Microsoft AI Centre of Excellence and developed AI solutions for Workday and other platforms.
**Strategic Developments**
Acquired Davis Pier, a Canadian consultancy, to strengthen North American presence.
Deepened Workday partnership with exclusive resell arrangements and joint product launches.
Continued investment in R&D, with expenditure rising by 12% to £8.6 million.
**Outlook**
Expects continued growth in Workday Products, Digital Services, and Workday Services in H2 2026.
Maintains full-year profit expectations in line with consensus forecasts.
Focused on long-term growth drivers, including AI adoption and digital transformation.
**Shareholder Returns**
Completed £30 million share buyback programme and announced a new £30 million programme.
**Conclusion**
Kainos demonstrated resilience and growth in H1 2026, underpinned by strong sales execution, strategic partnerships, and expansion into key markets. Despite short-term profit pressures, the company remains confident in its long-term strategy and ability to deliver shareholder value.
Here is the HTML table code comparing the financials and debt year on year for Kainos Group plc:
MetricH1 2026H1 2025Change
Revenue£196.1m£183.1m+7%
Statutory profit before tax£28.4m£34.2m-17%
Adjusted pre-tax profit£32.0m£38.2m-16%
Diluted earnings per share16.7p20.1p-17%
Adjusted diluted earnings per share18.9p22.5p-16%
Interim dividend per share9.8p9.3p+5%
Bookings£227.9m£179.5m+27%
Product annual recurring revenue (ARR)£77.5m£65.1m+19%
Contracted backlog£396.9m£354.1m+12%
Cash£105.5m£151.6m-30%

Note: Debt information is not explicitly mentioned in the provided text. However, the cash balance can be considered as a proxy for debt, with a decrease in cash potentially indicating an increase in debt or other liabilities.

Key Observations:

  • Revenue increased by 7% year-on-year, driven by strong sales performance across all divisions.
  • Profit metrics (statutory and adjusted) decreased by 16-17%, primarily due to increased costs associated with the Workday partnership, National Insurance, and contractor usage.
  • Bookings and contracted backlog increased significantly, indicating strong future revenue potential.
  • Cash balance decreased by 30%, partly due to share buybacks, acquisition of Davis Pier, and increased working capital requirements.
This table provides a clear comparison of key financial metrics between H1 2026 and H1 2025, highlighting the changes and trends in Kainos Group plc's financial performance.
CHG logo
All News 06:01
CHG

Post-close and contract wins update

Chemring Group PLC

**Chemring Group PLC Trading Statement Summary (November 10, 2025)**
Chemring Group PLC provided a post-close and contract wins update for FY25, highlighting key financial and operational developments as it enters its close period for the year ended October 31, 2025.
**Financial Performance**
**FY25 adjusted operating profit** is in line with analyst expectations, with a margin of ~14.7% (up from 14.2% in FY24).
**Adjusted EPS** is expected to benefit from slightly lower finance costs.
**Net debt** as of October 312025is ~£95m.
**Order book** increased to £1.3bn (from £1.0bn in October 2024), with order intake for the year at ~£781m.
**Operational Highlights**
**Energetics segment** outperformed, driven by increased demand for propellants, energetic materials, and high-integrity devices.
**Sensors & Information segment** faced softness due to delayed UK Government orders, particularly in National Security and Defence.
**Countermeasures & Energetics** achieved ~95% order cover for FY26, while **Sensors & Information** secured ~47% cover.
**Significant Contract Wins**
1. **Energetics**
Chemring Energetic Devices (US) won a $65m sole-source framework contract for aircrew flight equipment <mark style="background-color:yellow">test</mark>er systems.
Chemring Energetics UK secured a £24m order for rocket motors and components for the Next Generation Light Anti-Tank Weapon (NLAW) system.
Chemring Nobel (Norway) won a £23m order from Nammo for HMX products.
2. **Countermeasures**
Chemring Australia won a US$35m contract for airborne countermeasures.
Chemring Countermeasures UK secured a £15m order from NATO for airborne countermeasures.
3. **Sensors & Information**
Roke won over £40m in National Security contract renewals and a £20m contract for Project ZODIAC, a critical technology program for the British Army.
**Strategic Developments**
**Landguard Group acquisition** completed in August 2025, enhancing Roke’s growth and operational synergies.
**Alloy Surfaces** (US countermeasures business) will be reported as a discontinued operation due to declining demand from the US Department of Defense. Strategic options, including a potential sale, are under consideration.
**Outlook**
Robust market conditions and increasing demand for technology-driven solutions and traditional defence capabilities are expected to sustain growth.
Full-year results for FY25 will be released on December 9, 2025.
**Directorate Change**
Fiona MacAulay, Senior Independent Director, will step down at the February 2026 AGM after completing her second three-year term.
Chemring remains focused on its niche markets, leveraging R&D investments to meet evolving customer needs in defence, security, and aerospace.
NewContract
ONDO logo
All News 06:01
ONDO

Contract Win

Ondo InsurTech PLC

**Summary**
Ondo InsurTech PLC (LSEONDO), a leader in claims prevention technology for home insurers, announced on November 10, 2025, that Westfield Insurance has signed a contract to deploy 10,000 LeakBot devices and connected services for homeowners in Ohio, Indiana, and Pennsylvania. This partnership aims to proactively prevent water damage claims, reduce loss costs, and enhance customer experience. LeakBot, a patented self-install solution, detects leaks and alerts homeowners via a mobile app, offering access to expert engineers for repairs. Independent research shows LeakBot can reduce water damage claim costs by up to 70%. Westfield’s initiative aligns with its investment in innovative technology, while Ondo continues to expand its global partnerships with 25 insurance carriers. Ondo holds the London Stock Exchange’s Green Economy Mark, underscoring its commitment to sustainable solutions. Westfield, a leading U.S. insurer founded in 1848, strengthens its position with this collaboration, further solidifying Ondo’s role as a global leader in claims prevention technology.
NewContract
ABDX logo
All News 06:01
ABDX

c.US$2m multiplex diagnostic test contract win

Abingdon Health Plc

**Summary**
Abingdon Health plc, a leading developer and manufacturer of rapid diagnostic <mark style="background-color:yellow">test</mark>s, has secured a **c.US$2 million contract** with a US-based company for the development, scale-up, and technical transfer of a **semi-quantitative, multiplex lateral flow test system**. The 24-month project will be executed under a Master Service Agreement (MSA) and conducted at Abingdon Health’s Madison, Wisconsin facilities. This win highlights the strength of Abingdon Health’s **Contract Development and Manufacturing Organisation (CDMO)** services, which support customers from concept to commercial success. The contract underscores the company’s expanded U.S. manufacturing capabilities, bolstered by a recent £3.2 million fundraise, and its ability to meet growing demand from U.S.-based clients. Dr. Chris Hand, Executive Chairman, emphasized the value of Abingdon’s dual U.S. and U.K. sites and the versatility of lateral flow technology in measuring multiple analytes semi-quantitatively. The announcement reinforces Abingdon Health’s position as a comprehensive CDMO provider in the med-tech sector.
NewContract
AI 0 news titles 0

No news for this category in the selected date range.

Acquisitions 7 news titles 7
Agreement 0 news titles 0

No news for this category in the selected date range.

Approvals 3 news titles 3
GPE logo
Approvals 06:01
GPE

GPE gets planning approval for Whittington House

GREAT PORTLAND ESTATES PLC

**Summary**
Great Portland Estates PLC (GPE) has secured planning approval from Camden Council for the refurbishment of Whittington House, a 74,500 sq ft HQ building in Londons West End (WC1). The project, expected to complete in Q1 2027, will transform the building into a sustainable, Grade A workspace with eight floors of offices, a new rooftop terrace, and a pavilion. Located near Tottenham Court Road Elizabeth Line station, the development is part of a larger 220,000 sq ft cluster of prime office space, including the Gable Building, Courtyard Building, and 31/34 Alfred Place. Trevor Phyo, GPEs Senior Development Manager, highlighted the projects significance in preserving architectural heritage while creating a modern workplace. This approval strengthens GPEs HQ portfolio and underscores its commitment to delivering exceptional spaces in prime London locations.
Approvals
Authorisation 0 news titles 0

No news for this category in the selected date range.

Awards 1 news title 1
ELCO logo
Awards 06:01
ELCO

Industry Award Wins

Eleco PLC

**Summary**
Eleco plc (AIMELCO), a specialist software provider for the built environment, has been honored with two prestigious awards at the Construction Computing Awards 2025: *Company of the Year* and *Project Management Software of the Year* for the twelfth consecutive year. Jonathan Hunter, CEO of Eleco plc, expressed gratitude for the recognition, attributing the success to the company’s talented teams and their dedication to meeting customer needs in a competitive and fast-evolving industry. Eleco operates internationally through brands like Elecosoft, BestOutcome, and PEMAC, offering software solutions across the building lifecycle, from planning and design to asset and facilities management. The announcement was distributed via RNS Reach, a non-regulatory press release service of the London Stock Exchange.
Awards
BTC 0 news titles 0

No news for this category in the selected date range.

Blockchain 0 news titles 0

No news for this category in the selected date range.

Breakthrough 0 news titles 0

No news for this category in the selected date range.

BuyBack 1 news title 1
0RPR logo
BuyBack 06:28
0RPR

Share buyback programme - week 45

Ringkjoebing Landbobank A/S

**Summary of Ringkjøbing Landbobank A/S Share Buyback Programme - Week 45 (10 November 2025)**
Ringkjøbing Landbobank A/S announced the progress of its share buyback programme for Week 45, part of a larger initiative running from 2 June 2025 to 30 January 2026. The programme aims to repurchase up to DKK 1,000 million worth of shares, with a maximum of 1,600,000 shares, in compliance with EU regulations (Regulation No. 596/2014 and Delegated Regulation No. 2016/1052).
**Key Highlights**
1. **Total Shares Bought Back (Week 45)** 20,500 shares.
2. **Average Purchase Price (Week 45)** DKK 1,456.89.
3. **Total Programme Expenditure (Week 45):** DKK 707,975,445.
4. **Cumulative Shares Bought Back (Since Programme Start):** 910,877 shares (3.59% of share capital).
5. **Cumulative Programme Expenditure** DKK 1,207,964,151.
**Transactions Breakdown (Week 45)**
**3 November 2025:** 3500 shares at DKK 1472.79.
**4 November 2025:** 3500 shares at DKK 1470.64.
**5 November 2025:** 3500 shares at DKK 1466.14.
**6 November 2025:** 3500 shares at DKK 1456.89.
**7 November 2025:** 5000 shares at DKK 1428.41.
The bank now holds 910,877 of its own shares, excluding trading portfolio and customer investments. Detailed transaction data is attached to the corporate announcement for transparency.
**CEO Statement**
John Fisker, CEO, confirmed adherence to regulatory requirements and provided detailed transaction records for stakeholder review.
This update reflects the bank’s ongoing commitment to its share buyback strategy, with Week 45 transactions contributing to the programme’s overall progress.
BuyBack
Cancellations 1 news title 1
CashOffer 0 news titles 0

No news for this category in the selected date range.

Collaborate 0 news titles 0

No news for this category in the selected date range.

ContractWin 0 news titles 0

No news for this category in the selected date range.

Covid-19 0 news titles 0

No news for this category in the selected date range.

Deals 0 news titles 0

No news for this category in the selected date range.

Diamond 0 news titles 0

No news for this category in the selected date range.

DirectorDealing 30 news titles 30
BAG logo
DirectorDealing 15:45
BAG

Director/PDMR Shareholding

A.G.Barr PLC

<mark style="background-coloryellow">Purchase</mark> of shares in relation to the A.G. BARR All Employee Share Ownership Plan (AESOP) dividend reinvestment
BAG logo
DirectorDealing 15:39
BAG

Director/PDMR Shareholding

A.G.Barr PLC

<mark style="background-coloryellow">Purchase</mark> of shares in relation to the A.G. BARR All Employee Share Ownership Plan (AESOP). The AESOP is an all-employee trust arrangement approved by HM Revenue and Customs, under which employees are able to buy ordinary shares in the Company of 4⅙p each, using deductions from salary in each pay period, and receive allocations of matching free ordinary shares.
RR. logo
DirectorDealing 15:31
RR.

Director/PDMR Shareholding

RR.

Rolls-Royce Holdings plc (the Company) announces that the following person(s) discharging managerial responsibilities <mark style="background-color:yellow">purchase</mark>d ordinary shares of 20p each in the Company by way of a monthly share purchase plan.
ACSO logo
DirectorDealing 14:41
ACSO

Director/PDMR Shareholding

Accesso Technology Group PLC

<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
MAB logo
DirectorDealing 13:01
MAB

Director/PDMR Shareholding

Mitchells & Butlers PLC

<mark style="background-coloryellow">Purchase</mark> of partnership shares by the SIP Trustee (notified on 10 November 2025)
DGE logo
DirectorDealing 12:21
DGE

Director/PDMR Shareholding

Diageo PLC

Share <mark style="background-coloryellow">purchase</mark> under an arrangement with the Company
MSLH logo
DirectorDealing 09:31
MSLH

Director/PDMR Shareholding

Marshalls PLC

<mark style="background-coloryellow">Purchase</mark> of shares under the Marshalls plc Employee Share Purchase Plan 2015
MSLH logo
DirectorDealing 09:30
MSLH

Director/PDMR Shareholding

Marshalls PLC

<mark style="background-coloryellow">Purchase</mark> of shares under the Marshalls plc Employee Share Purchase Plan 2015
MSLH logo
DirectorDealing 09:28
MSLH

Director/PDMR Shareholding

Marshalls PLC

<mark style="background-coloryellow">Purchase</mark> of shares under the Marshalls plc Employee Share Purchase Plan 2015
ECEL logo
DirectorDealing 08:31
ECEL

Director/PDMR Shareholding

Eurocell PLC

Eurocell plc announces that, pursuant to the Non-executive Directors Share <mark style="background-color:yellow">Purchase</mark> Plan which was announced on 3 February 2023, five directors have purchased shares in the Company on 7 November 2025. As previously announced, following these trades, Will Trumans membership of the scheme has now ceased.
ASAI logo
DirectorDealing 06:58
ASAI

Director/PDMR Shareholding

ASA International Group PLC

<mark style="background-coloryellow">Purchase</mark> of ordinary shares
SEEN logo
DirectorDealing 06:01
SEEN

Director dealing

SEEEN PLC

<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares into SIPP
Discovery 0 news titles 0

No news for this category in the selected date range.

Exceeded 0 news titles 0

No news for this category in the selected date range.

FCA 0 news titles 0

No news for this category in the selected date range.

FDA 1 news title 1
AVG logo
FDA 06:01
AVG

Adaptix receives FDA 510(K) clearance

Avingtrans Plc

**Summary**
Avingtrans plc, a UK-based company specializing in critical components and systems for energy, medical, and industrial sectors, announced that its subsidiary Adaptix Limited has received FDA 510(k) clearance for its orthopaedic 3D imaging product, the Adaptix Ortho350. This compact, mobile, low-dose Digital Tomosynthesis (DT) system is designed for point-of-care use, offering fast, affordable, and high-quality 3D X-ray imaging for upper and lower extremity diagnostics. The clearance enables Adaptix to enter the U.S. human healthcare imaging market, marking a significant milestone in its mission to revolutionize radiology. The Ortho350 delivers superior image clarity compared to 2D X-ray systems while reducing radiation exposure, improving diagnostic accuracy, and enhancing patient outcomes. Adaptix has already commercialized similar technology in veterinary and industrial markets, and this FDA approval validates the technologys commercial potential. Company executives expressed excitement about the strong interest from healthcare providers and the systems potential impact on primary care, intensive care, and emergency departments.
FDA
Grants 0 news titles 0

No news for this category in the selected date range.

InvestmentPlan 0 news titles 0

No news for this category in the selected date range.

JV 0 news titles 0

No news for this category in the selected date range.

Launch 1 news title 1
SYM logo
Launch 06:01
SYM

New product launch, South Korea

Symphony Environmental Technologies plc

**Summary**
Symphony Environmental Technologies Plc, a global leader in sustainable plastic and rubber technologies, announced that its exclusive South Korean distributor, CPST, in collaboration with PetRize Inc., won the Grand Prize (Early Startup Division) at the Gyeonggi Province Pet Startup Competition for the **Wanspapa biodegradable Dog Waste Bag**. This product incorporates Symphonys **d2w® biodegradable masterbatch**, offering a sustainable solution for pet owners without compromising performance. Key advantages of Wanspapa include ASTM D6954-24 open-air biodegradability (leaving no microplastics), easy-open design, tear strength, reduced odor, lower CO₂ emissions, and South Korean manufacturing for quality assurance.
PetRize Inc., a startup with ambitious international expansion plans, aims to target major retail chains in Korea, North America, Canada, and Australia. Symphony’s CEO, Michael Laurier, praised the achievement, highlighting the success of their technology and CPST’s efforts. This milestone underscores the commercial and environmental value of Symphony’s d2w technology in the global pet market.
The announcement is non-regulatory and does not significantly impact Symphony’s performance expectations. Symphony continues to innovate with its d2p and NbR brands, offering diverse plastic technologies globally, with products available in nearly 100 countries.
**Key Points**
**Product** Wanspapa biodegradable Dog Waste Bag using Symphony’s d2w technology.
**Award** Grand Prize at Korean Pet Startup Competition.
**Advantages:** Biodegradabilityconveniencereliabilitysustainabilityand quality.
**Expansion** PetRize targets international markets, including North America, Canada, and Australia.
**Impact** Demonstrates Symphony’s technology’s commercial and environmental value.
Launch
Litigation 0 news titles 0

No news for this category in the selected date range.

NewContract 6 news titles 6
TIDE logo
NewContract 14:15
TIDE

Contract Renewal with Major Global Retailer

Crimson Tide plc

**Summary**
Crimson Tide PLC, the provider of the mpro5 process management app, has secured a three-year contract extension worth £3.88 million with one of the world’s largest retailers. This renewal strengthens the company’s long-standing relationship with the retailer, which already uses mpro5 across 3,000+ locations in the UK and Ireland, with potential for further international expansion. The platform has become integral to the retailer’s in-store operations, consolidating multiple systems and driving efficiency. The agreement highlights mpro5’s role as a mission-critical tool for large enterprises and aligns with the retailer’s digital transformation strategy. CEO Jon Clarke emphasized the renewal’s significance, noting it reflects the company’s successful customer retention and growth strategy, with four of its top five revenue customers renewing contracts this financial year. This positions Crimson Tide for future growth.
NewContract
EYE logo
NewContract 06:01
EYE

Multi-year contract with North American retailer

Eagle Eye Solutions Group plc

**Summary**
Eagle Eye Solutions Group PLC, a leading SaaS and AI technology company, has secured a five-year contract with one of North Americas largest independent food retailers. The retailer, operating over 450 stores across Texas and Mexico under five brands, will utilize Eagle Eyes AIR platform for promotional capabilities within its eCommerce business. The contract, expected to go live in the first half of 2026, marks a significant opportunity for Eagle Eye to deepen its relationship with the retailer and expand its presence in the North American market.
This win underscores Eagle Eyes strategic focus on North America, the worlds largest loyalty and promotions market, and reflects early success from initiatives aimed at growing the sales pipeline and improving conversion rates. Tim Mason, Eagle Eyes CEO, emphasized the companys commitment to accelerating growth in the region through enhanced personalization and customer experience.
Eagle Eyes technology, recognized by industry leaders like Gartner and Forrester, powers over 1 billion personalized offers weekly and manages 700 million loyalty member wallets globally. The company’s growing client base includes major retailers such as Loblaws, Tesco, and Carrefour. This contract reinforces Eagle Eyes position as a key player in real-time, omnichannel, and personalized marketing solutions.
NewContract
INSG logo
NewContract 06:01
INSG

New contract with global advisory firm

Insig Ai PLC

**Summary**
Insig AI Plc (AIMINSG), a leader in AI-led analytics and machine-learning solutions, has secured a new contract with a global advisory firm operating in over 70 countries. This agreement marks Insig AIs entry into the global advisory sector, a market with significant growth potential. The contract is based on a monthly subscription model, with expected value increases in 2026 as the solution is implemented across the clients business.
The client will utilize Insig AIs Generative Intelligence Engine (GIE) to automate the benchmarking of corporate reporting disclosures against international standards. GIE streamlines the process by converting documents into structured data, performing targeted analyses, and delivering auditable insights and recommendations. This automation enhances speed, reduces manual effort, and improves consistency in reporting.
Insig AI CEO Richard Bernstein highlighted the significance of this agreement, emphasizing its demonstration of the platforms commercial relevance and ability to support large, multinational clients. The deal is seen as a foundation for future recurring revenue growth in the advisory sector.
**Key Points**
Insig AI secures a new contract with a global advisory firm.
Entry into the global advisory sector, a new market vertical with growth potential.
Monthly subscription model with anticipated value increase in 2026.
Client will use Insig AIs Generative Intelligence Engine (GIE) for automated benchmarking of corporate reporting disclosures.
GIE enhances speed, reduces manual effort, and improves consistency in reporting.
Agreement demonstrates Insig AIs platform relevance and ability to support large clients.
Foundation for future recurring revenue growth in the advisory sector.
NewContract
CHG logo
NewContract 06:01
CHG

Post-close and contract wins update

Chemring Group PLC

**Chemring Group PLC Trading Statement Summary (November 10, 2025)**
Chemring Group PLC provided a post-close and contract wins update for FY25, highlighting key financial and operational developments as it enters its close period for the year ended October 31, 2025.
**Financial Performance**
**FY25 adjusted operating profit** is in line with analyst expectations, with a margin of ~14.7% (up from 14.2% in FY24).
**Adjusted EPS** is expected to benefit from slightly lower finance costs.
**Net debt** as of October 312025is ~£95m.
**Order book** increased to £1.3bn (from £1.0bn in October 2024), with order intake for the year at ~£781m.
**Operational Highlights**
**Energetics segment** outperformed, driven by increased demand for propellants, energetic materials, and high-integrity devices.
**Sensors & Information segment** faced softness due to delayed UK Government orders, particularly in National Security and Defence.
**Countermeasures & Energetics** achieved ~95% order cover for FY26, while **Sensors & Information** secured ~47% cover.
**Significant Contract Wins**
1. **Energetics**
Chemring Energetic Devices (US) won a $65m sole-source framework contract for aircrew flight equipment <mark style="background-color:yellow">test</mark>er systems.
Chemring Energetics UK secured a £24m order for rocket motors and components for the Next Generation Light Anti-Tank Weapon (NLAW) system.
Chemring Nobel (Norway) won a £23m order from Nammo for HMX products.
2. **Countermeasures**
Chemring Australia won a US$35m contract for airborne countermeasures.
Chemring Countermeasures UK secured a £15m order from NATO for airborne countermeasures.
3. **Sensors & Information**
Roke won over £40m in National Security contract renewals and a £20m contract for Project ZODIAC, a critical technology program for the British Army.
**Strategic Developments**
**Landguard Group acquisition** completed in August 2025, enhancing Roke’s growth and operational synergies.
**Alloy Surfaces** (US countermeasures business) will be reported as a discontinued operation due to declining demand from the US Department of Defense. Strategic options, including a potential sale, are under consideration.
**Outlook**
Robust market conditions and increasing demand for technology-driven solutions and traditional defence capabilities are expected to sustain growth.
Full-year results for FY25 will be released on December 9, 2025.
**Directorate Change**
Fiona MacAulay, Senior Independent Director, will step down at the February 2026 AGM after completing her second three-year term.
Chemring remains focused on its niche markets, leveraging R&D investments to meet evolving customer needs in defence, security, and aerospace.
NewContract
ONDO logo
NewContract 06:01
ONDO

Contract Win

Ondo InsurTech PLC

**Summary**
Ondo InsurTech PLC (LSEONDO), a leader in claims prevention technology for home insurers, announced on November 10, 2025, that Westfield Insurance has signed a contract to deploy 10,000 LeakBot devices and connected services for homeowners in Ohio, Indiana, and Pennsylvania. This partnership aims to proactively prevent water damage claims, reduce loss costs, and enhance customer experience. LeakBot, a patented self-install solution, detects leaks and alerts homeowners via a mobile app, offering access to expert engineers for repairs. Independent research shows LeakBot can reduce water damage claim costs by up to 70%. Westfield’s initiative aligns with its investment in innovative technology, while Ondo continues to expand its global partnerships with 25 insurance carriers. Ondo holds the London Stock Exchange’s Green Economy Mark, underscoring its commitment to sustainable solutions. Westfield, a leading U.S. insurer founded in 1848, strengthens its position with this collaboration, further solidifying Ondo’s role as a global leader in claims prevention technology.
NewContract
ABDX logo
NewContract 06:01
ABDX

c.US$2m multiplex diagnostic test contract win

Abingdon Health Plc

**Summary**
Abingdon Health plc, a leading developer and manufacturer of rapid diagnostic <mark style="background-color:yellow">test</mark>s, has secured a **c.US$2 million contract** with a US-based company for the development, scale-up, and technical transfer of a **semi-quantitative, multiplex lateral flow test system**. The 24-month project will be executed under a Master Service Agreement (MSA) and conducted at Abingdon Health’s Madison, Wisconsin facilities. This win highlights the strength of Abingdon Health’s **Contract Development and Manufacturing Organisation (CDMO)** services, which support customers from concept to commercial success. The contract underscores the company’s expanded U.S. manufacturing capabilities, bolstered by a recent £3.2 million fundraise, and its ability to meet growing demand from U.S.-based clients. Dr. Chris Hand, Executive Chairman, emphasized the value of Abingdon’s dual U.S. and U.K. sites and the versatility of lateral flow technology in measuring multiple analytes semi-quantitatively. The announcement reinforces Abingdon Health’s position as a comprehensive CDMO provider in the med-tech sector.
NewContract
Offers 3 news titles 3
Offtake 0 news titles 0

No news for this category in the selected date range.

Orders 0 news titles 0

No news for this category in the selected date range.

Partner 0 news titles 0

No news for this category in the selected date range.

Patents 0 news titles 0

No news for this category in the selected date range.

Placing 5 news titles 5
Positive 0 news titles 0

No news for this category in the selected date range.

Proposals 0 news titles 0

No news for this category in the selected date range.

Reports 5 news titles 5
CNSL logo
Reports 06:01
CNSL

Half-year Report

Cambridge Nutritional Sciences plc

**Summary of Cambridge Nutritional Sciences PLC Half-Year Report (H1 2025)**
**Financial Highlights**
**Revenue Decline** Revenue decreased to £3.9 million (H1 2024: £4.1 million), primarily due to slower orders in key regions like mainland Europe, Africa/Middle East, and the Americas.
**Gross Margin Improvement** Gross margin increased to 67.7% (H1 2024: 65.4%), driven by production efficiencies and product mix optimization.
**Adjusted EBITDA** Remained positive at £0.1 million (H1 2024: £0.2 million), despite lower sales.
**Loss Before Tax** Increased to £0.4 million (H1 2024: £0.2 million) due to lower revenue and higher operational costs.
**Cash Position** Cash balance decreased to £3.6 million (H1 2024: £4.5 million) due to working capital outflows, capital expenditures, and financing activities.
**Operational Highlights**
**Sales Restructuring** The sales and marketing teams were restructured to focus on long-term growth, separating customer service, acquisition, and success functions from sales.
**Product Performance** FoodPrint® sales declined by 7% to £2.4 million, while Food Detective® sales dropped by 23% to £0.6 million. CNS Lab sales grew by 9% to £0.9 million.
**Regional Growth** Strong growth in the UK (6%) and India (33%), offset by declines in Europe, Americas, and Africa/Middle East.
**New Product Launch** Introduced Gut Detective®, a comprehensive stool biomarker panel for gut health, targeting UK practitioners.
**Outlook**
**Full-Year Sales** Expected to be lower than the previous year due to longer sales cycles and slower commercialization in key regions.
**Strategic Focus** Emphasis on converting pipeline opportunities into orders, particularly in the USA and Europe.
**Cost Management** Aim to remain profitable at the adjusted EBITDA level through careful cost management.
**Cash Investment** Continued investment in strategic initiatives like IVDR development and new products, despite a decline in cash position.
**Management Commentary**
**Challenges** Carolyn Rand, Chair, acknowledged a frustrating first half due to underperformance in key regions, despite strong growth in the UK and India.
**Optimism** Confidence in long-term growth prospects as the restructured sales team begins to deliver, supported by improved gross margins and operational efficiencies.
**Investor Engagement**
A live investor presentation was held on 10 November 2025, led by CEO James Cooper and CFO Ajay Patel, to discuss the interim results.
**Conclusion**
Cambridge Nutritional Sciences PLC faces short-term challenges with revenue declines in key regions but remains focused on long-term growth through sales restructuring, operational efficiencies, and strategic investments. The company is well-funded to execute its strategy and expects to return to growth with a healthy gross margin.
Here is the HTML table code comparing the financials and debt year on year for Cambridge Nutritional Sciences PLC: tr>
MetricH1 2025H1 2024Change
Revenue (£'000)3,8634,134(6.6%)
Gross Margin (%)67.7%65.4%+2.3%
Adjusted EBITDA (£'000)102227(55.1%)
Loss Before Tax (£'000)(397)(196)-102.6%
Cash Balance (£'000)3,5944,520(20.5%)
Total Debt (£'000)1633,964(95.9%)

Regional Revenue Breakdown

RegionH1 2025 (£'000)H1 2024 (£'000)Change (%)
UK894840+6%
Rest of Europe707952(25.7%)
Americas737805(8.4%)
India402302+33.1%
Asia796826(3.6%)
Africa and Middle East327408(19.8%)

Product Revenue Breakdown

ProductH1 2025 (£'000)H1 2024 (£'000)Change (%)
FoodPrint®2,3802,564(7%)
Food Detective®554717(22.7%)
CNS Laboratory Service910842+8.1%
Food ELISA/Other1911+72.7%
**Notes:** * Total Debt is calculated as the sum of Short-term borrowings, Lease liabilities, and Long-term borrowings (if any). * The percentage changes are calculated based on the absolute values. * The tables provide a clear comparison of the company's financials and debt position year on year, as well as a breakdown of revenue by region and product.
Results 11 news titles 11
APN logo
Results 06:01
APN

Final Results

Applied Nutrition Plc

**Summary of Applied Nutrition PLCs Final Results for FY25**
Applied Nutrition PLC, a leading sports nutrition, health, and wellness brand, announced its final results for the fiscal year ended July 31, 2025 (FY25), highlighting significant growth and strategic achievements.
**Financial Highlights**
**Revenue Growth** FY25 revenue increased by 24.2% to £107.1 million, surpassing IPO guidance and market expectations.
**EBITDA and Profit** Adjusted EBITDA rose by 18.8% to £30.9 million, and unadjusted operating profit grew by 18.6% to £28.1 million.
**Cash Flow** Strong free cash flow conversion of 72.4% and net cash of £18.5 million at the period end.
**Operational and Strategic Achievements**
**Global Expansion** Deepened relationships with existing customers and expanded into new geographies, including Latin America and Asia.
**Product Innovation** Launched new products like Vimto-flavored gels, hydration products, and Sparkling Collagen Protein Water.
**Capacity Increase** Completed a factory extension in August 2024, increasing revenue capacity to approximately £200 million.
**Current Trading and Outlook**
**Continued Momentum** Strong sales growth in Q4 FY25 continued into Q1 FY26, with positive market share trends.
**Investment in Growth** Plans to invest in additional capacity and capabilities to support continued growth.
**Prudent Outlook** Despite a strong Q1 FY26, the Board maintains current market expectations for FY26 due to the early stage of the financial year.
**CEO Commentary**
Thomas Ryder, CEO, emphasized over-delivering on IPO targets, strengthening customer relationships, and expanding globally. The company aims to become the worlds most trusted and innovative sports nutrition brand.
**Key Financial Metrics**
**Revenue** £107.1 million (FY24: £86.2 million)
**Adjusted EBITDA** £30.9 million (FY24: £26.0 million)
**Operating Profit** £28.1 million (FY24: £23.7 million)
**Free Cash Flow** £16.5 million (FY24: £7.1 million)
**Strategic Focus**
**B2B Model** Leveraging a low-risk, cost-effective B2B strategy with complementary D2C growth.
**Innovation** Continuous product development to meet consumer trends and expand market share.
**Global Presence** Expanding into new markets and strengthening distributor relationships.
**Future Investments**
**Production Expansion** Investing £2.0-£2.5 million to increase capacity to £300 million in revenue.
**New Distribution Facility** Planning a new global distribution facility and head office, expected to cost £3.5-£4.0 million.
**Conclusion**
Applied Nutrition PLC demonstrated robust financial and operational performance in FY25, exceeding expectations and positioning itself for continued growth in FY26. The company remains focused on innovation, global expansion, and strengthening its market position in the sports nutrition and wellness sector.
Here is the HTML table code comparing the financials and debt year on year for Applied Nutrition PLC:
MetricFY25 (£m)FY24 (£m)Change
Revenue107.186.224.2%
Gross Profit49.341.319.4%
Adjusted EBITDA30.926.018.8%
Adjusted Profit Before Tax30.225.717.5%
Free Cash Flow16.57.1132.4%
Net Cash18.518.7(1.1%)
Lease Liabilities (Current)0.60.3100.0%
Lease Liabilities (Non-Current)2.41.560.0%
Total Lease Liabilities3.01.866.7%
**Notes:** * The table compares key financial metrics and debt (lease liabilities) for Applied Nutrition PLC between FY25 and FY24. * Net Cash is calculated as Cash and Cash Equivalents minus Total Lease Liabilities. * The percentage change is calculated as ((FY25 - FY24) / FY24) * 100. * This table provides a snapshot of the company's financial performance and debt position, highlighting areas of growth and potential concerns.
CMCL logo
Results 06:01
CMCL

3rd Quarter Results

Caledonia Mining Corporation Plc

**Summary of Caledonia Mining Corporation Plcs 3rd Quarter 2025 Results**
Caledonia Mining Corporation Plc reported strong financial and operational results for the third quarter of 2025, driven by higher gold prices and increased sales. Key highlights include
1. **Financial Performance**
**Revenue**Increased by 52% to $71.4 million compared to Q3 2024, due to a 40% rise in the average realized gold price and an 8.7% increase in ounces sold.
**Gross Profit**Rose to $36.9 million, up from $19.3 million in Q3 2024.
**EBITDA**Surged by 162% to $33.5 million.
**Profit After Tax**Jumped 467% to $18.7 million.
**Free Cash Flow**Turned positive at $5.9 million, compared to a negative $2.4 million in Q3 2024.
2. **Operational Highlights**
**Gold Production**19,106 ounces from the Blanket Mine, with an additional 437 ounces from the Bilboes oxide mine.
**Gold Sales**20,355 ounces from Blanket, with 2,861 ounces of bullion on hand sold at the start of Q4.
**On-Mine Cost**$1,228/oz sold, with an all-in sustaining cost (AISC) of $1,937/oz sold.
**Ore Production**Increased tonnes broken and hoisted, with 229.5 thousand tonnes and 208.7 thousand tonnes, respectively.
3. **Safety and Sustainability**
Reported a fatality at Blanket Mine due to a secondary blasting accident, leading to a comprehensive review of safety procedures and training.
Group Lost Time Injury Frequency Rate (LTIFR) and Total Injury Frequency Rate (TIFR) showed slight increases, with ongoing efforts to improve safety.
4. **Exploration and Development**
Continued deep exploration drilling at Blanket, targeting down-dip continuations of mineralized zones, with encouraging results.
Surface trenching at Blanket identified anomalous gold values, leading to a 5,000-metre reverse circulation drilling program.
Motapa project exploration progressed, with 17,787 metres of reverse circulation drilling and 1,763.4 metres of diamond drilling completed.
5. **Capital Expenditure and Liquidity**
Total liquidity stood at $44.3 million, supporting ongoing capital projects.
Sustaining capital expenditure totaled $5.174 million, with non-sustaining capex at $1.585 million.
Completion of the new tailings storage facility (TSF) and ongoing mine development to access new areas.
6. **Corporate Developments**
Appointed Mr. July Ndlovu as an independent non-executive director.
Approved a quarterly dividend of 14 cents per share, payable on December 5, 2025.
Bilboes feasibility study expected to be released imminently.
7. **Guidance**
Maintained 2025 gold production guidance at 75,500 to 79,500 ounces.
Revised on-mine cost guidance to $1,150 to $1,250/oz sold and AISC to $1,850 to $1,950/oz sold, reflecting higher costs and royalties.
**CEO Commentary**
Mark Learmonth, CEO, emphasized the companys focus on stable production, disciplined capital investment, and modernization of operations at Blanket. Despite the tragic fatality, the company remains committed to safety and long-term growth, with strategic investments to strengthen its foundations.
**Conclusion**
Caledonia Mining Corporation Plc demonstrated robust performance in Q3 2025, with significant improvements in revenue, profitability, and cash flow, supported by strong gold prices and operational efficiency. The company continues to invest in exploration and development to sustain long-term growth while addressing safety concerns.
Here is the HTML table code comparing the financials and debt year on year for Caledonia Mining Corporation Plc: 25.9%
MetricQ3 2025Q3 2024% Change9-Months 20259-Months 2024% Change
Revenue (US$ 000)71,44046,86852.4%192,927135,50342.4%
EBITDA (US$ 000)33,49112,756162.6%95,50242,269
Profit after tax (US$ 000)18,6543,284468.0%53,41215,538243.8%
Free cash-flow (US$ 000)5,911(2,406)345.7%48,3289,767394.8%
Total liquidity (US$ 000)44,31838,000 (approx.)16.6%44,31838,000 (approx.)16.6%
Debt (Loans and borrowings, US$ 000)1,313 (non-current) + 1,281 (current)1,500 (non-current) + 1,174 (current)-12.5% (total)1,313 (non-current) + 1,281 (current)1,500 (non-current) + 1,174 (current)-12.5% (total)

Notes:

  • Total liquidity for Q3 2024 is approximated based on the available data.
  • Debt is represented by loans and borrowings, both non-current and current.
This table provides a comparison of key financials and debt metrics for Caledonia Mining Corporation Plc between Q3 2025 and Q3 2024, as well as for the 9-month periods ending September 30, 2025, and 2024. The data is extracted from the provided text.
KNOS logo
Results 06:01
KNOS

Interim results

Kainos Group PLC

**Summary of Kainos Group plc Interim Results for H1 2026**
**Overview**
Kainos Group plc, a UK-based IT provider specializing in Digital Services, Workday Services, and Workday Products, reported strong interim results for the six months ended 30 September 2025. The company highlighted robust sales performance, revenue growth, and strategic advancements despite challenges like cost increases and investment in partnerships.
**Financial Highlights**
**Revenue**Increased by 7% to £196.1 million (H1 2025: £183.1 million), driven by organic growth and currency benefits.
**Adjusted Pre-Tax Profit**Declined by 16% to £32.0 million (H1 2025: £38.2 million) due to increased investment in the Workday partnership, National Insurance costs, and short-term use of contractors.
**Bookings**Surged by 27% to £227.9 million (H1 2025: £179.5 million), reflecting strong sales across all divisions.
**Contracted Backlog**Grew by 12% to £396.9 million (H1 2025: £354.1 million).
**Cash**Decreased by 30% to £105.5 million (H1 2025: £151.6 million) due to restructuring costs, working capital increases, and shareholder returns.
**Interim Dividend**Increased by 5% to 9.8p per share (H1 2025: 9.3p).
**Operational Highlights**
1. **Workday Products**
Revenue grew by 14% to £39.2 millionwith ARR up 19% to £77.5 million.
Achieved $100 million ARR milestone in July 2025, a significant SaaS industry benchmark.
Launched "Pay Transparency Analyzer powered by Kainos" in partnership with Workday, targeting EU compliance requirements.
2. **Digital Services**
Revenue increased by 6% to £103.5 million, driven by healthcare sector growth (33%) and North American expansion (152% revenue growth).
Secured major contracts in the UK public sector, including a £73 million deal with the DVSA.
3. **Workday Services**
Revenue grew by 4% to £53.4 million, with strong performance in North America and emerging markets like Australia and Latin America.
Bookings increased by 35% to £54.0 million.
4. **International Growth**
International revenue rose by 13% to £84.9 million, accounting for 43% of Group revenue.
5. **Customer Satisfaction**
Net Promoter Score (NPS) improved to 70 (H1 2025: 58), reflecting high customer satisfaction.
6. **Employee Engagement**
Employee retention remained strong at 92%, with engagement levels at 75%.
Recognized as one of the "50 Best Places to Work in the UK" by Glassdoor.
7. **AI Initiatives**
AI-related revenue grew by 6% to £15.3 million.
Launched Microsoft AI Centre of Excellence and developed AI solutions for Workday and other platforms.
**Strategic Developments**
Acquired Davis Pier, a Canadian consultancy, to strengthen North American presence.
Deepened Workday partnership with exclusive resell arrangements and joint product launches.
Continued investment in R&D, with expenditure rising by 12% to £8.6 million.
**Outlook**
Expects continued growth in Workday Products, Digital Services, and Workday Services in H2 2026.
Maintains full-year profit expectations in line with consensus forecasts.
Focused on long-term growth drivers, including AI adoption and digital transformation.
**Shareholder Returns**
Completed £30 million share buyback programme and announced a new £30 million programme.
**Conclusion**
Kainos demonstrated resilience and growth in H1 2026, underpinned by strong sales execution, strategic partnerships, and expansion into key markets. Despite short-term profit pressures, the company remains confident in its long-term strategy and ability to deliver shareholder value.
Here is the HTML table code comparing the financials and debt year on year for Kainos Group plc:
MetricH1 2026H1 2025Change
Revenue£196.1m£183.1m+7%
Statutory profit before tax£28.4m£34.2m-17%
Adjusted pre-tax profit£32.0m£38.2m-16%
Diluted earnings per share16.7p20.1p-17%
Adjusted diluted earnings per share18.9p22.5p-16%
Interim dividend per share9.8p9.3p+5%
Bookings£227.9m£179.5m+27%
Product annual recurring revenue (ARR)£77.5m£65.1m+19%
Contracted backlog£396.9m£354.1m+12%
Cash£105.5m£151.6m-30%

Note: Debt information is not explicitly mentioned in the provided text. However, the cash balance can be considered as a proxy for debt, with a decrease in cash potentially indicating an increase in debt or other liabilities.

Key Observations:

  • Revenue increased by 7% year-on-year, driven by strong sales performance across all divisions.
  • Profit metrics (statutory and adjusted) decreased by 16-17%, primarily due to increased costs associated with the Workday partnership, National Insurance, and contractor usage.
  • Bookings and contracted backlog increased significantly, indicating strong future revenue potential.
  • Cash balance decreased by 30%, partly due to share buybacks, acquisition of Davis Pier, and increased working capital requirements.
This table provides a clear comparison of key financial metrics between H1 2026 and H1 2025, highlighting the changes and trends in Kainos Group plc's financial performance.
Significant 0 news titles 0

No news for this category in the selected date range.

Speculation 0 news titles 0

No news for this category in the selected date range.

Strategic 0 news titles 0

No news for this category in the selected date range.

Suspension 0 news titles 0

No news for this category in the selected date range.

TR1 40 news titles 40
JCGI logo
TR1 15:48
JCGI

Holding(s) in Company

JPMorgan China Growth & Income PLC

TR1 Buy
['City of London Investment Management Company Limited', '19.130000', '18.020000']
SST logo
TR1 15:42
SST

Holding(s) in Company

The Scottish Oriental Smaller Companies Trust plc

TR1 Buy
['City of London Investment Management Company Limited', '13.050000', '12.090000']
WIZZ logo
TR1 15:39
WIZZ

Holding(s) in Company

Wizz Air Holdings PLC

<mark style="background-coloryellow">TR1</mark> Buy
['Barclays PLC', '0.030000', 'Below minimum threshold ']
NFG logo
TR1 15:31
NFG

Holding(s) in Company

Next 15 Group PLC

TR1 Buy
['Liontrust Investment Partners LLP', '9.855000', '10.977700']
AWE logo
TR1 15:02
AWE

Holding(s) in Company

Alphawave IP Group PLC

<mark style="background-coloryellow">TR1</mark> Buy
['JPMorgan Chase & Co.', 'Below minimum threshold', '1.344761']
GNC logo
TR1 14:01
GNC

Holding(s) in Company

Greencore Group

TR1 Buy
['UBS Group AG-Investment Bank & Global Wealth Management', '3.980700', '0.000000']
BGEU logo
TR1 13:56
BGEU

Holding(s) in Company

Baillie Gifford European Growth Trust PLC

TR1 Buy
['Allspring Global Investments Holdings.', '21.031000', '20.633000']
GAMA logo
TR1 13:01
GAMA

Holding(s) in Company

Gamma Communications PLC

TR1 Buy
['Allianz Global Investors GmbH', '10.800000', '11.010000']
PCGH logo
TR1 12:47
PCGH

Holding(s) in Company

Polar Capital Global Healthcare Trust plc

TR1 Buy
['Rathbones Investment Management Ltd', '13.978800', '14.003100']
AMS logo
TR1 11:39
AMS

Holding(s) in Company

Advanced Medical Solutions Group plc

TR1 Buy
['Richard Griffiths and controlled holdings', '0.53', '0.37']
APN logo
TR1 10:51
APN

Holding(s) in Company

Applied Nutrition Plc

TR1 Buy
['UBS Group AG-Investment Bank & Global Wealth Management', '0.000000', '5.016711']
JUP logo
TR1 10:16
JUP

Holding(s) in Company

Jupiter Fund Management Plc

TR1 Buy
['SILCHESTER INTERNATIONAL INVESTORS LLP', '15.970000', '16.997000']
EWI logo
TR1 09:39
EWI

Holding(s) in Company

Edinburgh Worldwide Investment Trust plc

TR1 Buy
['Saba Capital Management, L.P.', '25.051939', '24.887687']
DOM logo
TR1 09:01
DOM

Holding(s) in Company

Domino’s Pizza Group PLC

TR1 Buy
['The Capital Group Companies, Inc.', '9.730380', '10.615023']
WIZZ logo
TR1 08:47
WIZZ

Holding(s) in Company

Wizz Air Holdings PLC

<mark style="background-coloryellow">TR1</mark> Buy
['Barclays PLC', 'Below minimum threshold', '0.030000']
Takeover 1 news title 1
Understanding 0 news titles 0

No news for this category in the selected date range.

Updates 12 news titles 12
RHIM logo
Updates 06:01
RHIM

Trading Update

RHI Magnesita NV

<mark style="background-coloryellow"></mark>
Vaccine 0 news titles 0

No news for this category in the selected date range.

Wins 0 news titles 0

No news for this category in the selected date range.

Worth 0 news titles 0

No news for this category in the selected date range.

Trading Floor
2025-11-10
536
Headlines
49
News Types
News Flow 536 items today
AI
0
Acquisitions
7
Agreement
0
Approvals
3
Authorisation
0
Awards
1
BTC
0
Blockchain
0
Breakthrough
0
BuyBack
1
Cancellations
1
CashOffer
0
Collaborate
0
ContractWin
0
Covid-19
0
Deals
0
Diamond
0
DirectorDealing
30
Discovery
0
Exceeded
0
FCA
0
FDA
1
Grants
0
InvestmentPlan
0
JV
0
Launch
1
Litigation
0
NewContract
6
Offers
3
Offtake
0
Orders
0
Partner
0
Patents
0
Placing
5
Positive
0
Proposals
0
Reports
5
Results
11
Significant
0
Speculation
0
Strategic
0
Suspension
0
TR1
40
Takeover
1
Understanding
0
Updates
12
Vaccine
0
Wins
0
Worth
0
Loading LSTM picks & Results Radar…

My Watchlist

RNS Alerts

Tap any ticker row to open its mobile stock terminal. Today’s move updates from the same stock-terminal feed.

No tickers on your watchlist yet.

RNS Alerts

Push Notifications
Alert me when a watchlist ticker gets new RNS
Email Alerts
2025-11-10 30 picks
80 Positive
TIDE
Crimson Tide plc
Positive
Contract Renewal with Major Global Retailer
**Summary:** Crimson Tide PLC, the provider of the mpro5 process management app, has secured a three-year contract extension worth £3.88 million with one of the world’s largest retailers. This renewal strengthens the company’s long-standing relationship with the retailer, which already uses mpro5 across 3,000+ locations in the UK and Ireland, with potential for further international expansion. The platform has become integral to the retailer’s in-store operations, consolidating multiple systems and driving efficiency. The agreement highlights mpro5’s role as a mission-critical tool for large enterprises and aligns with the retailer’s digital transformation strategy. CEO Jon Clarke emphasized the renewal’s significance, noting it reflects the company’s successful customer retention and growth strategy, with four of its top five revenue customers renewing contracts this financial year. This positions Crimson Tide for future growth.
**Summary**
Crimson Tide PLC, the provider of the mpro5 process management app, has secured a three-year contract extension worth £3.88 million with one of the world’s largest retailers. This renewal strengthens the company’s long-standing relationship with the retailer, which already uses mpro5 across 3,000+ locations in the UK and Ireland, with potential for further international expansion. The platform has become integral to the retailer’s in-store operations, consolidating multiple systems and driving efficiency. The agreement highlights mpro5’s role as a mission-critical tool for large enterprises and aligns with the retailer’s digital transformation strategy. CEO Jon Clarke emphasized the renewal’s significance, noting it reflects the company’s successful customer retention and growth strategy, with four of its top five revenue customers renewing contracts this financial year. This positions Crimson Tide for future growth.
NewContract
14:15
Open Terminal ↗ RNS Source
80 Positive
0RPR
Ringkjoebing Landbobank A/S
Positive
Share buyback programme - week 45
**Summary of Ringkjøbing Landbobank A/S Share Buyback Programme - Week 45 (10 November 2025)** Ringkjøbing Landbobank A/S announced the progress of its share buyback programme for Week 45, part of a larger initiative running from 2 June 2025 to 30 January 2026. The programme aims to repurchase up to DKK 1,000 million worth of shares, with a maximum of 1,600,000 shares, in compliance with EU regulations (Regulation No. 596/2014 and Delegated Regulation No. 2016/1052). **Key Highlights:** 1. **Total Shares Bought Back (Week 45):** 20,500 shares. 2. **Average Purchase Price (Week 45):** DKK 1,456.89. 3. **Total Programme Expenditure (Week 45):** DKK 707,975,445. 4. **Cumulative Shares Bought Back (Since Programme Start):** 910,877 shares (3.59% of share capital). 5. **Cumulative Programme Expenditure:** DKK 1,207,964,151. **Transactions Breakdown (Week 45):** - **3 November 2025:** 3,500 shares at DKK 1,472.79. - **4 November 2025:** 3,500 shares at DKK 1,470.64. - **5 November 2025:** 3,500 shares at DKK 1,466.14. - **6 November 2025:** 3,500 shares at DKK 1,456.89. - **7 November 2025:** 5,000 shares at DKK 1,428.41. The bank now holds 910,877 of its own shares, excluding trading portfolio and customer investments. Detailed transaction data is attached to the corporate announcement for transparency. **CEO Statement:** John Fisker, CEO, confirmed adherence to regulatory requirements and provided detailed transaction records for stakeholder review. This update reflects the bank’s ongoing commitment to its share buyback strategy, with Week 45 transactions contributing to the programme’s overall progress.
**Summary of Ringkjøbing Landbobank A/S Share Buyback Programme - Week 45 (10 November 2025)**
Ringkjøbing Landbobank A/S announced the progress of its share buyback programme for Week 45, part of a larger initiative running from 2 June 2025 to 30 January 2026. The programme aims to repurchase up to DKK 1,000 million worth of shares, with a maximum of 1,600,000 shares, in compliance with EU regulations (Regulation No. 596/2014 and Delegated Regulation No. 2016/1052).
**Key Highlights**
1. **Total Shares Bought Back (Week 45)** 20,500 shares.
2. **Average Purchase Price (Week 45)** DKK 1,456.89.
3. **Total Programme Expenditure (Week 45):** DKK 707,975,445.
4. **Cumulative Shares Bought Back (Since Programme Start):** 910,877 shares (3.59% of share capital).
5. **Cumulative Programme Expenditure** DKK 1,207,964,151.
**Transactions Breakdown (Week 45)**
**3 November 2025:** 3500 shares at DKK 1472.79.
**4 November 2025:** 3500 shares at DKK 1470.64.
**5 November 2025:** 3500 shares at DKK 1466.14.
**6 November 2025:** 3500 shares at DKK 1456.89.
**7 November 2025:** 5000 shares at DKK 1428.41.
The bank now holds 910,877 of its own shares, excluding trading portfolio and customer investments. Detailed transaction data is attached to the corporate announcement for transparency.
**CEO Statement**
John Fisker, CEO, confirmed adherence to regulatory requirements and provided detailed transaction records for stakeholder review.
This update reflects the bank’s ongoing commitment to its share buyback strategy, with Week 45 transactions contributing to the programme’s overall progress.
BuyBack
06:28
Open Terminal ↗ RNS Source
80 Positive
SYM
Symphony Environmental Technologies plc
Positive
New product launch, South Korea
**Summary:** Symphony Environmental Technologies Plc, a global leader in sustainable plastic and rubber technologies, announced that its exclusive South Korean distributor, CPST, in collaboration with PetRize Inc., won the Grand Prize (Early Startup Division) at the Gyeonggi Province Pet Startup Competition for the **Wanspapa biodegradable Dog Waste Bag**. This product incorporates Symphonys **d2w® biodegradable masterbatch**, offering a sustainable solution for pet owners without compromising performance. Key advantages of Wanspapa include ASTM D6954-24 open-air biodegradability (leaving no microplastics), easy-open design, tear strength, reduced odor, lower CO₂ emissions, and South Korean manufacturing for quality assurance. PetRize Inc., a startup with ambitious international expansion plans, aims to target major retail chains in Korea, North America, Canada, and Australia. Symphony’s CEO, Michael Laurier, praised the achievement, highlighting the success of their technology and CPST’s efforts. This milestone underscores the commercial and environmental value of Symphony’s d2w technology in the global pet market. The announcement is non-regulatory and does not significantly impact Symphony’s performance expectations. Symphony continues to innovate with its d2p and NbR brands, offering diverse plastic technologies globally, with products available in nearly 100 countries. **Key Points:** - **Product:** Wanspapa biodegradable Dog Waste Bag using Symphony’s d2w technology. - **Award:** Grand Prize at Korean Pet Startup Competition. - **Advantages:** Biodegradability, convenience, reliability, sustainability, and quality. - **Expansion:** PetRize targets international markets, including North America, Canada, and Australia. - **Impact:** Demonstrates Symphony’s technology’s commercial and environmental value.
**Summary**
Symphony Environmental Technologies Plc, a global leader in sustainable plastic and rubber technologies, announced that its exclusive South Korean distributor, CPST, in collaboration with PetRize Inc., won the Grand Prize (Early Startup Division) at the Gyeonggi Province Pet Startup Competition for the **Wanspapa biodegradable Dog Waste Bag**. This product incorporates Symphonys **d2w® biodegradable masterbatch**, offering a sustainable solution for pet owners without compromising performance. Key advantages of Wanspapa include ASTM D6954-24 open-air biodegradability (leaving no microplastics), easy-open design, tear strength, reduced odor, lower CO₂ emissions, and South Korean manufacturing for quality assurance.
PetRize Inc., a startup with ambitious international expansion plans, aims to target major retail chains in Korea, North America, Canada, and Australia. Symphony’s CEO, Michael Laurier, praised the achievement, highlighting the success of their technology and CPST’s efforts. This milestone underscores the commercial and environmental value of Symphony’s d2w technology in the global pet market.
The announcement is non-regulatory and does not significantly impact Symphony’s performance expectations. Symphony continues to innovate with its d2p and NbR brands, offering diverse plastic technologies globally, with products available in nearly 100 countries.
**Key Points**
**Product** Wanspapa biodegradable Dog Waste Bag using Symphony’s d2w technology.
**Award** Grand Prize at Korean Pet Startup Competition.
**Advantages:** Biodegradabilityconveniencereliabilitysustainabilityand quality.
**Expansion** PetRize targets international markets, including North America, Canada, and Australia.
**Impact** Demonstrates Symphony’s technology’s commercial and environmental value.
Launch
06:01
Open Terminal ↗ RNS Source
80 Positive
EYE
Eagle Eye Solutions Group plc
Positive
Multi-year contract with North American retailer
**Summary:** Eagle Eye Solutions Group PLC, a leading SaaS and AI technology company, has secured a five-year contract with one of North Americas largest independent food retailers. The retailer, operating over 450 stores across Texas and Mexico under five brands, will utilize Eagle Eyes AIR platform for promotional capabilities within its eCommerce business. The contract, expected to go live in the first half of 2026, marks a significant opportunity for Eagle Eye to deepen its relationship with the retailer and expand its presence in the North American market. This win underscores Eagle Eyes strategic focus on North America, the worlds largest loyalty and promotions market, and reflects early success from initiatives aimed at growing the sales pipeline and improving conversion rates. Tim Mason, Eagle Eyes CEO, emphasized the companys commitment to accelerating growth in the region through enhanced personalization and customer experience. Eagle Eyes technology, recognized by industry leaders like Gartner and Forrester, powers over 1 billion personalized offers weekly and manages 700 million loyalty member wallets globally. The company’s growing client base includes major retailers such as Loblaws, Tesco, and Carrefour. This contract reinforces Eagle Eyes position as a key player in real-time, omnichannel, and personalized marketing solutions.
**Summary**
Eagle Eye Solutions Group PLC, a leading SaaS and AI technology company, has secured a five-year contract with one of North Americas largest independent food retailers. The retailer, operating over 450 stores across Texas and Mexico under five brands, will utilize Eagle Eyes AIR platform for promotional capabilities within its eCommerce business. The contract, expected to go live in the first half of 2026, marks a significant opportunity for Eagle Eye to deepen its relationship with the retailer and expand its presence in the North American market.
This win underscores Eagle Eyes strategic focus on North America, the worlds largest loyalty and promotions market, and reflects early success from initiatives aimed at growing the sales pipeline and improving conversion rates. Tim Mason, Eagle Eyes CEO, emphasized the companys commitment to accelerating growth in the region through enhanced personalization and customer experience.
Eagle Eyes technology, recognized by industry leaders like Gartner and Forrester, powers over 1 billion personalized offers weekly and manages 700 million loyalty member wallets globally. The company’s growing client base includes major retailers such as Loblaws, Tesco, and Carrefour. This contract reinforces Eagle Eyes position as a key player in real-time, omnichannel, and personalized marketing solutions.
NewContract
06:01
Open Terminal ↗ RNS Source
80 Positive
ELCO
Eleco PLC
Positive
Industry Award Wins
**Summary:** Eleco plc (AIM: ELCO), a specialist software provider for the built environment, has been honored with two prestigious awards at the Construction Computing Awards 2025: *Company of the Year* and *Project Management Software of the Year* for the twelfth consecutive year. Jonathan Hunter, CEO of Eleco plc, expressed gratitude for the recognition, attributing the success to the company’s talented teams and their dedication to meeting customer needs in a competitive and fast-evolving industry. Eleco operates internationally through brands like Elecosoft, BestOutcome, and PEMAC, offering software solutions across the building lifecycle, from planning and design to asset and facilities management. The announcement was distributed via RNS Reach, a non-regulatory press release service of the London Stock Exchange.
**Summary**
Eleco plc (AIMELCO), a specialist software provider for the built environment, has been honored with two prestigious awards at the Construction Computing Awards 2025: *Company of the Year* and *Project Management Software of the Year* for the twelfth consecutive year. Jonathan Hunter, CEO of Eleco plc, expressed gratitude for the recognition, attributing the success to the company’s talented teams and their dedication to meeting customer needs in a competitive and fast-evolving industry. Eleco operates internationally through brands like Elecosoft, BestOutcome, and PEMAC, offering software solutions across the building lifecycle, from planning and design to asset and facilities management. The announcement was distributed via RNS Reach, a non-regulatory press release service of the London Stock Exchange.
Awards
06:01
Open Terminal ↗ RNS Source
80 Positive
GPE
GREAT PORTLAND ESTATES PLC
Positive
GPE gets planning approval for Whittington House
**Summary:** Great Portland Estates PLC (GPE) has secured planning approval from Camden Council for the refurbishment of Whittington House, a 74,500 sq ft HQ building in Londons West End (WC1). The project, expected to complete in Q1 2027, will transform the building into a sustainable, Grade A workspace with eight floors of offices, a new rooftop terrace, and a pavilion. Located near Tottenham Court Road Elizabeth Line station, the development is part of a larger 220,000 sq ft cluster of prime office space, including the Gable Building, Courtyard Building, and 31/34 Alfred Place. Trevor Phyo, GPEs Senior Development Manager, highlighted the projects significance in preserving architectural heritage while creating a modern workplace. This approval strengthens GPEs HQ portfolio and underscores its commitment to delivering exceptional spaces in prime London locations.
**Summary**
Great Portland Estates PLC (GPE) has secured planning approval from Camden Council for the refurbishment of Whittington House, a 74,500 sq ft HQ building in Londons West End (WC1). The project, expected to complete in Q1 2027, will transform the building into a sustainable, Grade A workspace with eight floors of offices, a new rooftop terrace, and a pavilion. Located near Tottenham Court Road Elizabeth Line station, the development is part of a larger 220,000 sq ft cluster of prime office space, including the Gable Building, Courtyard Building, and 31/34 Alfred Place. Trevor Phyo, GPEs Senior Development Manager, highlighted the projects significance in preserving architectural heritage while creating a modern workplace. This approval strengthens GPEs HQ portfolio and underscores its commitment to delivering exceptional spaces in prime London locations.
Approvals
06:01
Open Terminal ↗ RNS Source
80 Positive
AVG
Avingtrans Plc
Positive
Adaptix receives FDA 510(K) clearance
**Summary:** Avingtrans plc, a UK-based company specializing in critical components and systems for energy, medical, and industrial sectors, announced that its subsidiary Adaptix Limited has received FDA 510(k) clearance for its orthopaedic 3D imaging product, the Adaptix Ortho350. This compact, mobile, low-dose Digital Tomosynthesis (DT) system is designed for point-of-care use, offering fast, affordable, and high-quality 3D X-ray imaging for upper and lower extremity diagnostics. The clearance enables Adaptix to enter the U.S. human healthcare imaging market, marking a significant milestone in its mission to revolutionize radiology. The Ortho350 delivers superior image clarity compared to 2D X-ray systems while reducing radiation exposure, improving diagnostic accuracy, and enhancing patient outcomes. Adaptix has already commercialized similar technology in veterinary and industrial markets, and this FDA approval validates the technologys commercial potential. Company executives expressed excitement about the strong interest from healthcare providers and the systems potential impact on primary care, intensive care, and emergency departments.
**Summary**
Avingtrans plc, a UK-based company specializing in critical components and systems for energy, medical, and industrial sectors, announced that its subsidiary Adaptix Limited has received FDA 510(k) clearance for its orthopaedic 3D imaging product, the Adaptix Ortho350. This compact, mobile, low-dose Digital Tomosynthesis (DT) system is designed for point-of-care use, offering fast, affordable, and high-quality 3D X-ray imaging for upper and lower extremity diagnostics. The clearance enables Adaptix to enter the U.S. human healthcare imaging market, marking a significant milestone in its mission to revolutionize radiology. The Ortho350 delivers superior image clarity compared to 2D X-ray systems while reducing radiation exposure, improving diagnostic accuracy, and enhancing patient outcomes. Adaptix has already commercialized similar technology in veterinary and industrial markets, and this FDA approval validates the technologys commercial potential. Company executives expressed excitement about the strong interest from healthcare providers and the systems potential impact on primary care, intensive care, and emergency departments.
FDA
06:01
Open Terminal ↗ RNS Source
80 Positive
INSG
Insig Ai PLC
Positive
New contract with global advisory firm
**Summary:** Insig AI Plc (AIM: INSG), a leader in AI-led analytics and machine-learning solutions, has secured a new contract with a global advisory firm operating in over 70 countries. This agreement marks Insig AIs entry into the global advisory sector, a market with significant growth potential. The contract is based on a monthly subscription model, with expected value increases in 2026 as the solution is implemented across the clients business. The client will utilize Insig AIs Generative Intelligence Engine (GIE) to automate the benchmarking of corporate reporting disclosures against international standards. GIE streamlines the process by converting documents into structured data, performing targeted analyses, and delivering auditable insights and recommendations. This automation enhances speed, reduces manual effort, and improves consistency in reporting. Insig AI CEO Richard Bernstein highlighted the significance of this agreement, emphasizing its demonstration of the platforms commercial relevance and ability to support large, multinational clients. The deal is seen as a foundation for future recurring revenue growth in the advisory sector. **Key Points:** - Insig AI secures a new contract with a global advisory firm. - Entry into the global advisory sector, a new market vertical with growth potential. - Monthly subscription model with anticipated value increase in 2026. - Client will use Insig AIs Generative Intelligence Engine (GIE) for automated benchmarking of corporate reporting disclosures. - GIE enhances speed, reduces manual effort, and improves consistency in reporting. - Agreement demonstrates Insig AIs platform relevance and ability to support large clients. - Foundation for future recurring revenue growth in the advisory sector.
**Summary**
Insig AI Plc (AIMINSG), a leader in AI-led analytics and machine-learning solutions, has secured a new contract with a global advisory firm operating in over 70 countries. This agreement marks Insig AIs entry into the global advisory sector, a market with significant growth potential. The contract is based on a monthly subscription model, with expected value increases in 2026 as the solution is implemented across the clients business.
The client will utilize Insig AIs Generative Intelligence Engine (GIE) to automate the benchmarking of corporate reporting disclosures against international standards. GIE streamlines the process by converting documents into structured data, performing targeted analyses, and delivering auditable insights and recommendations. This automation enhances speed, reduces manual effort, and improves consistency in reporting.
Insig AI CEO Richard Bernstein highlighted the significance of this agreement, emphasizing its demonstration of the platforms commercial relevance and ability to support large, multinational clients. The deal is seen as a foundation for future recurring revenue growth in the advisory sector.
**Key Points**
Insig AI secures a new contract with a global advisory firm.
Entry into the global advisory sector, a new market vertical with growth potential.
Monthly subscription model with anticipated value increase in 2026.
Client will use Insig AIs Generative Intelligence Engine (GIE) for automated benchmarking of corporate reporting disclosures.
GIE enhances speed, reduces manual effort, and improves consistency in reporting.
Agreement demonstrates Insig AIs platform relevance and ability to support large clients.
Foundation for future recurring revenue growth in the advisory sector.
NewContract
06:01
Open Terminal ↗ RNS Source
93 Strong Beat
APN
Applied Nutrition Plc
Positive
Final Results
**Summary of Applied Nutrition PLCs Final Results for FY25** Applied Nutrition PLC, a leading sports nutrition, health, and wellness brand, announced its final results for the fiscal year ended July 31, 2025 (FY25), highlighting significant growth and strategic achievements. **Financial Highlights:** - **Revenue Growth:** FY25 revenue increased by 24.2% to £107.1 million, surpassing IPO guidance and market expectations. - **EBITDA and Profit:** Adjusted EBITDA rose by 18.8% to £30.9 million, and unadjusted operating profit grew by 18.6% to £28.1 million. - **Cash Flow:** Strong free cash flow conversion of 72.4% and net cash of £18.5 million at the period end. **Operational and Strategic Achievements:** - **Global Expansion:** Deepened relationships with existing customers and expanded into new geographies, including Latin America and Asia. - **Product Innovation:** Launched new products like Vimto-flavored gels, hydration products, and Sparkling Collagen Protein Water. - **Capacity Increase:** Completed a factory extension in August 2024, increasing revenue capacity to approximately £200 million. **Current Trading and Outlook:** - **Continued Momentum:** Strong sales growth in Q4 FY25 continued into Q1 FY26, with positive market share trends. - **Investment in Growth:** Plans to invest in additional capacity and capabilities to support continued growth. - **Prudent Outlook:** Despite a strong Q1 FY26, the Board maintains current market expectations for FY26 due to the early stage of the financial year. **CEO Commentary:** Thomas Ryder, CEO, emphasized over-delivering on IPO targets, strengthening customer relationships, and expanding globally. The company aims to become the worlds most trusted and innovative sports nutrition brand. **Key Financial Metrics:** - **Revenue:** £107.1 million (FY24: £86.2 million) - **Adjusted EBITDA:** £30.9 million (FY24: £26.0 million) - **Operating Profit:** £28.1 million (FY24: £23.7 million) - **Free Cash Flow:** £16.5 million (FY24: £7.1 million) **Strategic Focus:** - **B2B Model:** Leveraging a low-risk, cost-effective B2B strategy with complementary D2C growth. - **Innovation:** Continuous product development to meet consumer trends and expand market share. - **Global Presence:** Expanding into new markets and strengthening distributor relationships. **Future Investments:** - **Production Expansion:** Investing £2.0-£2.5 million to increase capacity to £300 million in revenue. - **New Distribution Facility:** Planning a new global distribution facility and head office, expected to cost £3.5-£4.0 million. **Conclusion:** Applied Nutrition PLC demonstrated robust financial and operational performance in FY25, exceeding expectations and positioning itself for continued growth in FY26. The company remains focused on innovation, global expansion, and strengthening its market position in the sports nutrition and wellness sector.
**Summary of Applied Nutrition PLCs Final Results for FY25**
Applied Nutrition PLC, a leading sports nutrition, health, and wellness brand, announced its final results for the fiscal year ended July 31, 2025 (FY25), highlighting significant growth and strategic achievements.
**Financial Highlights**
**Revenue Growth** FY25 revenue increased by 24.2% to £107.1 million, surpassing IPO guidance and market expectations.
**EBITDA and Profit** Adjusted EBITDA rose by 18.8% to £30.9 million, and unadjusted operating profit grew by 18.6% to £28.1 million.
**Cash Flow** Strong free cash flow conversion of 72.4% and net cash of £18.5 million at the period end.
**Operational and Strategic Achievements**
**Global Expansion** Deepened relationships with existing customers and expanded into new geographies, including Latin America and Asia.
**Product Innovation** Launched new products like Vimto-flavored gels, hydration products, and Sparkling Collagen Protein Water.
**Capacity Increase** Completed a factory extension in August 2024, increasing revenue capacity to approximately £200 million.
**Current Trading and Outlook**
**Continued Momentum** Strong sales growth in Q4 FY25 continued into Q1 FY26, with positive market share trends.
**Investment in Growth** Plans to invest in additional capacity and capabilities to support continued growth.
**Prudent Outlook** Despite a strong Q1 FY26, the Board maintains current market expectations for FY26 due to the early stage of the financial year.
**CEO Commentary**
Thomas Ryder, CEO, emphasized over-delivering on IPO targets, strengthening customer relationships, and expanding globally. The company aims to become the worlds most trusted and innovative sports nutrition brand.
**Key Financial Metrics**
**Revenue** £107.1 million (FY24: £86.2 million)
**Adjusted EBITDA** £30.9 million (FY24: £26.0 million)
**Operating Profit** £28.1 million (FY24: £23.7 million)
**Free Cash Flow** £16.5 million (FY24: £7.1 million)
**Strategic Focus**
**B2B Model** Leveraging a low-risk, cost-effective B2B strategy with complementary D2C growth.
**Innovation** Continuous product development to meet consumer trends and expand market share.
**Global Presence** Expanding into new markets and strengthening distributor relationships.
**Future Investments**
**Production Expansion** Investing £2.0-£2.5 million to increase capacity to £300 million in revenue.
**New Distribution Facility** Planning a new global distribution facility and head office, expected to cost £3.5-£4.0 million.
**Conclusion**
Applied Nutrition PLC demonstrated robust financial and operational performance in FY25, exceeding expectations and positioning itself for continued growth in FY26. The company remains focused on innovation, global expansion, and strengthening its market position in the sports nutrition and wellness sector.
Here is the HTML table code comparing the financials and debt year on year for Applied Nutrition PLC:
MetricFY25 (£m)FY24 (£m)Change
Revenue107.186.224.2%
Gross Profit49.341.319.4%
Adjusted EBITDA30.926.018.8%
Adjusted Profit Before Tax30.225.717.5%
Free Cash Flow16.57.1132.4%
Net Cash18.518.7(1.1%)
Lease Liabilities (Current)0.60.3100.0%
Lease Liabilities (Non-Current)2.41.560.0%
Total Lease Liabilities3.01.866.7%
**Notes:** * The table compares key financial metrics and debt (lease liabilities) for Applied Nutrition PLC between FY25 and FY24. * Net Cash is calculated as Cash and Cash Equivalents minus Total Lease Liabilities. * The percentage change is calculated as ((FY25 - FY24) / FY24) * 100. * This table provides a snapshot of the company's financial performance and debt position, highlighting areas of growth and potential concerns.
06:01
Open Terminal ↗ RNS Source
93 Strong Beat
CMCL
Caledonia Mining Corporation Plc
Positive
3rd Quarter Results
**Summary of Caledonia Mining Corporation Plcs 3rd Quarter 2025 Results** Caledonia Mining Corporation Plc reported strong financial and operational results for the third quarter of 2025, driven by higher gold prices and increased sales. Key highlights include: 1. **Financial Performance**: - **Revenue**: Increased by 52% to $71.4 million compared to Q3 2024, due to a 40% rise in the average realized gold price and an 8.7% increase in ounces sold. - **Gross Profit**: Rose to $36.9 million, up from $19.3 million in Q3 2024. - **EBITDA**: Surged by 162% to $33.5 million. - **Profit After Tax**: Jumped 467% to $18.7 million. - **Free Cash Flow**: Turned positive at $5.9 million, compared to a negative $2.4 million in Q3 2024. 2. **Operational Highlights**: - **Gold Production**: 19,106 ounces from the Blanket Mine, with an additional 437 ounces from the Bilboes oxide mine. - **Gold Sales**: 20,355 ounces from Blanket, with 2,861 ounces of bullion on hand sold at the start of Q4. - **On-Mine Cost**: $1,228/oz sold, with an all-in sustaining cost (AISC) of $1,937/oz sold. - **Ore Production**: Increased tonnes broken and hoisted, with 229.5 thousand tonnes and 208.7 thousand tonnes, respectively. 3. **Safety and Sustainability**: - Reported a fatality at Blanket Mine due to a secondary blasting accident, leading to a comprehensive review of safety procedures and training. - Group Lost Time Injury Frequency Rate (LTIFR) and Total Injury Frequency Rate (TIFR) showed slight increases, with ongoing efforts to improve safety. 4. **Exploration and Development**: - Continued deep exploration drilling at Blanket, targeting down-dip continuations of mineralized zones, with encouraging results. - Surface trenching at Blanket identified anomalous gold values, leading to a 5,000-metre reverse circulation drilling program. - Motapa project exploration progressed, with 17,787 metres of reverse circulation drilling and 1,763.4 metres of diamond drilling completed. 5. **Capital Expenditure and Liquidity**: - Total liquidity stood at $44.3 million, supporting ongoing capital projects. - Sustaining capital expenditure totaled $5.174 million, with non-sustaining capex at $1.585 million. - Completion of the new tailings storage facility (TSF) and ongoing mine development to access new areas. 6. **Corporate Developments**: - Appointed Mr. July Ndlovu as an independent non-executive director. - Approved a quarterly dividend of 14 cents per share, payable on December 5, 2025. - Bilboes feasibility study expected to be released imminently. 7. **Guidance**: - Maintained 2025 gold production guidance at 75,500 to 79,500 ounces. - Revised on-mine cost guidance to $1,150 to $1,250/oz sold and AISC to $1,850 to $1,950/oz sold, reflecting higher costs and royalties. **CEO Commentary**: Mark Learmonth, CEO, emphasized the companys focus on stable production, disciplined capital investment, and modernization of operations at Blanket. Despite the tragic fatality, the company remains committed to safety and long-term growth, with strategic investments to strengthen its foundations. **Conclusion**: Caledonia Mining Corporation Plc demonstrated robust performance in Q3 2025, with significant improvements in revenue, profitability, and cash flow, supported by strong gold prices and operational efficiency. The company continues to invest in exploration and development to sustain long-term growth while addressing safety concerns.
**Summary of Caledonia Mining Corporation Plcs 3rd Quarter 2025 Results**
Caledonia Mining Corporation Plc reported strong financial and operational results for the third quarter of 2025, driven by higher gold prices and increased sales. Key highlights include
1. **Financial Performance**
**Revenue**Increased by 52% to $71.4 million compared to Q3 2024, due to a 40% rise in the average realized gold price and an 8.7% increase in ounces sold.
**Gross Profit**Rose to $36.9 million, up from $19.3 million in Q3 2024.
**EBITDA**Surged by 162% to $33.5 million.
**Profit After Tax**Jumped 467% to $18.7 million.
**Free Cash Flow**Turned positive at $5.9 million, compared to a negative $2.4 million in Q3 2024.
2. **Operational Highlights**
**Gold Production**19,106 ounces from the Blanket Mine, with an additional 437 ounces from the Bilboes oxide mine.
**Gold Sales**20,355 ounces from Blanket, with 2,861 ounces of bullion on hand sold at the start of Q4.
**On-Mine Cost**$1,228/oz sold, with an all-in sustaining cost (AISC) of $1,937/oz sold.
**Ore Production**Increased tonnes broken and hoisted, with 229.5 thousand tonnes and 208.7 thousand tonnes, respectively.
3. **Safety and Sustainability**
Reported a fatality at Blanket Mine due to a secondary blasting accident, leading to a comprehensive review of safety procedures and training.
Group Lost Time Injury Frequency Rate (LTIFR) and Total Injury Frequency Rate (TIFR) showed slight increases, with ongoing efforts to improve safety.
4. **Exploration and Development**
Continued deep exploration drilling at Blanket, targeting down-dip continuations of mineralized zones, with encouraging results.
Surface trenching at Blanket identified anomalous gold values, leading to a 5,000-metre reverse circulation drilling program.
Motapa project exploration progressed, with 17,787 metres of reverse circulation drilling and 1,763.4 metres of diamond drilling completed.
5. **Capital Expenditure and Liquidity**
Total liquidity stood at $44.3 million, supporting ongoing capital projects.
Sustaining capital expenditure totaled $5.174 million, with non-sustaining capex at $1.585 million.
Completion of the new tailings storage facility (TSF) and ongoing mine development to access new areas.
6. **Corporate Developments**
Appointed Mr. July Ndlovu as an independent non-executive director.
Approved a quarterly dividend of 14 cents per share, payable on December 5, 2025.
Bilboes feasibility study expected to be released imminently.
7. **Guidance**
Maintained 2025 gold production guidance at 75,500 to 79,500 ounces.
Revised on-mine cost guidance to $1,150 to $1,250/oz sold and AISC to $1,850 to $1,950/oz sold, reflecting higher costs and royalties.
**CEO Commentary**
Mark Learmonth, CEO, emphasized the companys focus on stable production, disciplined capital investment, and modernization of operations at Blanket. Despite the tragic fatality, the company remains committed to safety and long-term growth, with strategic investments to strengthen its foundations.
**Conclusion**
Caledonia Mining Corporation Plc demonstrated robust performance in Q3 2025, with significant improvements in revenue, profitability, and cash flow, supported by strong gold prices and operational efficiency. The company continues to invest in exploration and development to sustain long-term growth while addressing safety concerns.
Here is the HTML table code comparing the financials and debt year on year for Caledonia Mining Corporation Plc: 25.9%
MetricQ3 2025Q3 2024% Change9-Months 20259-Months 2024% Change
Revenue (US$ 000)71,44046,86852.4%192,927135,50342.4%
EBITDA (US$ 000)33,49112,756162.6%95,50242,269
Profit after tax (US$ 000)18,6543,284468.0%53,41215,538243.8%
Free cash-flow (US$ 000)5,911(2,406)345.7%48,3289,767394.8%
Total liquidity (US$ 000)44,31838,000 (approx.)16.6%44,31838,000 (approx.)16.6%
Debt (Loans and borrowings, US$ 000)1,313 (non-current) + 1,281 (current)1,500 (non-current) + 1,174 (current)-12.5% (total)1,313 (non-current) + 1,281 (current)1,500 (non-current) + 1,174 (current)-12.5% (total)

Notes:

  • Total liquidity for Q3 2024 is approximated based on the available data.
  • Debt is represented by loans and borrowings, both non-current and current.
This table provides a comparison of key financials and debt metrics for Caledonia Mining Corporation Plc between Q3 2025 and Q3 2024, as well as for the 9-month periods ending September 30, 2025, and 2024. The data is extracted from the provided text.
06:01
Open Terminal ↗ RNS Source
84 Broker Upgrade
CNSL
Cambridge Nutritional Sciences plc
Positive
Half-year Report
**Summary of Cambridge Nutritional Sciences PLC Half-Year Report (H1 2025)** **Financial Highlights:** - **Revenue Decline:** Revenue decreased to £3.9 million (H1 2024: £4.1 million), primarily due to slower orders in key regions like mainland Europe, Africa/Middle East, and the Americas. - **Gross Margin Improvement:** Gross margin increased to 67.7% (H1 2024: 65.4%), driven by production efficiencies and product mix optimization. - **Adjusted EBITDA:** Remained positive at £0.1 million (H1 2024: £0.2 million), despite lower sales. - **Loss Before Tax:** Increased to £0.4 million (H1 2024: £0.2 million) due to lower revenue and higher operational costs. - **Cash Position:** Cash balance decreased to £3.6 million (H1 2024: £4.5 million) due to working capital outflows, capital expenditures, and financing activities. **Operational Highlights:** - **Sales Restructuring:** The sales and marketing teams were restructured to focus on long-term growth, separating customer service, acquisition, and success functions from sales. - **Product Performance:** FoodPrint® sales declined by 7% to £2.4 million, while Food Detective® sales dropped by 23% to £0.6 million. CNS Lab sales grew by 9% to £0.9 million. - **Regional Growth:** Strong growth in the UK (6%) and India (33%), offset by declines in Europe, Americas, and Africa/Middle East. - **New Product Launch:** Introduced Gut Detective®, a comprehensive stool biomarker panel for gut health, targeting UK practitioners. **Outlook:** - **Full-Year Sales:** Expected to be lower than the previous year due to longer sales cycles and slower commercialization in key regions. - **Strategic Focus:** Emphasis on converting pipeline opportunities into orders, particularly in the USA and Europe. - **Cost Management:** Aim to remain profitable at the adjusted EBITDA level through careful cost management. - **Cash Investment:** Continued investment in strategic initiatives like IVDR development and new products, despite a decline in cash position. **Management Commentary:** - **Challenges:** Carolyn Rand, Chair, acknowledged a frustrating first half due to underperformance in key regions, despite strong growth in the UK and India. - **Optimism:** Confidence in long-term growth prospects as the restructured sales team begins to deliver, supported by improved gross margins and operational efficiencies. **Investor Engagement:** - A live investor presentation was held on 10 November 2025, led by CEO James Cooper and CFO Ajay Patel, to discuss the interim results. **Conclusion:** Cambridge Nutritional Sciences PLC faces short-term challenges with revenue declines in key regions but remains focused on long-term growth through sales restructuring, operational efficiencies, and strategic investments. The company is well-funded to execute its strategy and expects to return to growth with a healthy gross margin.
**Summary of Cambridge Nutritional Sciences PLC Half-Year Report (H1 2025)**
**Financial Highlights**
**Revenue Decline** Revenue decreased to £3.9 million (H1 2024: £4.1 million), primarily due to slower orders in key regions like mainland Europe, Africa/Middle East, and the Americas.
**Gross Margin Improvement** Gross margin increased to 67.7% (H1 2024: 65.4%), driven by production efficiencies and product mix optimization.
**Adjusted EBITDA** Remained positive at £0.1 million (H1 2024: £0.2 million), despite lower sales.
**Loss Before Tax** Increased to £0.4 million (H1 2024: £0.2 million) due to lower revenue and higher operational costs.
**Cash Position** Cash balance decreased to £3.6 million (H1 2024: £4.5 million) due to working capital outflows, capital expenditures, and financing activities.
**Operational Highlights**
**Sales Restructuring** The sales and marketing teams were restructured to focus on long-term growth, separating customer service, acquisition, and success functions from sales.
**Product Performance** FoodPrint® sales declined by 7% to £2.4 million, while Food Detective® sales dropped by 23% to £0.6 million. CNS Lab sales grew by 9% to £0.9 million.
**Regional Growth** Strong growth in the UK (6%) and India (33%), offset by declines in Europe, Americas, and Africa/Middle East.
**New Product Launch** Introduced Gut Detective®, a comprehensive stool biomarker panel for gut health, targeting UK practitioners.
**Outlook**
**Full-Year Sales** Expected to be lower than the previous year due to longer sales cycles and slower commercialization in key regions.
**Strategic Focus** Emphasis on converting pipeline opportunities into orders, particularly in the USA and Europe.
**Cost Management** Aim to remain profitable at the adjusted EBITDA level through careful cost management.
**Cash Investment** Continued investment in strategic initiatives like IVDR development and new products, despite a decline in cash position.
**Management Commentary**
**Challenges** Carolyn Rand, Chair, acknowledged a frustrating first half due to underperformance in key regions, despite strong growth in the UK and India.
**Optimism** Confidence in long-term growth prospects as the restructured sales team begins to deliver, supported by improved gross margins and operational efficiencies.
**Investor Engagement**
A live investor presentation was held on 10 November 2025, led by CEO James Cooper and CFO Ajay Patel, to discuss the interim results.
**Conclusion**
Cambridge Nutritional Sciences PLC faces short-term challenges with revenue declines in key regions but remains focused on long-term growth through sales restructuring, operational efficiencies, and strategic investments. The company is well-funded to execute its strategy and expects to return to growth with a healthy gross margin.
Here is the HTML table code comparing the financials and debt year on year for Cambridge Nutritional Sciences PLC: tr>
MetricH1 2025H1 2024Change
Revenue (£'000)3,8634,134(6.6%)
Gross Margin (%)67.7%65.4%+2.3%
Adjusted EBITDA (£'000)102227(55.1%)
Loss Before Tax (£'000)(397)(196)-102.6%
Cash Balance (£'000)3,5944,520(20.5%)
Total Debt (£'000)1633,964(95.9%)

Regional Revenue Breakdown

RegionH1 2025 (£'000)H1 2024 (£'000)Change (%)
UK894840+6%
Rest of Europe707952(25.7%)
Americas737805(8.4%)
India402302+33.1%
Asia796826(3.6%)
Africa and Middle East327408(19.8%)

Product Revenue Breakdown

ProductH1 2025 (£'000)H1 2024 (£'000)Change (%)
FoodPrint®2,3802,564(7%)
Food Detective®554717(22.7%)
CNS Laboratory Service910842+8.1%
Food ELISA/Other1911+72.7%
**Notes:** * Total Debt is calculated as the sum of Short-term borrowings, Lease liabilities, and Long-term borrowings (if any). * The percentage changes are calculated based on the absolute values. * The tables provide a clear comparison of the company's financials and debt position year on year, as well as a breakdown of revenue by region and product.
06:01
Open Terminal ↗ RNS Source
93 Strong Beat
KNOS
Kainos Group PLC
Positive
Interim results
**Summary of Kainos Group plc Interim Results for H1 2026** **Overview** Kainos Group plc, a UK-based IT provider specializing in Digital Services, Workday Services, and Workday Products, reported strong interim results for the six months ended 30 September 2025. The company highlighted robust sales performance, revenue growth, and strategic advancements despite challenges like cost increases and investment in partnerships. **Financial Highlights** - **Revenue**: Increased by 7% to £196.1 million (H1 2025: £183.1 million), driven by organic growth and currency benefits. - **Adjusted Pre-Tax Profit**: Declined by 16% to £32.0 million (H1 2025: £38.2 million) due to increased investment in the Workday partnership, National Insurance costs, and short-term use of contractors. - **Bookings**: Surged by 27% to £227.9 million (H1 2025: £179.5 million), reflecting strong sales across all divisions. - **Contracted Backlog**: Grew by 12% to £396.9 million (H1 2025: £354.1 million). - **Cash**: Decreased by 30% to £105.5 million (H1 2025: £151.6 million) due to restructuring costs, working capital increases, and shareholder returns. - **Interim Dividend**: Increased by 5% to 9.8p per share (H1 2025: 9.3p). **Operational Highlights** 1. **Workday Products**: - Revenue grew by 14% to £39.2 million, with ARR up 19% to £77.5 million. - Achieved $100 million ARR milestone in July 2025, a significant SaaS industry benchmark. - Launched "Pay Transparency Analyzer powered by Kainos" in partnership with Workday, targeting EU compliance requirements. 2. **Digital Services**: - Revenue increased by 6% to £103.5 million, driven by healthcare sector growth (33%) and North American expansion (152% revenue growth). - Secured major contracts in the UK public sector, including a £73 million deal with the DVSA. 3. **Workday Services**: - Revenue grew by 4% to £53.4 million, with strong performance in North America and emerging markets like Australia and Latin America. - Bookings increased by 35% to £54.0 million. 4. **International Growth**: - International revenue rose by 13% to £84.9 million, accounting for 43% of Group revenue. 5. **Customer Satisfaction**: - Net Promoter Score (NPS) improved to 70 (H1 2025: 58), reflecting high customer satisfaction. 6. **Employee Engagement**: - Employee retention remained strong at 92%, with engagement levels at 75%. - Recognized as one of the "50 Best Places to Work in the UK" by Glassdoor. 7. **AI Initiatives**: - AI-related revenue grew by 6% to £15.3 million. - Launched Microsoft AI Centre of Excellence and developed AI solutions for Workday and other platforms. **Strategic Developments** - Acquired Davis Pier, a Canadian consultancy, to strengthen North American presence. - Deepened Workday partnership with exclusive resell arrangements and joint product launches. - Continued investment in R&D, with expenditure rising by 12% to £8.6 million. **Outlook** - Expects continued growth in Workday Products, Digital Services, and Workday Services in H2 2026. - Maintains full-year profit expectations in line with consensus forecasts. - Focused on long-term growth drivers, including AI adoption and digital transformation. **Shareholder Returns** - Completed £30 million share buyback programme and announced a new £30 million programme. **Conclusion** Kainos demonstrated resilience and growth in H1 2026, underpinned by strong sales execution, strategic partnerships, and expansion into key markets. Despite short-term profit pressures, the company remains confident in its long-term strategy and ability to deliver shareholder value.
**Summary of Kainos Group plc Interim Results for H1 2026**
**Overview**
Kainos Group plc, a UK-based IT provider specializing in Digital Services, Workday Services, and Workday Products, reported strong interim results for the six months ended 30 September 2025. The company highlighted robust sales performance, revenue growth, and strategic advancements despite challenges like cost increases and investment in partnerships.
**Financial Highlights**
**Revenue**Increased by 7% to £196.1 million (H1 2025: £183.1 million), driven by organic growth and currency benefits.
**Adjusted Pre-Tax Profit**Declined by 16% to £32.0 million (H1 2025: £38.2 million) due to increased investment in the Workday partnership, National Insurance costs, and short-term use of contractors.
**Bookings**Surged by 27% to £227.9 million (H1 2025: £179.5 million), reflecting strong sales across all divisions.
**Contracted Backlog**Grew by 12% to £396.9 million (H1 2025: £354.1 million).
**Cash**Decreased by 30% to £105.5 million (H1 2025: £151.6 million) due to restructuring costs, working capital increases, and shareholder returns.
**Interim Dividend**Increased by 5% to 9.8p per share (H1 2025: 9.3p).
**Operational Highlights**
1. **Workday Products**
Revenue grew by 14% to £39.2 millionwith ARR up 19% to £77.5 million.
Achieved $100 million ARR milestone in July 2025, a significant SaaS industry benchmark.
Launched "Pay Transparency Analyzer powered by Kainos" in partnership with Workday, targeting EU compliance requirements.
2. **Digital Services**
Revenue increased by 6% to £103.5 million, driven by healthcare sector growth (33%) and North American expansion (152% revenue growth).
Secured major contracts in the UK public sector, including a £73 million deal with the DVSA.
3. **Workday Services**
Revenue grew by 4% to £53.4 million, with strong performance in North America and emerging markets like Australia and Latin America.
Bookings increased by 35% to £54.0 million.
4. **International Growth**
International revenue rose by 13% to £84.9 million, accounting for 43% of Group revenue.
5. **Customer Satisfaction**
Net Promoter Score (NPS) improved to 70 (H1 2025: 58), reflecting high customer satisfaction.
6. **Employee Engagement**
Employee retention remained strong at 92%, with engagement levels at 75%.
Recognized as one of the "50 Best Places to Work in the UK" by Glassdoor.
7. **AI Initiatives**
AI-related revenue grew by 6% to £15.3 million.
Launched Microsoft AI Centre of Excellence and developed AI solutions for Workday and other platforms.
**Strategic Developments**
Acquired Davis Pier, a Canadian consultancy, to strengthen North American presence.
Deepened Workday partnership with exclusive resell arrangements and joint product launches.
Continued investment in R&D, with expenditure rising by 12% to £8.6 million.
**Outlook**
Expects continued growth in Workday Products, Digital Services, and Workday Services in H2 2026.
Maintains full-year profit expectations in line with consensus forecasts.
Focused on long-term growth drivers, including AI adoption and digital transformation.
**Shareholder Returns**
Completed £30 million share buyback programme and announced a new £30 million programme.
**Conclusion**
Kainos demonstrated resilience and growth in H1 2026, underpinned by strong sales execution, strategic partnerships, and expansion into key markets. Despite short-term profit pressures, the company remains confident in its long-term strategy and ability to deliver shareholder value.
Here is the HTML table code comparing the financials and debt year on year for Kainos Group plc:
MetricH1 2026H1 2025Change
Revenue£196.1m£183.1m+7%
Statutory profit before tax£28.4m£34.2m-17%
Adjusted pre-tax profit£32.0m£38.2m-16%
Diluted earnings per share16.7p20.1p-17%
Adjusted diluted earnings per share18.9p22.5p-16%
Interim dividend per share9.8p9.3p+5%
Bookings£227.9m£179.5m+27%
Product annual recurring revenue (ARR)£77.5m£65.1m+19%
Contracted backlog£396.9m£354.1m+12%
Cash£105.5m£151.6m-30%

Note: Debt information is not explicitly mentioned in the provided text. However, the cash balance can be considered as a proxy for debt, with a decrease in cash potentially indicating an increase in debt or other liabilities.

Key Observations:

  • Revenue increased by 7% year-on-year, driven by strong sales performance across all divisions.
  • Profit metrics (statutory and adjusted) decreased by 16-17%, primarily due to increased costs associated with the Workday partnership, National Insurance, and contractor usage.
  • Bookings and contracted backlog increased significantly, indicating strong future revenue potential.
  • Cash balance decreased by 30%, partly due to share buybacks, acquisition of Davis Pier, and increased working capital requirements.
This table provides a clear comparison of key financial metrics between H1 2026 and H1 2025, highlighting the changes and trends in Kainos Group plc's financial performance.
06:01
Open Terminal ↗ RNS Source
80 Positive
CHG
Chemring Group PLC
Positive
Post-close and contract wins update
**Chemring Group PLC Trading Statement Summary (November 10, 2025)** Chemring Group PLC provided a post-close and contract wins update for FY25, highlighting key financial and operational developments as it enters its close period for the year ended October 31, 2025. **Financial Performance:** - **FY25 adjusted operating profit** is in line with analyst expectations, with a margin of ~14.7% (up from 14.2% in FY24). - **Adjusted EPS** is expected to benefit from slightly lower finance costs. - **Net debt** as of October 31, 2025, is ~£95m. - **Order book** increased to £1.3bn (from £1.0bn in October 2024), with order intake for the year at ~£781m. **Operational Highlights:** - **Energetics segment** outperformed, driven by increased demand for propellants, energetic materials, and high-integrity devices. - **Sensors & Information segment** faced softness due to delayed UK Government orders, particularly in National Security and Defence. - **Countermeasures & Energetics** achieved ~95% order cover for FY26, while **Sensors & Information** secured ~47% cover. **Significant Contract Wins:** 1. **Energetics:** - Chemring Energetic Devices (US) won a $65m sole-source framework contract for aircrew flight equipment <mark style="background-color:yellow">test</mark>er systems. - Chemring Energetics UK secured a £24m order for rocket motors and components for the Next Generation Light Anti-Tank Weapon (NLAW) system. - Chemring Nobel (Norway) won a £23m order from Nammo for HMX products. 2. **Countermeasures:** - Chemring Australia won a US$35m contract for airborne countermeasures. - Chemring Countermeasures UK secured a £15m order from NATO for airborne countermeasures. 3. **Sensors & Information:** - Roke won over £40m in National Security contract renewals and a £20m contract for Project ZODIAC, a critical technology program for the British Army. **Strategic Developments:** - **Landguard Group acquisition** completed in August 2025, enhancing Roke’s growth and operational synergies. - **Alloy Surfaces** (US countermeasures business) will be reported as a discontinued operation due to declining demand from the US Department of Defense. Strategic options, including a potential sale, are under consideration. **Outlook:** - Robust market conditions and increasing demand for technology-driven solutions and traditional defence capabilities are expected to sustain growth. - Full-year results for FY25 will be released on December 9, 2025. **Directorate Change:** - Fiona MacAulay, Senior Independent Director, will step down at the February 2026 AGM after completing her second three-year term. Chemring remains focused on its niche markets, leveraging R&D investments to meet evolving customer needs in defence, security, and aerospace.
**Chemring Group PLC Trading Statement Summary (November 10, 2025)**
Chemring Group PLC provided a post-close and contract wins update for FY25, highlighting key financial and operational developments as it enters its close period for the year ended October 31, 2025.
**Financial Performance**
**FY25 adjusted operating profit** is in line with analyst expectations, with a margin of ~14.7% (up from 14.2% in FY24).
**Adjusted EPS** is expected to benefit from slightly lower finance costs.
**Net debt** as of October 312025is ~£95m.
**Order book** increased to £1.3bn (from £1.0bn in October 2024), with order intake for the year at ~£781m.
**Operational Highlights**
**Energetics segment** outperformed, driven by increased demand for propellants, energetic materials, and high-integrity devices.
**Sensors & Information segment** faced softness due to delayed UK Government orders, particularly in National Security and Defence.
**Countermeasures & Energetics** achieved ~95% order cover for FY26, while **Sensors & Information** secured ~47% cover.
**Significant Contract Wins**
1. **Energetics**
Chemring Energetic Devices (US) won a $65m sole-source framework contract for aircrew flight equipment <mark style="background-color:yellow">test</mark>er systems.
Chemring Energetics UK secured a £24m order for rocket motors and components for the Next Generation Light Anti-Tank Weapon (NLAW) system.
Chemring Nobel (Norway) won a £23m order from Nammo for HMX products.
2. **Countermeasures**
Chemring Australia won a US$35m contract for airborne countermeasures.
Chemring Countermeasures UK secured a £15m order from NATO for airborne countermeasures.
3. **Sensors & Information**
Roke won over £40m in National Security contract renewals and a £20m contract for Project ZODIAC, a critical technology program for the British Army.
**Strategic Developments**
**Landguard Group acquisition** completed in August 2025, enhancing Roke’s growth and operational synergies.
**Alloy Surfaces** (US countermeasures business) will be reported as a discontinued operation due to declining demand from the US Department of Defense. Strategic options, including a potential sale, are under consideration.
**Outlook**
Robust market conditions and increasing demand for technology-driven solutions and traditional defence capabilities are expected to sustain growth.
Full-year results for FY25 will be released on December 9, 2025.
**Directorate Change**
Fiona MacAulay, Senior Independent Director, will step down at the February 2026 AGM after completing her second three-year term.
Chemring remains focused on its niche markets, leveraging R&D investments to meet evolving customer needs in defence, security, and aerospace.
NewContract
06:01
Open Terminal ↗ RNS Source
80 Positive
ONDO
Ondo InsurTech PLC
Positive
Contract Win
**Summary:** Ondo InsurTech PLC (LSE: ONDO), a leader in claims prevention technology for home insurers, announced on November 10, 2025, that Westfield Insurance has signed a contract to deploy 10,000 LeakBot devices and connected services for homeowners in Ohio, Indiana, and Pennsylvania. This partnership aims to proactively prevent water damage claims, reduce loss costs, and enhance customer experience. LeakBot, a patented self-install solution, detects leaks and alerts homeowners via a mobile app, offering access to expert engineers for repairs. Independent research shows LeakBot can reduce water damage claim costs by up to 70%. Westfield’s initiative aligns with its investment in innovative technology, while Ondo continues to expand its global partnerships with 25 insurance carriers. Ondo holds the London Stock Exchange’s Green Economy Mark, underscoring its commitment to sustainable solutions. Westfield, a leading U.S. insurer founded in 1848, strengthens its position with this collaboration, further solidifying Ondo’s role as a global leader in claims prevention technology.
**Summary**
Ondo InsurTech PLC (LSEONDO), a leader in claims prevention technology for home insurers, announced on November 10, 2025, that Westfield Insurance has signed a contract to deploy 10,000 LeakBot devices and connected services for homeowners in Ohio, Indiana, and Pennsylvania. This partnership aims to proactively prevent water damage claims, reduce loss costs, and enhance customer experience. LeakBot, a patented self-install solution, detects leaks and alerts homeowners via a mobile app, offering access to expert engineers for repairs. Independent research shows LeakBot can reduce water damage claim costs by up to 70%. Westfield’s initiative aligns with its investment in innovative technology, while Ondo continues to expand its global partnerships with 25 insurance carriers. Ondo holds the London Stock Exchange’s Green Economy Mark, underscoring its commitment to sustainable solutions. Westfield, a leading U.S. insurer founded in 1848, strengthens its position with this collaboration, further solidifying Ondo’s role as a global leader in claims prevention technology.
NewContract
06:01
Open Terminal ↗ RNS Source
80 Positive
ABDX
Abingdon Health Plc
Positive
c.US$2m multiplex diagnostic test contract win
**Summary:** Abingdon Health plc, a leading developer and manufacturer of rapid diagnostic <mark style="background-color:yellow">test</mark>s, has secured a **c.US$2 million contract** with a US-based company for the development, scale-up, and technical transfer of a **semi-quantitative, multiplex lateral flow test system**. The 24-month project will be executed under a Master Service Agreement (MSA) and conducted at Abingdon Health’s Madison, Wisconsin facilities. This win highlights the strength of Abingdon Health’s **Contract Development and Manufacturing Organisation (CDMO)** services, which support customers from concept to commercial success. The contract underscores the company’s expanded U.S. manufacturing capabilities, bolstered by a recent £3.2 million fundraise, and its ability to meet growing demand from U.S.-based clients. Dr. Chris Hand, Executive Chairman, emphasized the value of Abingdon’s dual U.S. and U.K. sites and the versatility of lateral flow technology in measuring multiple analytes semi-quantitatively. The announcement reinforces Abingdon Health’s position as a comprehensive CDMO provider in the med-tech sector.
**Summary**
Abingdon Health plc, a leading developer and manufacturer of rapid diagnostic <mark style="background-color:yellow">test</mark>s, has secured a **c.US$2 million contract** with a US-based company for the development, scale-up, and technical transfer of a **semi-quantitative, multiplex lateral flow test system**. The 24-month project will be executed under a Master Service Agreement (MSA) and conducted at Abingdon Health’s Madison, Wisconsin facilities. This win highlights the strength of Abingdon Health’s **Contract Development and Manufacturing Organisation (CDMO)** services, which support customers from concept to commercial success. The contract underscores the company’s expanded U.S. manufacturing capabilities, bolstered by a recent £3.2 million fundraise, and its ability to meet growing demand from U.S.-based clients. Dr. Chris Hand, Executive Chairman, emphasized the value of Abingdon’s dual U.S. and U.K. sites and the versatility of lateral flow technology in measuring multiple analytes semi-quantitatively. The announcement reinforces Abingdon Health’s position as a comprehensive CDMO provider in the med-tech sector.
NewContract
06:01
Open Terminal ↗ RNS Source
Market Pulse --
Up
0
Down
0
Good0
Bad0
AI Net0
Most Active Tickers 0
No active AI ticker data for this session.
Strongest Bullish 0
No bullish tickers scored yet.
Strongest Bearish 0
No bearish tickers scored yet.
SMIF
SMIF
Price --
Move --
News 0
Mode AI
Site ↗
🤖 AI Chartist
Full AI chart intelligence
LSTM forecast path, EMA stack, RSI, MACD, support & resistance — all live in the Chart tab.
SMIF logo
Ticker Overview

SMIF

Pulse--
AI Net0
Market News536
Up
0
Down
0
🏢
Company Overview
Profile · broker target · market cap · sector · catalyst count
Select a ticker above
AI VIP Intelligence

Signal Storm

⚡ Live 2025-11-10 536 alerts
SMIF
SMIF TwentyFour Select Monthly I…
17:16
Market

Issue of Equity

Open Terminal Source RNS
IBT
IBT International Biotechnology…
17:04
Market

Transaction in Own Shares

Open Terminal Source RNS
IPO
IPO IP Group
17:03
Market

Transaction in Own Shares

Open Terminal Source RNS
60VT
60VT 60VT
17:01
Market

Half-year unaudited financials

Open Terminal Source RNS
FSTA
FSTA Fuller Smith & Turner
16:58
Market

Fuller, Smith & Turner PLC: Transaction in own shares

Open Terminal Source RNS
ELM
ELM Elementis PLC
16:57
Market

Transaction in Own Shares

Open Terminal Source RNS
JTC
JTC JTC PLC
16:57
Market

Form 8.3

Open Terminal Source RNS
GROW
GROW Draper Esprit PLC
16:56
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
None
Open Terminal Source RNS
WIL
WIL Wilmington PLC
16:55
Market

Directorate change

Open Terminal Source RNS
SOI
SOI Schroder Oriental Income Fu…
16:45
Market

Transaction in Own Shares

Open Terminal Source RNS
BU33
BU33 BU33
16:44
Market

Publication of a Prospectus

Open Terminal Source RNS
CRE
CRE Conduit Holdings Ltd
16:43
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Perpetual Limited', '4.904487', 0]
Open Terminal Source RNS
SOI
SOI Schroder Oriental Income Fu…
16:41
Market

Annual Financial Report on NSM

Open Terminal Source RNS
BEMO
BEMO Baring Emerging Europe Plc
16:41
Market

Transaction in Own Shares

Open Terminal Source RNS
AUTO
AUTO Auto Trader Group plc
16:40
Market

Transaction in Own Shares

Open Terminal Source RNS
SMIN
SMIN Smiths Group PLC
16:39
Market

Transaction in Own Shares

Open Terminal Source RNS
FOXT
FOXT Foxtons Group Plc
16:38
Market

Transaction in Own Shares

Open Terminal Source RNS
BRIG
BRIG BlackRock Income and Growth…
16:37
Market

Transaction in Own Shares

Open Terminal Source RNS
LLOY
LLOY Lloyds Banking Group PLC
16:36
Market

Transaction in Own Shares

Open Terminal Source RNS
BGEO
BGEO Lion Finance Group PLC
16:35
Market

Transaction in Own Shares

Open Terminal Source RNS
BHMG
BHMG BH Macro Limited
16:34
Market

Transaction in Own Shares

Open Terminal Source RNS
SHEL
SHEL Shell plc
16:32
Market

Transaction in Own Shares

Open Terminal Source RNS
BP.
BP. BP.
16:31
Market

Transaction in Own Shares

Open Terminal Source RNS
PCTN
PCTN Picton Property Income Ltd
16:29
Market

Transaction in Own Shares

Open Terminal Source RNS
CGT
CGT Capital Gearing Trust
16:29
Market

Transaction in Own Shares

Open Terminal Source RNS
PAC
PAC Pacific Assets Trust plc
16:28
Market

Transaction in Own Shares

Open Terminal Source RNS
AUSC
AUSC Abrdn UK Smaller Companies …
16:27
Market

Transaction in Own Shares

Open Terminal Source RNS
NG.
NG. NG.
16:27
Market

Director/PDMR Shareholding

Monthly <mark style="background-color:yellow">purchase</mark> of securities ("partnership

Monthly <mark style="background-coloryellow">purchase</mark> of securities ("partnership
Open Terminal Source RNS
ATT
ATT Allianz Technology Trust PLC
16:27
Market

Top 10 holdings & Geographical distribution

Open Terminal Source RNS
ANII
ANII Aberdeen New India Investme…
16:26
Market

Transaction in Own Shares

Open Terminal Source RNS
BRGE
BRGE BlackRock Greater Europe In…
16:26
Market

Transaction in Own Shares

Open Terminal Source RNS
TFIF
TFIF TwentyFour Income Fund Ltd
16:25
Market

Issue of Equity

Open Terminal Source RNS
ARR
ARR Aurora Investment Trust plc
16:24
Market

Transaction in Own Shares

Open Terminal Source RNS
DIG
DIG Dunedin Income Growth Inves…
16:24
Market

Transaction in Own Shares

Open Terminal Source RNS
FEVR
FEVR Fevertree Drinks Plc
16:23
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
MRCH
MRCH Merchants Trust PLC
16:23
Market

Top 10 holdings & Geographical distribution

Open Terminal Source RNS
BUT
BUT Brunner Investment Trust
16:23
Market

Top 10 holdings & Geographical distribution

Open Terminal Source RNS
BRSC
BRSC Blackrock Smaller Companies…
16:23
Market

Transaction in Own Shares

Open Terminal Source RNS
GJ03
GJ03 GJ03
16:22
Market

Stabilisation Notice

Open Terminal Source RNS
AGT
AGT AVI Global Trust PLC
16:22
Market

Transaction in Own Shares

Open Terminal Source RNS
MTU
MTU Montanaro UK Smaller Compan…
16:22
Market

Transaction in Own Shares

Open Terminal Source RNS
FCSS
FCSS Fidelity China Special Situ…
16:22
Market

Transaction in Own Shares

Open Terminal Source RNS
JAM
JAM JPMorgan American Investmen…
16:22
Market

Transaction in Own Shares

Open Terminal Source RNS
MYI
MYI Murray International Trust
16:21
Market

Transaction in Own Shares

Open Terminal Source RNS
ABF
ABF Associated British Foods PLC
16:21
Market

Transaction in Own Shares

Open Terminal Source RNS
REL
REL Relx PLC
16:20
Market

Transaction in Own Shares

Open Terminal Source RNS
AAS
AAS Abrdn Asia Focus PLC
16:20
Market

Transaction in Own Shares

Open Terminal Source RNS
TRC
TRC Revel Collective PLC
16:19
Market

Form 8.3 - Revel Collective Plc

Open Terminal Source RNS
SSON
SSON Smithson Investment Trust P…
16:19
Market

Transaction in Own Shares

Open Terminal Source RNS
PCT
PCT Polar Capital Technology Tr…
16:18
Market

Transaction in Own Shares

Open Terminal Source RNS
AAIF
AAIF abrdn Asian Income Fund Lim…
16:18
Market

Transaction in Own Shares

Open Terminal Source RNS
JEMI
JEMI JPMorgan Global Emerging Ma…
16:18
Market

Transaction in Own Shares

Open Terminal Source RNS
ALW
ALW Alliance Witan Ord
16:18
Market

Transaction in Own Shares

Open Terminal Source RNS
IMB
IMB Imperial Brands PLC
16:16
Market

Transaction in Own Shares

Open Terminal Source RNS
JUGI
JUGI JPMorgan UK Small Cap Growt…
16:16
Market

Transaction in Own Shares

Open Terminal Source RNS
PCFT
PCFT Polar Capital Global Financ…
16:16
Market

Transaction in Own Shares

Open Terminal Source RNS
FCIT
FCIT F&C Investment Trust PLC
16:16
Market

Transaction in Own Shares

Open Terminal Source RNS
MTE
MTE Montanaro European Smaller …
16:15
Market

Transaction in Own Shares

Open Terminal Source RNS
NAIT
NAIT The North American Income T…
16:14
Market

Transaction in Own Shares

Open Terminal Source RNS
JUSC
JUSC JPmorgan US Smaller Compani…
16:14
Market

Transaction in Own Shares

Open Terminal Source RNS
SXS
SXS Spectris PLC
16:14
Market

Director/PDMR Shareholding

Open Terminal Source RNS
GSCT
GSCT The Global Smaller Companie…
16:14
Market

Transaction in Own Shares

Open Terminal Source RNS
JGGI
JGGI JP Morgan Global Growth & I…
16:13
Market

Transaction in Own Shares

Open Terminal Source RNS
FGT
FGT Finsbury Growth & Income Tr…
16:13
Market

Transaction in Own Shares

Open Terminal Source RNS
BNKR
BNKR Bankers Investment Trust
16:12
Market

Transaction in Own Shares

Open Terminal Source RNS
JAGI
JAGI JPMorgan Asia Growth & Inco…
16:11
Market

Transaction in Own Shares

Open Terminal Source RNS
TEM
TEM Templeton Emerging Markets …
16:11
Market

Transaction in Own Shares

Open Terminal Source RNS
HWDN
HWDN Howden Joinery Group Plc
16:09
Market

Transaction in Own Shares

Open Terminal Source RNS
JIGI
JIGI JPMorgan India Growth & Inc…
16:07
Market

Transaction in Own Shares

Open Terminal Source RNS
CGEO
CGEO Georgia Capital PLC
16:07
Market

Transaction in Own Shares

Open Terminal Source RNS
RMV
RMV Rightmove PLC
16:06
Market

Transaction in Own Shares

Open Terminal Source RNS
JD.
JD. JD.
16:05
Market

Transaction in Own Shares

Open Terminal Source RNS
ASL
ASL Aberforth Smaller Companies…
16:05
Market

Transaction in Own Shares

Open Terminal Source RNS
MONY
MONY MONY Group plc
16:02
Market

Transaction in Own Shares

Open Terminal Source RNS
ROAD
ROAD Roadside Real Estate plc
16:01
Market

Notification of Major Holdings

TR1 Buy

TR1 Buy
['Mrs Davina Dickson', '15.01', '19.01']
Open Terminal Source RNS
HTWS
HTWS Helios Towers Plc
16:00
Market

Statement re Secondary Placing in Helios Towers

Open Terminal Source RNS
FRGT
FRGT Franklin Global Trust Ord
16:00
Market

Transaction in Own Shares

Open Terminal Source RNS
EWI
EWI Edinburgh Worldwide Investm…
15:59
Market

Transaction in Own Shares

Open Terminal Source RNS
BASC
BASC Brown Advisory US Smaller C…
15:58
Market

Result of AGM

Open Terminal Source RNS
ATT
ATT Allianz Technology Trust PLC
15:56
Market

Transaction in Own Shares

Open Terminal Source RNS
BGUK
BGUK Baillie Gifford UK Growth F…
15:55
Market

Transaction in Own Shares

Open Terminal Source RNS
MNKS
MNKS Monks Investment Trust PLC
15:54
Market

Transaction in Own Shares

Open Terminal Source RNS
FCH
FCH Funding Circle Holdings PLC
15:52
Market

Funding Circle Holdings plc: POS-Transaction in Own Shares

Open Terminal Source RNS
BGCG
BGCG Baillie Gifford China Growt…
15:52
Market

Transaction in Own Shares

Open Terminal Source RNS
EVST
EVST Everest Global PLC
15:52
Market

Completion of Capital Re-Organisation & TVR

Open Terminal Source RNS
MWY
MWY Mid Wynd International Inve…
15:51
Market

Transaction in Own Shares

Open Terminal Source RNS
SAIN
SAIN Scottish American Investmen…
15:49
Market

Transaction in Own Shares

Open Terminal Source RNS
JCGI
JCGI JPMorgan China Growth & Inc…
15:48
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['City of London Investment Management Company Limited', '19.130000', '18.020000']
Open Terminal Source RNS
BGEU
BGEU Baillie Gifford European Gr…
15:46
Market

Transaction in Own Shares

Open Terminal Source RNS
UEM
UEM Utilico Emerging Markets Ltd
15:46
Market

Transaction in Own Shares & Total Voting Rights

Open Terminal Source RNS
BAG
BAG A.G.Barr PLC
15:45
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of shares in relation to the A.G. BARR All Employee Share Ownership Plan (AESOP) dividend reinvestment

<mark style="background-coloryellow">Purchase</mark> of shares in relation to the A.G. BARR All Employee Share Ownership Plan (AESOP) dividend reinvestment
Open Terminal Source RNS
SST
SST The Scottish Oriental Small…
15:42
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['City of London Investment Management Company Limited', '13.050000', '12.090000']
Open Terminal Source RNS
UTL
UTL UIL Ltd
15:41
Market

Transaction in Own Shares & Total Voting Rights

Open Terminal Source RNS
WIZZ
WIZZ Wizz Air Holdings PLC
15:39
Market

Holding(s) in Company

<mark style="background-color:yellow">TR1</mark> Buy

<mark style="background-coloryellow">TR1</mark> Buy
['Barclays PLC', '0.030000', 'Below minimum threshold ']
Open Terminal Source RNS
BAG
BAG A.G.Barr PLC
15:39
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of shares in relation to the A.G. BARR All Employee Share Ownership Plan (AESOP). The AESOP is an all-employee trust arrangement approved by HM Revenue and Customs, under which employee…

<mark style="background-coloryellow">Purchase</mark> of shares in relation to the A.G. BARR All Employee Share Ownership Plan (AESOP). The AESOP is an all-employee trust arrangement approved by HM Revenue and Customs, under which employees are able to buy ordinary shares in the Company of 4⅙p each, using deductions from salary in each pay period, and receive allocations of matching free ordinary shares.
Open Terminal Source RNS
INVP
INVP Investec PLC
15:36
Market

Investec Ltd & Investec plc Pref Share Dividends

Open Terminal Source RNS
BIPS
BIPS Invesco Bond Income Plus Li…
15:36
Market

Issue of Equity

Open Terminal Source RNS
CTUK
CTUK CT UK Capital And Income In…
15:35
Market

Transaction in Own Shares

Open Terminal Source RNS
IGET
IGET Invesco Perpetual Select Tr…
15:35
Market

Issue of Equity

Open Terminal Source RNS
SOS
SOS Sosandar Plc
15:34
Market

Notification of Major Holdings

TR1 Buy

TR1 Buy
Open Terminal Source RNS
NFG
NFG Next 15 Group PLC
15:31
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Liontrust Investment Partners LLP', '9.855000', '10.977700']
Open Terminal Source RNS
DEC
DEC Diversified Energy Company …
15:31
Market

Diversified Energy Results of the Court Meeting and General Meeting

Open Terminal Source RNS
BT.A
BT.A BT.A
15:31
Market

Director/PDMR Shareholding

Open Terminal Source RNS
ASC
ASC ASOS Plc
15:31
Market

Block listing Interim Review

Open Terminal Source RNS
RR.
RR. RR.
15:31
Market

Director/PDMR Shareholding

Rolls-Royce Holdings plc (the Company) announces that the following person(s) discharging managerial responsibilities <mark style="background-color:yellow">purchase</mark>d ordinary shares of 20p each in the Company by way of a monthly sha…

Rolls-Royce Holdings plc (the Company) announces that the following person(s) discharging managerial responsibilities <mark style="background-color:yellow">purchase</mark>d ordinary shares of 20p each in the Company by way of a monthly share purchase plan.
Open Terminal Source RNS
GAW
GAW Games Workshop Group PLC
15:24
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Baillie Gifford & Co', '5.050000', '4.970000']
Open Terminal Source RNS
ATN
ATN Eastinco Mining & Explorati…
15:21
Market

Issue of Equity

Open Terminal Source RNS
WIX
WIX Wickes Group PLC
15:17
Market

Director/PDMR Shareholding

Open Terminal Source RNS
AWE
AWE Alphawave IP Group PLC
15:02
Market

Holding(s) in Company

<mark style="background-color:yellow">TR1</mark> Buy

<mark style="background-coloryellow">TR1</mark> Buy
['JPMorgan Chase & Co.', 'Below minimum threshold', '1.344761']
Open Terminal Source RNS
BOOK
BOOK Literacy Capital PLC
15:01
Market

B Share scheme return of capital

Open Terminal Source RNS
LSL
LSL LSL Property Services Plc
15:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
CCT
CCT Character Group
14:55
Market

Transaction in Own Shares and Total Voting Rights

Open Terminal Source RNS
HSS
HSS HSS Hire Group PLC
14:54
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Harwood Capital LLP', '4.723000', '3.674000']
Open Terminal Source RNS
CMCL
CMCL Caledonia Mining Corporatio…
14:54
Market

Caledonia approves quarterly dividend

Open Terminal Source RNS
MONY
MONY MONY Group plc
14:50
Market

Director/PDMR Shareholding

Open Terminal Source RNS
SQZ
SQZ Serica Energy PLC
14:50
Market

Update: proposed acquisition of UK assets from BP

Open Terminal Source RNS
FRGT
FRGT Franklin Global Trust Ord
14:49
Market

TR1 - notification of major shareholding

Open Terminal Source RNS
GJ03
GJ03 GJ03
14:48
Market

Form 8.5 (EPT/RI)- Replacement of Aqua Acquisition

Open Terminal Source RNS
HAMA
HAMA Hamak Gold Ltd
14:46
Market

Correction: Director’s Dealings

Open Terminal Source RNS
MNDI
MNDI Mondi PLC
14:46
Market

Director/PDMR Shareholding

Open Terminal Source RNS
SNDA
SNDA Sunda Energy Plc
14:42
Market

Result of General Meeting

Open Terminal Source RNS
ACSO
ACSO Accesso Technology Group PLC
14:41
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of Ordinary Shares

<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
Open Terminal Source RNS
0QPR
0QPR Cicor Technologies Ltd.
14:36
Market

Disclosure under Rule 2.10(c) of the Takeover Code

Open Terminal Source RNS
0QZ3
0QZ3 Qualcomm Inc.
14:36
Market

Form 8.3

Open Terminal Source RNS
WG.
WG. WG.
14:34
Market

Form 8.3

Open Terminal Source RNS
SXS
SXS Spectris PLC
14:31
Market

Form 8.3

Open Terminal Source RNS
SBRY
SBRY J Sainsbury PLC
14:31
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of Ordinary Shares

<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
Open Terminal Source RNS
JUST
JUST Just Group plc
14:29
Market

Form 8.3

Open Terminal Source RNS
BARC
BARC Barclays PLC
14:28
Market

Irish Form 8.3 DALATA HOTEL GROUP PLC

Open Terminal Source RNS
DWL
DWL Dowlais Group Plc
14:27
Market

Form 8.3

Open Terminal Source RNS
AWE
AWE Alphawave IP Group PLC
14:26
Market

Form 8.3

Open Terminal Source RNS
JTC
JTC JTC PLC
14:26
Market

Form 8.3

Open Terminal Source RNS
0QZ3
0QZ3 Qualcomm Inc.
14:26
Market

Form 8.3

Open Terminal Source RNS
71LF
71LF 71LF
14:24
Market

ISM- MSBV- EARLY REDEMPTION - 10th Nov 2025

Open Terminal Source RNS
BARC
BARC Barclays PLC
14:21
Market

Form 8.3 - UNITE GROUP PLC

Open Terminal Source RNS
TBCG
TBCG TBC Bank Group PLC
14:21
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['FIL Limited', '5.534400', '5.004700']
Open Terminal Source RNS
71LF
71LF 71LF
14:20
Market

ISM - MSBV- PARTIAL_RETIREMENT -10th Nov 25

Open Terminal Source RNS
BARC
BARC Barclays PLC
14:20
Market

Form 8.3 - JUST GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
14:16
Market

Form 8.3 - SPIRE HEALTHCARE GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
14:16
Market

Form 8.3 - PETERSHILL PARTNERS PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
14:16
Market

Form 8.3 - BAKKAVOR GROUP PLC

Open Terminal Source RNS
TIDE
TIDE Crimson Tide plc
14:15
Market

Contract Renewal with Major Global Retailer

**Summary:** Crimson Tide PLC, the provider of the mpro5 process management app, has secured a three-year contract extension worth £3.88 million with one of the world’s largest retailers. This renewal strengthens the company’s long-standi…

**Summary**
Crimson Tide PLC, the provider of the mpro5 process management app, has secured a three-year contract extension worth £3.88 million with one of the world’s largest retailers. This renewal strengthens the company’s long-standing relationship with the retailer, which already uses mpro5 across 3,000+ locations in the UK and Ireland, with potential for further international expansion. The platform has become integral to the retailer’s in-store operations, consolidating multiple systems and driving efficiency. The agreement highlights mpro5’s role as a mission-critical tool for large enterprises and aligns with the retailer’s digital transformation strategy. CEO Jon Clarke emphasized the renewal’s significance, noting it reflects the company’s successful customer retention and growth strategy, with four of its top five revenue customers renewing contracts this financial year. This positions Crimson Tide for future growth.
NewContract
Open Terminal Source RNS
IBAI
IBAI IBAI
14:15
Market

IB Announces Completion of Phase 1 Trial of GaM

Open Terminal Source RNS
BRGE
BRGE BlackRock Greater Europe In…
14:15
Market

Submission of Documents

Open Terminal Source RNS
AWE
AWE Alphawave IP Group PLC
14:15
Market

Form 8.3

Open Terminal Source RNS
DO72
DO72 DO72
14:14
Market

ISM- MSESE- EARLY REDEMPTION -10th Nov 2025

Open Terminal Source RNS
SXS
SXS Spectris PLC
14:13
Market

Form 8.3

Open Terminal Source RNS
BARC
BARC Barclays PLC
14:12
Market

Form 8.3 - WOOD GROUP (JOHN) PLC

Open Terminal Source RNS
DO72
DO72 DO72
14:12
Market

ISM - MSESE- PARTIAL_RETIREMENT -10th Nov 25

Open Terminal Source RNS
BARC
BARC Barclays PLC
14:11
Market

Form 8.3 - EMPIRIC STUDENT PROPERTY PLC

Open Terminal Source RNS
WKP
WKP Workspace Group PLC
14:09
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Jefferies Financial Group Inc', '0.996000', '1.563000']
Open Terminal Source RNS
UKW
UKW Greencoat UK Wind PLC
14:08
Market

Kepler Trust Intelligence: Flash Update

Open Terminal Source RNS
GNC
GNC Greencore Group
14:07
Market

Form 8.3

Open Terminal Source RNS
BAKK
BAKK Bakkavor Group PLC
14:06
Market

Form 8.3

Open Terminal Source RNS
AIRE
AIRE Alternative Income REIT PLC
14:05
Market

Result of AGM

Open Terminal Source RNS
BARC
BARC Barclays PLC
14:03
Market

Form 8.3 JTC PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
14:03
Market

Form 8.3 NCC GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
14:03
Market

Form 8.3 - GREENCORE GROUP PLC

Open Terminal Source RNS
SXS
SXS Spectris PLC
14:03
Market

Form 8.3

Open Terminal Source RNS
GJ03
GJ03 GJ03
14:02
Market

Form 8.5 (EPT/RI)-Replacement of Alphawave IP

Open Terminal Source RNS
BARC
BARC Barclays PLC
14:01
Market

Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC

Open Terminal Source RNS
IDOX
IDOX IDOX plc
14:01
Market

Form 8.3

Open Terminal Source RNS
IPF
IPF International Personal Fina…
14:01
Market

Form 8.3

Open Terminal Source RNS
TTG
TTG TT Electronics Plc
14:01
Market

Form 8.3

Open Terminal Source RNS
JUST
JUST Just Group plc
14:01
Market

Form 8.3

Open Terminal Source RNS
0QPR
0QPR Cicor Technologies Ltd.
14:01
Market

Form 8.3

Open Terminal Source RNS
AZN
AZN AstraZeneca PLC
14:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
GNC
GNC Greencore Group
14:01
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['UBS Group AG-Investment Bank & Global Wealth Management', '3.980700', '0.000000']
Open Terminal Source RNS
GSK
GSK GSK plc
14:01
Market

GSK publishes provisional dividend dates

Open Terminal Source RNS
0QZ3
0QZ3 Qualcomm Inc.
13:59
Market

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated

Open Terminal Source RNS
JUST
JUST Just Group plc
13:59
Market

Form 8.3

Open Terminal Source RNS
JTC
JTC JTC PLC
13:57
Market

Form 8.3 - The Vanguard Group, Inc.: JTC plc

Open Terminal Source RNS
GJ03
GJ03 GJ03
13:57
Market

Form 8.5 (EPT/RI) - Replacement of John Wood Group

Open Terminal Source RNS
BGEU
BGEU Baillie Gifford European Gr…
13:56
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Allspring Global Investments Holdings.', '21.031000', '20.633000']
Open Terminal Source RNS
WG.
WG. WG.
13:56
Market

Form 8.3 - The Vanguard Group, Inc.: Wood Group (John) plc

Open Terminal Source RNS
UTG
UTG Unite Group PLC
13:55
Market

Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The

Open Terminal Source RNS
ESP
ESP Empiric Student Property Plc
13:55
Market

Form 8.3

Open Terminal Source RNS
LIO
LIO Liontrust Asset Management
13:54
Market

Form 8.3 - JTC PLC

Open Terminal Source RNS
SXS
SXS Spectris PLC
13:53
Market

Form 8.3 - The Vanguard Group, Inc.: Spectris plc

Open Terminal Source RNS
UTG
UTG Unite Group PLC
13:53
Market

Form 8.3

Open Terminal Source RNS
TMPL
TMPL Temple Bar Investment Trust
13:47
Market

Third Interim Dividend

Open Terminal Source RNS
TBCG
TBCG TBC Bank Group PLC
13:46
Market

Director/PDMR Shareholding

Open Terminal Source RNS
TATE
TATE Tate & Lyle PLC
13:41
Market

Director Declaration

Open Terminal Source RNS
MUT
MUT Murray Income Trust
13:36
Market

Gearing disclosure

Open Terminal Source RNS
AAIF
AAIF abrdn Asian Income Fund Lim…
13:36
Market

Gearing disclosure

Open Terminal Source RNS
AUSC
AUSC Abrdn UK Smaller Companies …
13:36
Market

Gearing disclosure

Open Terminal Source RNS
AEI
AEI abrdn Equity Income Trust p…
13:36
Market

Gearing disclosure

Open Terminal Source RNS
AAS
AAS Abrdn Asia Focus PLC
13:36
Market

Gearing disclosure

Open Terminal Source RNS
ANII
ANII Aberdeen New India Investme…
13:36
Market

Gearing disclosure

Open Terminal Source RNS
SHRS
SHRS Shires Income
13:36
Market

Gearing disclosure

Open Terminal Source RNS
MYI
MYI Murray International Trust
13:36
Market

Gearing disclosure

Open Terminal Source RNS
DIG
DIG Dunedin Income Growth Inves…
13:36
Market

Gearing disclosure

Open Terminal Source RNS
MHC
MHC MyHealthChecked Plc
13:36
Market

Change of Company name - Replacement

Open Terminal Source RNS
AAS
AAS Abrdn Asia Focus PLC
13:21
Market

First Interim Dividend

Open Terminal Source RNS
GLDA
GLDA Amundi Physical Gold ETC C
13:14
Market

Amundi Physical Metals plc: Final Terms

Open Terminal Source RNS
JD.
JD. JD.
13:12
Market

Appointment of Non-Executive Director

Open Terminal Source RNS
GLDA
GLDA Amundi Physical Gold ETC C
13:09
Market

Amundi Physical Metals plc: UK Final Terms

Open Terminal Source RNS
W7L
W7L Warpaint London PLC
13:07
Market

BLOCK LISTING RETURN

Open Terminal Source RNS
MAB
MAB Mitchells & Butlers PLC
13:01
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of partnership shares by the SIP Trustee (notified on 10 November 2025)

<mark style="background-coloryellow">Purchase</mark> of partnership shares by the SIP Trustee (notified on 10 November 2025)
Open Terminal Source RNS
GAMA
GAMA Gamma Communications PLC
13:01
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Allianz Global Investors GmbH', '10.800000', '11.010000']
Open Terminal Source RNS
81RX
81RX 81RX
12:50
Market

Issue of Debt

Open Terminal Source RNS
PCGH
PCGH Polar Capital Global Health…
12:47
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Rathbones Investment Management Ltd', '13.978800', '14.003100']
Open Terminal Source RNS
SN.
SN. SN.
12:47
Market

Director/PDMR Shareholding

Open Terminal Source RNS
BYG
BYG Big Yellow Group PLC
12:47
Market

Form 8.3

Open Terminal Source RNS
UTG
UTG Unite Group PLC
12:47
Market

Form 8.3

Open Terminal Source RNS
POW
POW Power Metal Resources plc
12:34
Market

Result of General Meeting

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
12:34
Market

Form 8.3 - Unite Group Plc

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
12:31
Market

Form 8.3 - Idox Plc

Open Terminal Source RNS
CREI
CREI Custodian REIT PLC
12:30
Market

Custodian Property Income REIT plc: Share Buyback

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
12:27
Market

Form 8.3 - Empiric Student Property Plc

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
12:25
Market

Form 8.3 - Bluefield Solar Income Fund Ltd

Open Terminal Source RNS
DGE
DGE Diageo PLC
12:21
Market

Director/PDMR Shareholding

Share <mark style="background-color:yellow">purchase</mark> under an arrangement with the Company

Share <mark style="background-coloryellow">purchase</mark> under an arrangement with the Company
Open Terminal Source RNS
CRTM
CRTM Critical Metals Plc
12:05
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Russell Fryer', ' 9.3', 0]
Open Terminal Source RNS
RGG
RGG RGG
12:01
Market

Notice of General Meeting

Open Terminal Source RNS
SYN
SYN Synergia Energy Ltd.
12:01
Market

Cambay PSC Update

Open Terminal Source RNS
BP.
BP. BP.
12:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
INVP
INVP Investec PLC
12:01
Market

Investec Ltd & Investec plc Pref Share Dividends

Open Terminal Source RNS
87FZ
87FZ AECI Ltd
12:01
Market

Changes to Board Committees

Open Terminal Source RNS
MGAM
MGAM Morgan Advanced Materials p…
11:50
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Perpetual Limited', '5.030396', 0]
Open Terminal Source RNS
MET1
MET1 Metals One PLC
11:43
Market

Investee Company Update: CleanTech Lithium

Open Terminal Source RNS
AMS
AMS Advanced Medical Solutions …
11:39
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Richard Griffiths and controlled holdings', '0.53', '0.37']
Open Terminal Source RNS
WINE
WINE Naked Wines plc
11:36
Market

Block Listing Six Monthly Return

Open Terminal Source RNS
MHC
MHC MyHealthChecked Plc
11:34
Market

Change of Company name

Open Terminal Source RNS
JPEL
JPEL JPEL Private Equity Ltd
11:20
Market

2025 AGM Circular Statement

Open Terminal Source RNS
FJV
FJV Fidelity Japanese Values PL…
11:19
Market

Results of Scheme Elections

Open Terminal Source RNS
XGDU
XGDU Xtrackers IE Physical Gold …
11:17
Market

Final Terms

Open Terminal Source RNS
XGDU
XGDU Xtrackers IE Physical Gold …
11:16
Market

Final Terms

Open Terminal Source RNS
UEM
UEM Utilico Emerging Markets Ltd
11:14
Market

Investor Presentation

Open Terminal Source RNS
JCGI
JCGI JPMorgan China Growth & Inc…
11:11
Market

Gearing Announcement

Open Terminal Source RNS
JMG
JMG JPMorgan Emerging Markets O…
11:11
Market

Gearing Announcement

Open Terminal Source RNS
JFJ
JFJ JPMorgan Japanese Investmen…
11:11
Market

Gearing Announcement

Open Terminal Source RNS
JEMI
JEMI JPMorgan Global Emerging Ma…
11:11
Market

Gearing Announcement

Open Terminal Source RNS
JIGI
JIGI JPMorgan India Growth & Inc…
11:11
Market

Gearing Announcement

Open Terminal Source RNS
JAGI
JAGI JPMorgan Asia Growth & Inco…
11:11
Market

Gearing Announcement

Open Terminal Source RNS
JEDT
JEDT JPMorgan Euro Small Compani…
11:11
Market

Gearing Announcement

Open Terminal Source RNS
JUGI
JUGI JPMorgan UK Small Cap Growt…
11:11
Market

Gearing Announcement

Open Terminal Source RNS
JEGI
JEGI JPMorgan European Growth & …
11:11
Market

Gearing Announcement

Open Terminal Source RNS
MRC
MRC The Mercantile Investment T…
11:11
Market

Gearing Announcement

Open Terminal Source RNS
JGGI
JGGI JP Morgan Global Growth & I…
11:11
Market

Gearing Announcement

Open Terminal Source RNS
JUSC
JUSC JPmorgan US Smaller Compani…
11:11
Market

Gearing Announcement

Open Terminal Source RNS
JAM
JAM JPMorgan American Investmen…
11:10
Market

Gearing Announcement

Open Terminal Source RNS
JCH
JCH JPMorgan Claverhouse Invest…
11:10
Market

Gearing Announcement

Open Terminal Source RNS
UEM
UEM Utilico Emerging Markets Ltd
11:08
Market

Publication of monthly factsheet

Open Terminal Source RNS
BRIG
BRIG BlackRock Income and Growth…
11:07
Market

Compliance with Listing Rule 15.6.8R

Open Terminal Source RNS
HAMA
HAMA Hamak Gold Ltd
11:04
Market

Director’s Dealings

Open Terminal Source RNS
BARC
BARC Barclays PLC
11:02
Market

Form 8.5 EPT/Non RI BIG YELLOW GROUP PLC

Open Terminal Source RNS
MSMN
MSMN Mosman Oil and Gas Ltd
11:01
Market

Result of Annual General Meeting

Open Terminal Source RNS
BARC
BARC Barclays PLC
11:01
Market

Form 8.5 (EPT/NON-RI) - Alphawave IP Group plc

Open Terminal Source RNS
BARC
BARC Barclays PLC
11:00
Market

Form 8.5 (EPT/NON-RI) - Spectris plc

Open Terminal Source RNS
BARC
BARC Barclays PLC
11:00
Market

Form8.5EPT/NonRIAQUAACQUISITIONSUBLLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
11:00
Market

Form8.5EPT/NonRIAMERICANAXLE&MANUFACTURINGHOLDINGS

Open Terminal Source RNS
BARC
BARC Barclays PLC
10:59
Market

Form 8.5 (EPT/NON-RI) - Dowlais Group plc

Open Terminal Source RNS
0UKI
0UKI Bank of Nova Scotia
10:54
Market

Form 8.3 - NCC Group plc

Open Terminal Source RNS
APN
APN Applied Nutrition Plc
10:51
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['UBS Group AG-Investment Bank & Global Wealth Management', '0.000000', '5.016711']
Open Terminal Source RNS
0UKH
0UKH Bank of Montreal
10:44
Market

Form 8 (DD) - Qualcomm Inc

Open Terminal Source RNS
APTD
APTD Aptitude Software Group PLC
10:42
Market

Total Voting Rights

Open Terminal Source RNS
GEN
GEN Genuit Group plc
10:41
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['FIL Limited', '9.490300', '9.752100']
Open Terminal Source RNS
0UKH
0UKH Bank of Montreal
10:41
Market

Form 8 (DD) - Qualcomm Inc

Open Terminal Source RNS
ABDN
ABDN Abrdn PLC
10:34
Market

Form 8.3 - Empiric Student Property plc

Open Terminal Source RNS
BAKK
BAKK Bakkavor Group PLC
10:33
Market

Form 8.3

Open Terminal Source RNS
UTG
UTG Unite Group PLC
10:30
Market

Form 8.3

Open Terminal Source RNS
TFG
TFG Tetragon Financial Group Ltd
10:28
Market

Statement re: Dividend Information

Open Terminal Source RNS
GNC
GNC Greencore Group
10:28
Market

Form 8.3

Open Terminal Source RNS
JUST
JUST Just Group plc
10:28
Market

Form 8.3

Open Terminal Source RNS
SXS
SXS Spectris PLC
10:27
Market

Form 8.3

Open Terminal Source RNS
SE77
SE77 SE77
10:26
Market

Publication of a Supplementary Prospectus

Open Terminal Source RNS
ABDN
ABDN Abrdn PLC
10:25
Market

Form 8.3 Wood Group (John) plc

Open Terminal Source RNS
ESP
ESP Empiric Student Property Plc
10:24
Market

Form 8.3

Open Terminal Source RNS
DWL
DWL Dowlais Group Plc
10:23
Market

Form 8.3

Open Terminal Source RNS
GNC
GNC Greencore Group
10:20
Market

Form 8.3

Open Terminal Source RNS
BAKK
BAKK Bakkavor Group PLC
10:19
Market

Form 8.3

Open Terminal Source RNS
JUP
JUP Jupiter Fund Management Plc
10:16
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['SILCHESTER INTERNATIONAL INVESTORS LLP', '15.970000', '16.997000']
Open Terminal Source RNS
NTVO
NTVO Nativo Resources plc
10:06
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Richard Edwards', '5.68', '6.48']
Open Terminal Source RNS
SE77
SE77 SE77
10:02
Market

Publication of a Supplementary Prospectus

Open Terminal Source RNS
MHC
MHC MyHealthChecked Plc
10:01
Market

Completion of Disposal and Board Changes

Open Terminal Source RNS
AAL
AAL Anglo American PLC
10:01
Market

Anglo American publishes shareholder circular

Open Terminal Source RNS
50AS
50AS 50AS
10:00
Market

Publication of a Prospectus

Open Terminal Source RNS
GJ03
GJ03 GJ03
10:00
Market

Form 8.5 (EPT/RI) - John Wood Group plc

Open Terminal Source RNS
YJ18
YJ18 YJ18
09:59
Market

Funding Announcement

Open Terminal Source RNS
STG
STG Strip Tinning Holdings PLC
09:59
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['GPIM Limited', '11.33', '10']
Open Terminal Source RNS
GJ03
GJ03 GJ03
09:57
Market

Form 8.5 (EPT/RI) - Alphawave IP Group plc

Open Terminal Source RNS
BF48
BF48 BF48
09:57
Market

Annual Financial Report

Open Terminal Source RNS
DO72
DO72 DO72
09:54
Market

Form 8.5 (EPT/NON-RI) -Alphawave IP Group plc

Open Terminal Source RNS
DO72
DO72 DO72
09:53
Market

Form 8.5 (EPT/NON-RI) - John Wood Group plc

Open Terminal Source RNS
BBY
BBY Balfour Beatty plc
09:52
Market

Transaction in Own Shares

Open Terminal Source RNS
XF92
XF92 XF92
09:52
Market

Notice to noteholders XS2736750279 - Replacement

Open Terminal Source RNS
GJ03
GJ03 GJ03
09:39
Market

Rule 38.5_A - Avadel Pharmaceuticals plc

Open Terminal Source RNS
EWI
EWI Edinburgh Worldwide Investm…
09:39
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Saba Capital Management, L.P.', '25.051939', '24.887687']
Open Terminal Source RNS
AMP
AMP AMPEAK ENERGY LIMITED
09:35
Market

Ampeak Energy welcomes Cabinet Secretary to MeyGen

Open Terminal Source RNS
GMS
GMS Gulf Marine Services PLC
09:34
Market

Block Listing Six Monthly Return

Open Terminal Source RNS
FTC
FTC Filtronic
09:34
Market

Exercise of Options and Total Voting Rights

Open Terminal Source RNS
JAR
JAR Jardine Matheson Holdings L…
09:32
Market

JC&C Interim Management Statement

Open Terminal Source RNS
NWG
NWG NatWest Group PLC
09:31
Market

Final Terms

Open Terminal Source RNS
MSLH
MSLH Marshalls PLC
09:31
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of shares under the Marshalls plc Employee Share Purchase Plan 2015

<mark style="background-coloryellow">Purchase</mark> of shares under the Marshalls plc Employee Share Purchase Plan 2015
Open Terminal Source RNS
IRSH
IRSH IRSH
09:31
Market

SATO Oyj - Managers' Transactions

Open Terminal Source RNS
MSLH
MSLH Marshalls PLC
09:30
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of shares under the Marshalls plc Employee Share Purchase Plan 2015

<mark style="background-coloryellow">Purchase</mark> of shares under the Marshalls plc Employee Share Purchase Plan 2015
Open Terminal Source RNS
IRSH
IRSH IRSH
09:30
Market

Form 8.3 - Dalata Hotel Group PLC

Open Terminal Source RNS
IRSH
IRSH IRSH
09:30
Market

Form 8.3 - Dowlais Group plc

Open Terminal Source RNS
WISE
WISE Wise plc
09:29
Market

Director/PDMR Shareholding

Open Terminal Source RNS
MSLH
MSLH Marshalls PLC
09:28
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of shares under the Marshalls plc Employee Share Purchase Plan 2015

<mark style="background-coloryellow">Purchase</mark> of shares under the Marshalls plc Employee Share Purchase Plan 2015
Open Terminal Source RNS
IRSH
IRSH IRSH
09:26
Market

Form 8.3 - Wood Group (John) plc

Open Terminal Source RNS
IRSH
IRSH IRSH
09:26
Market

Form 8.3 - Spectris plc

Open Terminal Source RNS
IRSH
IRSH IRSH
09:25
Market

Form 8.3 - Qualcomm Incorporated

Open Terminal Source RNS
IRSH
IRSH IRSH
09:24
Market

Form 8.3 - Petershill Partners plc

Open Terminal Source RNS
GJ03
GJ03 GJ03
09:23
Market

Form 8.5 (EPT/RI) - Aqua Acquisition Sub LLC

Open Terminal Source RNS
IRSH
IRSH IRSH
09:22
Market

Form 8.3 - American Axle & Manufacturing Holdings

Open Terminal Source RNS
ECOR
ECOR Ecora Resources PLC
09:22
Market

Phalaborwa Rare Earths Project Update

Open Terminal Source RNS
IRSH
IRSH IRSH
09:20
Market

Form 8.3 - Bakkavor Group Plc

Open Terminal Source RNS
THRG
THRG Throgmorton Trust Plc
09:19
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Jefferies Financial Group Inc', '1.218000', '2.011000']
Open Terminal Source RNS
DO72
DO72 DO72
09:16
Market

Form 8.5 (EPT/NON-RI) - Aqua Acquisition Sub LLC

Open Terminal Source RNS
PET
PET Petrel Resources
09:03
Market

Board Changes

Open Terminal Source RNS
DOM
DOM Domino’s Pizza Group PLC
09:01
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['The Capital Group Companies, Inc.', '9.730380', '10.615023']
Open Terminal Source RNS
HGT
HGT HG Capital Trust PLC
09:01
Market

Hg announces an investment in Diamant Software

Open Terminal Source RNS
PTSB
PTSB Permanent TSB Group Holding…
09:01
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['The Goldman Sachs Group, Inc.', '3.68', '3.73']
Open Terminal Source RNS
PTSB
PTSB Permanent TSB Group Holding…
09:01
Market

Form 8.3 - Permanent TSB Group Holdings plc

Open Terminal Source RNS
WIZZ
WIZZ Wizz Air Holdings PLC
08:47
Market

Holding(s) in Company

<mark style="background-color:yellow">TR1</mark> Buy

<mark style="background-coloryellow">TR1</mark> Buy
['Barclays PLC', 'Below minimum threshold', '0.030000']
Open Terminal Source RNS
HILS
HILS Hill & Smith Holdings PLC
08:45
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['BlackRock, Inc.', '4.990000', '5.020000']
Open Terminal Source RNS
IDOX
IDOX IDOX plc
08:43
Market

Form 8 - Idox plc

Open Terminal Source RNS
31TK
31TK 31TK
08:39
Market

Tender Offer

Open Terminal Source RNS
INVP
INVP Investec PLC
08:36
Market

Form 8.5 (EPT/RI)-Dowlais Group plc

Open Terminal Source RNS
INVP
INVP Investec PLC
08:32
Market

Form 8.5 (EPT/RI)-NCC Group plc

Open Terminal Source RNS
ECEL
ECEL Eurocell PLC
08:31
Market

Director/PDMR Shareholding

Eurocell plc announces that, pursuant to the Non-executive Directors Share <mark style="background-color:yellow">Purchase</mark> Plan which was announced on 3 February 2023, five directors have purchased shares in the Company on 7 November…

Eurocell plc announces that, pursuant to the Non-executive Directors Share <mark style="background-color:yellow">Purchase</mark> Plan which was announced on 3 February 2023, five directors have purchased shares in the Company on 7 November 2025. As previously announced, following these trades, Will Trumans membership of the scheme has now ceased.
Open Terminal Source RNS
CRH
CRH CRH PLC
08:31
Market

Transaction in Own Shares

Open Terminal Source RNS
KRM
KRM KRM22 Plc
08:29
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['CANACCORD GENUITY GROUP INC', '12.0669', '10.0010']
Open Terminal Source RNS
71GA
71GA 71GA
08:29
Market

Publication of Final Terms

Open Terminal Source RNS
HHPD
HHPD Hon Hai Precision Industry …
08:28
Market

FULLERTAIN obtaining SSTEC Shares

Open Terminal Source RNS
HHV
HHV Hargreave Hale Aim Vct PLC
08:20
Market

Interim Management Statement Q4 2025

Open Terminal Source RNS
AG79
AG79 AG79
08:20
Market

3rd Quarter Results

Open Terminal Source RNS
BK64
BK64 BK64
08:07
Market

Fifth Consent Requests - Super Senior Funding

Open Terminal Source RNS
0RYA
0RYA Ryanair Holdings plc
08:02
Market

Transaction in Own Shares

Open Terminal Source RNS
AW14
AW14 AW14
08:01
Market

Fifth Consent Requests - Super Senior Funding

Open Terminal Source RNS
IRSH
IRSH IRSH
07:56
Market

Landsbankinn hf.: Offering of covered bonds

Open Terminal Source RNS
82GS
82GS 82GS
07:43
Market

Tender Offer

Open Terminal Source RNS
OTES
OTES HELLENIC TELECOMMUNICATIONS…
07:37
Market

Purchase of own shares

Open Terminal Source RNS
94AW
94AW 94AW
07:33
Market

Early Redemption(s)

Open Terminal Source RNS
MACF
MACF Macfarlane Group PLC
07:28
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Hauser Brothers GmbH', '5.060000', '4.027000']
Open Terminal Source RNS
AQ39
AQ39 AQ39
07:25
Market

Early Redemption(s)

Open Terminal Source RNS
17WI
17WI 17WI
07:24
Market

Pre Stabilisation Notice Danske short 3y/7y CB

Open Terminal Source RNS
WNX
WNX Wellnex Life Limited
07:23
Market

Update on Loan Repayment

Open Terminal Source RNS
PRN
PRN Princes Group plc
07:02
Market

Stabilisation Notice

Open Terminal Source RNS
0RLW
0RLW Commerzbank AG
07:01
Market

Post Stabilisation - Land Brandenburg EUR500mil 2.75% LSA 2033

Open Terminal Source RNS
ENT
ENT Entain PLC
07:01
Market

Proposed Refinancing Transaction

Open Terminal Source RNS
ASAI
ASAI ASA International Group PLC
06:58
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of ordinary shares

<mark style="background-coloryellow">Purchase</mark> of ordinary shares
Open Terminal Source RNS
GGP
GGP Greatland Resources Limited
06:48
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['BlackRock, Inc.', '2.94', '3.20']
Open Terminal Source RNS
0HAF
0HAF Nokia Oyj
06:46
Market

Nokia nimittää Kristen Pressnerin henkilöstöjohtajaksi ja johtoryhmän jäseneksi

Open Terminal Source RNS
0HAF
0HAF Nokia Oyj
06:46
Market

Nokia appoints Kristen Pressner as Chief People Officer and member of the Group Leadership Team

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
06:31
Market

Transaction in Own Shares

Open Terminal Source RNS
HSX
HSX Hiscox Ltd
06:31
Market

Syndicates 33 and 6104 – results and estimates

Open Terminal Source RNS
BYIT
BYIT Bytes Technology Ltd
06:31
Market

Transaction in Own Shares

Open Terminal Source RNS
0RPR
0RPR Ringkjoebing Landbobank A/S
06:28
Market

Share buyback programme - week 45

**Summary of Ringkjøbing Landbobank A/S Share Buyback Programme - Week 45 (10 November 2025)** Ringkjøbing Landbobank A/S announced the progress of its share buyback programme for Week 45, part of a larger initiative running from 2 June…

**Summary of Ringkjøbing Landbobank A/S Share Buyback Programme - Week 45 (10 November 2025)**
Ringkjøbing Landbobank A/S announced the progress of its share buyback programme for Week 45, part of a larger initiative running from 2 June 2025 to 30 January 2026. The programme aims to repurchase up to DKK 1,000 million worth of shares, with a maximum of 1,600,000 shares, in compliance with EU regulations (Regulation No. 596/2014 and Delegated Regulation No. 2016/1052).
**Key Highlights**
1. **Total Shares Bought Back (Week 45)** 20,500 shares.
2. **Average Purchase Price (Week 45)** DKK 1,456.89.
3. **Total Programme Expenditure (Week 45):** DKK 707,975,445.
4. **Cumulative Shares Bought Back (Since Programme Start):** 910,877 shares (3.59% of share capital).
5. **Cumulative Programme Expenditure** DKK 1,207,964,151.
**Transactions Breakdown (Week 45)**
**3 November 2025:** 3500 shares at DKK 1472.79.
**4 November 2025:** 3500 shares at DKK 1470.64.
**5 November 2025:** 3500 shares at DKK 1466.14.
**6 November 2025:** 3500 shares at DKK 1456.89.
**7 November 2025:** 5000 shares at DKK 1428.41.
The bank now holds 910,877 of its own shares, excluding trading portfolio and customer investments. Detailed transaction data is attached to the corporate announcement for transparency.
**CEO Statement**
John Fisker, CEO, confirmed adherence to regulatory requirements and provided detailed transaction records for stakeholder review.
This update reflects the bank’s ongoing commitment to its share buyback strategy, with Week 45 transactions contributing to the programme’s overall progress.
BuyBack
Open Terminal Source RNS
BARC
BARC Barclays PLC
06:16
Market

Transaction in Own Shares

Open Terminal Source RNS
0A3F
0A3F 0A3F
06:11
Market

Net Asset Value(s)

Open Terminal Source RNS
0A3D
0A3D iShares VII Public Limited …
06:11
Market

Net Asset Value

Open Terminal Source RNS
0A3E
0A3E 0A3E
06:11
Market

Net Asset Value

Open Terminal Source RNS
CMB1
CMB1 iShares FTSE MIB UCITS
06:11
Market

Net Asset Value

Open Terminal Source RNS
0A3G
0A3G 0A3G
06:11
Market

Net Asset Value

Open Terminal Source RNS
TRST
TRST Trustpilot Group PLC
06:06
Market

Transaction in Own Shares

Open Terminal Source RNS
TRC
TRC Revel Collective PLC
06:03
Market

Form 8.3 - Revel Collective Plc

Open Terminal Source RNS
GROW
GROW Draper Esprit PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SYM
SYM Symphony Environmental Tech…
06:01
Market

New product launch, South Korea

**Summary:** Symphony Environmental Technologies Plc, a global leader in sustainable plastic and rubber technologies, announced that its exclusive South Korean distributor, CPST, in collaboration with PetRize Inc., won the Grand Prize (Ea…

**Summary**
Symphony Environmental Technologies Plc, a global leader in sustainable plastic and rubber technologies, announced that its exclusive South Korean distributor, CPST, in collaboration with PetRize Inc., won the Grand Prize (Early Startup Division) at the Gyeonggi Province Pet Startup Competition for the **Wanspapa biodegradable Dog Waste Bag**. This product incorporates Symphonys **d2w® biodegradable masterbatch**, offering a sustainable solution for pet owners without compromising performance. Key advantages of Wanspapa include ASTM D6954-24 open-air biodegradability (leaving no microplastics), easy-open design, tear strength, reduced odor, lower CO₂ emissions, and South Korean manufacturing for quality assurance.
PetRize Inc., a startup with ambitious international expansion plans, aims to target major retail chains in Korea, North America, Canada, and Australia. Symphony’s CEO, Michael Laurier, praised the achievement, highlighting the success of their technology and CPST’s efforts. This milestone underscores the commercial and environmental value of Symphony’s d2w technology in the global pet market.
The announcement is non-regulatory and does not significantly impact Symphony’s performance expectations. Symphony continues to innovate with its d2p and NbR brands, offering diverse plastic technologies globally, with products available in nearly 100 countries.
**Key Points**
**Product** Wanspapa biodegradable Dog Waste Bag using Symphony’s d2w technology.
**Award** Grand Prize at Korean Pet Startup Competition.
**Advantages:** Biodegradabilityconveniencereliabilitysustainabilityand quality.
**Expansion** PetRize targets international markets, including North America, Canada, and Australia.
**Impact** Demonstrates Symphony’s technology’s commercial and environmental value.
Launch
Open Terminal Source RNS
TOO
TOO Tooru Plc
06:01
Market

Corporate Update – Juvela and Pulsin

Open Terminal Source RNS
EYE
EYE Eagle Eye Solutions Group p…
06:01
Market

Multi-year contract with North American retailer

**Summary:** Eagle Eye Solutions Group PLC, a leading SaaS and AI technology company, has secured a five-year contract with one of North Americas largest independent food retailers. The retailer, operating over 450 stores across Texas and…

**Summary**
Eagle Eye Solutions Group PLC, a leading SaaS and AI technology company, has secured a five-year contract with one of North Americas largest independent food retailers. The retailer, operating over 450 stores across Texas and Mexico under five brands, will utilize Eagle Eyes AIR platform for promotional capabilities within its eCommerce business. The contract, expected to go live in the first half of 2026, marks a significant opportunity for Eagle Eye to deepen its relationship with the retailer and expand its presence in the North American market.
This win underscores Eagle Eyes strategic focus on North America, the worlds largest loyalty and promotions market, and reflects early success from initiatives aimed at growing the sales pipeline and improving conversion rates. Tim Mason, Eagle Eyes CEO, emphasized the companys commitment to accelerating growth in the region through enhanced personalization and customer experience.
Eagle Eyes technology, recognized by industry leaders like Gartner and Forrester, powers over 1 billion personalized offers weekly and manages 700 million loyalty member wallets globally. The company’s growing client base includes major retailers such as Loblaws, Tesco, and Carrefour. This contract reinforces Eagle Eyes position as a key player in real-time, omnichannel, and personalized marketing solutions.
NewContract
Open Terminal Source RNS
TEK
TEK Tekcapital plc
06:01
Market

Strategic Alliance signed with Nexscient Inc

Open Terminal Source RNS
EEE
EEE Empire Metals Limited
06:01
Market

Speaking at TZMI Congress

Open Terminal Source RNS
ELCO
ELCO Eleco PLC
06:01
Market

Industry Award Wins

**Summary:** Eleco plc (AIM: ELCO), a specialist software provider for the built environment, has been honored with two prestigious awards at the Construction Computing Awards 2025: *Company of the Year* and *Project Management Software…

**Summary**
Eleco plc (AIMELCO), a specialist software provider for the built environment, has been honored with two prestigious awards at the Construction Computing Awards 2025: *Company of the Year* and *Project Management Software of the Year* for the twelfth consecutive year. Jonathan Hunter, CEO of Eleco plc, expressed gratitude for the recognition, attributing the success to the company’s talented teams and their dedication to meeting customer needs in a competitive and fast-evolving industry. Eleco operates internationally through brands like Elecosoft, BestOutcome, and PEMAC, offering software solutions across the building lifecycle, from planning and design to asset and facilities management. The announcement was distributed via RNS Reach, a non-regulatory press release service of the London Stock Exchange.
Awards
Open Terminal Source RNS
ANIC
ANIC Agronomics Ltd
06:01
Market

EVERY raise US$ 55 million in fresh capital

Open Terminal Source RNS
ACG
ACG ACG Acquisition Co. Ltd.
06:01
Market

Treasury Warrants Cancellation

Open Terminal Source RNS
FXPO
FXPO Ferrexpo PLC
06:01
Market

Limited attack on power infrastructure

Open Terminal Source RNS
LND
LND Landore Resources Plc
06:01
Market

Amalgamation of Landore Canada and Lamaune

Open Terminal Source RNS
AXS
AXS Accsys Technologies PLC
06:01
Market

Notice of Interim Results & Investor Presentation

Open Terminal Source RNS
ARS
ARS Asiamet Resources Limited
06:01
Market

Notice of Annual General Meeting

Open Terminal Source RNS
EAH
EAH Eco Animal Health Group Plc
06:01
Market

EMA Positive Opinion Received for ECOVAXXIN® MS

Open Terminal Source RNS
TXP
TXP Touchstone Exploration Inc
06:01
Market

MANAGEMENT CHANGE

Open Terminal Source RNS
BREE
BREE Breedon Group PLC
06:01
Market

Appointment of Joint Corporate Broker

Open Terminal Source RNS
FSFL
FSFL Foresight Solar Fund Ltd
06:01
Market

Investment management team update

Open Terminal Source RNS
BOOK
BOOK Literacy Capital PLC
06:01
Market

B Share scheme return of capital

Open Terminal Source RNS
GPE
GPE GREAT PORTLAND ESTATES PLC
06:01
Market

GPE gets planning approval for Whittington House

**Summary:** Great Portland Estates PLC (GPE) has secured planning approval from Camden Council for the refurbishment of Whittington House, a 74,500 sq ft HQ building in Londons West End (WC1). The project, expected to complete in Q1 2027…

**Summary**
Great Portland Estates PLC (GPE) has secured planning approval from Camden Council for the refurbishment of Whittington House, a 74,500 sq ft HQ building in Londons West End (WC1). The project, expected to complete in Q1 2027, will transform the building into a sustainable, Grade A workspace with eight floors of offices, a new rooftop terrace, and a pavilion. Located near Tottenham Court Road Elizabeth Line station, the development is part of a larger 220,000 sq ft cluster of prime office space, including the Gable Building, Courtyard Building, and 31/34 Alfred Place. Trevor Phyo, GPEs Senior Development Manager, highlighted the projects significance in preserving architectural heritage while creating a modern workplace. This approval strengthens GPEs HQ portfolio and underscores its commitment to delivering exceptional spaces in prime London locations.
Approvals
Open Terminal Source RNS
ZNWD
ZNWD Zinnwald Lithium PLC
06:01
Market

Publication of ESIA Scoping Study

Open Terminal Source RNS
AVG
AVG Avingtrans Plc
06:01
Market

Adaptix receives FDA 510(K) clearance

**Summary:** Avingtrans plc, a UK-based company specializing in critical components and systems for energy, medical, and industrial sectors, announced that its subsidiary Adaptix Limited has received FDA 510(k) clearance for its orthopaed…

**Summary**
Avingtrans plc, a UK-based company specializing in critical components and systems for energy, medical, and industrial sectors, announced that its subsidiary Adaptix Limited has received FDA 510(k) clearance for its orthopaedic 3D imaging product, the Adaptix Ortho350. This compact, mobile, low-dose Digital Tomosynthesis (DT) system is designed for point-of-care use, offering fast, affordable, and high-quality 3D X-ray imaging for upper and lower extremity diagnostics. The clearance enables Adaptix to enter the U.S. human healthcare imaging market, marking a significant milestone in its mission to revolutionize radiology. The Ortho350 delivers superior image clarity compared to 2D X-ray systems while reducing radiation exposure, improving diagnostic accuracy, and enhancing patient outcomes. Adaptix has already commercialized similar technology in veterinary and industrial markets, and this FDA approval validates the technologys commercial potential. Company executives expressed excitement about the strong interest from healthcare providers and the systems potential impact on primary care, intensive care, and emergency departments.
FDA
Open Terminal Source RNS
ALK
ALK Alkemy Capital Investments …
06:01
Market

Tees Valley Lithium Financing and Project Delivery

Open Terminal Source RNS
LSEG
LSEG London Stock Exchange Group…
06:01
Market

LSEG Innovation Forum

Open Terminal Source RNS
450
450 450 PLC
06:01
Market

Notice of Annual General Meeting

Open Terminal Source RNS
GATC
GATC GATTACA Plc
06:01
Market

Availability of Report & Accounts and AGM Notice

Open Terminal Source RNS
DGE
DGE Diageo PLC
06:01
Market

Sir Dave Lewis appointed Diageo plc CEO

Open Terminal Source RNS
SSPG
SSPG SSP Group PLC
06:01
Market

SSP Group Board Change

Open Terminal Source RNS
HLN
HLN Haleon PLC
06:01
Market

Appointment of Vindi Banga as Chair

Open Terminal Source RNS
AET
AET Afentra PLC
06:01
Market

Board and Audit Chair Appointment

Open Terminal Source RNS
OBD
OBD Oxford Biodynamics PLC
06:01
Market

PDMR Dealing / Grant of Share Options

Open Terminal Source RNS
COBR
COBR Cobra Resources PLC
06:01
Market

Block Listing Application

Open Terminal Source RNS
WKP
WKP Workspace Group PLC
06:01
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Saba Capital Management, L.P.', '0.162330', '0.162330']
Open Terminal Source RNS
CPX
CPX CAP-XX Limited
06:01
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of ordinary shares

<mark style="background-coloryellow">Purchase</mark> of ordinary shares
Open Terminal Source RNS
0QZ3
0QZ3 Qualcomm Inc.
06:01
Market

Rule 2.9 Announcement

Open Terminal Source RNS
VAL
VAL ValiRx plc
06:01
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Peel Hunt LLP', '10.061786', '9.459765']
Open Terminal Source RNS
PTAL
PTAL Petrotal Corp
06:01
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Kite Lake Capital Management (UK) LLP', '0', '0']
Open Terminal Source RNS
PTAL
PTAL Petrotal Corp
06:01
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Kite Lake Capital Management (UK) LLP', '0', '0']
Open Terminal Source RNS
CHG
CHG Chemring Group PLC
06:01
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Albion River Management LLC', '3.021618', 0]
Open Terminal Source RNS
SEEN
SEEN SEEEN PLC
06:01
Market

Director dealing

<mark style="background-color:yellow">Purchase</mark> of Ordinary Shares into SIPP

<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares into SIPP
Open Terminal Source RNS
GFM
GFM Griffin Mining
06:01
Market

SHARE DEALINGS

Open Terminal Source RNS
ESNT
ESNT Essentra PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
DKL
DKL Dekeloil Public Ltd
06:01
Market

October Palm Oil & Cashew Update

Open Terminal Source RNS
KZG
KZG Kazera Global PLC
06:01
Market

Subscription to Raise £1.3 million

Open Terminal Source RNS
STAN
STAN Standard Chartered PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BUCE
BUCE Buccaneer Energy plc.
06:01
Market

Results of Allar #1

Open Terminal Source RNS
SOLG
SOLG SolGold PLC
06:01
Market

Strong Drilling Results at Tandayama-América

Open Terminal Source RNS
JTC
JTC JTC PLC
06:01
Market

Recommended Cash Acquisition of JTC PLC

Open Terminal Source RNS
ENQ
ENQ Enquest Plc
06:01
Market

New senior secured debt facilities

Open Terminal Source RNS
BYG
BYG Big Yellow Group PLC
06:01
Market

Extension of PUSU Deadline

Open Terminal Source RNS
INSG
INSG Insig Ai PLC
06:01
Market

New contract with global advisory firm

**Summary:** Insig AI Plc (AIM: INSG), a leader in AI-led analytics and machine-learning solutions, has secured a new contract with a global advisory firm operating in over 70 countries. This agreement marks Insig AIs entry into the globa…

**Summary**
Insig AI Plc (AIMINSG), a leader in AI-led analytics and machine-learning solutions, has secured a new contract with a global advisory firm operating in over 70 countries. This agreement marks Insig AIs entry into the global advisory sector, a market with significant growth potential. The contract is based on a monthly subscription model, with expected value increases in 2026 as the solution is implemented across the clients business.
The client will utilize Insig AIs Generative Intelligence Engine (GIE) to automate the benchmarking of corporate reporting disclosures against international standards. GIE streamlines the process by converting documents into structured data, performing targeted analyses, and delivering auditable insights and recommendations. This automation enhances speed, reduces manual effort, and improves consistency in reporting.
Insig AI CEO Richard Bernstein highlighted the significance of this agreement, emphasizing its demonstration of the platforms commercial relevance and ability to support large, multinational clients. The deal is seen as a foundation for future recurring revenue growth in the advisory sector.
**Key Points**
Insig AI secures a new contract with a global advisory firm.
Entry into the global advisory sector, a new market vertical with growth potential.
Monthly subscription model with anticipated value increase in 2026.
Client will use Insig AIs Generative Intelligence Engine (GIE) for automated benchmarking of corporate reporting disclosures.
GIE enhances speed, reduces manual effort, and improves consistency in reporting.
Agreement demonstrates Insig AIs platform relevance and ability to support large clients.
Foundation for future recurring revenue growth in the advisory sector.
NewContract
Open Terminal Source RNS
MBH
MBH Michelmersh Brick Holdings …
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HUI
HUI HYDROGEN UTOPIA INTERNATION…
06:01
Market

Extension of IPO Warrants

Open Terminal Source RNS
APN
APN Applied Nutrition Plc
06:01
Market

Final Results

**Summary of Applied Nutrition PLCs Final Results for FY25** Applied Nutrition PLC, a leading sports nutrition, health, and wellness brand, announced its final results for the fiscal year ended July 31, 2025 (FY25), highlighting significa…

**Summary of Applied Nutrition PLCs Final Results for FY25**
Applied Nutrition PLC, a leading sports nutrition, health, and wellness brand, announced its final results for the fiscal year ended July 31, 2025 (FY25), highlighting significant growth and strategic achievements.
**Financial Highlights**
**Revenue Growth** FY25 revenue increased by 24.2% to £107.1 million, surpassing IPO guidance and market expectations.
**EBITDA and Profit** Adjusted EBITDA rose by 18.8% to £30.9 million, and unadjusted operating profit grew by 18.6% to £28.1 million.
**Cash Flow** Strong free cash flow conversion of 72.4% and net cash of £18.5 million at the period end.
**Operational and Strategic Achievements**
**Global Expansion** Deepened relationships with existing customers and expanded into new geographies, including Latin America and Asia.
**Product Innovation** Launched new products like Vimto-flavored gels, hydration products, and Sparkling Collagen Protein Water.
**Capacity Increase** Completed a factory extension in August 2024, increasing revenue capacity to approximately £200 million.
**Current Trading and Outlook**
**Continued Momentum** Strong sales growth in Q4 FY25 continued into Q1 FY26, with positive market share trends.
**Investment in Growth** Plans to invest in additional capacity and capabilities to support continued growth.
**Prudent Outlook** Despite a strong Q1 FY26, the Board maintains current market expectations for FY26 due to the early stage of the financial year.
**CEO Commentary**
Thomas Ryder, CEO, emphasized over-delivering on IPO targets, strengthening customer relationships, and expanding globally. The company aims to become the worlds most trusted and innovative sports nutrition brand.
**Key Financial Metrics**
**Revenue** £107.1 million (FY24: £86.2 million)
**Adjusted EBITDA** £30.9 million (FY24: £26.0 million)
**Operating Profit** £28.1 million (FY24: £23.7 million)
**Free Cash Flow** £16.5 million (FY24: £7.1 million)
**Strategic Focus**
**B2B Model** Leveraging a low-risk, cost-effective B2B strategy with complementary D2C growth.
**Innovation** Continuous product development to meet consumer trends and expand market share.
**Global Presence** Expanding into new markets and strengthening distributor relationships.
**Future Investments**
**Production Expansion** Investing £2.0-£2.5 million to increase capacity to £300 million in revenue.
**New Distribution Facility** Planning a new global distribution facility and head office, expected to cost £3.5-£4.0 million.
**Conclusion**
Applied Nutrition PLC demonstrated robust financial and operational performance in FY25, exceeding expectations and positioning itself for continued growth in FY26. The company remains focused on innovation, global expansion, and strengthening its market position in the sports nutrition and wellness sector.
Here is the HTML table code comparing the financials and debt year on year for Applied Nutrition PLC:
MetricFY25 (£m)FY24 (£m)Change
Revenue107.186.224.2%
Gross Profit49.341.319.4%
Adjusted EBITDA30.926.018.8%
Adjusted Profit Before Tax30.225.717.5%
Free Cash Flow16.57.1132.4%
Net Cash18.518.7(1.1%)
Lease Liabilities (Current)0.60.3100.0%
Lease Liabilities (Non-Current)2.41.560.0%
Total Lease Liabilities3.01.866.7%
**Notes:** * The table compares key financial metrics and debt (lease liabilities) for Applied Nutrition PLC between FY25 and FY24. * Net Cash is calculated as Cash and Cash Equivalents minus Total Lease Liabilities. * The percentage change is calculated as ((FY25 - FY24) / FY24) * 100. * This table provides a snapshot of the company's financial performance and debt position, highlighting areas of growth and potential concerns.
Open Terminal Source RNS
SKA
SKA Shuka Minerals Plc
06:01
Market

Update of financing for Kabwe transaction

Open Terminal Source RNS
VTU
VTU Vertu Motors Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SML
SML Strategic Minerals Plc
06:01
Market

Redmoor – Update to Previous Drilling Results

Open Terminal Source RNS
MPAL
MPAL MEDPAL AI PLC ORD 0.02P
06:01
Market

NHS Approval & Operational Update

Open Terminal Source RNS
CVSG
CVSG CVS Group Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
RHIM
RHIM RHI Magnesita NV
06:01
Market

Trading Update

<mark style="background-color:yellow"></mark>

<mark style="background-coloryellow"></mark>
Open Terminal Source RNS
OTB
OTB On The Beach Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CMCL
CMCL Caledonia Mining Corporatio…
06:01
Market

3rd Quarter Results

**Summary of Caledonia Mining Corporation Plcs 3rd Quarter 2025 Results** Caledonia Mining Corporation Plc reported strong financial and operational results for the third quarter of 2025, driven by higher gold prices and increased sales. …

**Summary of Caledonia Mining Corporation Plcs 3rd Quarter 2025 Results**
Caledonia Mining Corporation Plc reported strong financial and operational results for the third quarter of 2025, driven by higher gold prices and increased sales. Key highlights include
1. **Financial Performance**
**Revenue**Increased by 52% to $71.4 million compared to Q3 2024, due to a 40% rise in the average realized gold price and an 8.7% increase in ounces sold.
**Gross Profit**Rose to $36.9 million, up from $19.3 million in Q3 2024.
**EBITDA**Surged by 162% to $33.5 million.
**Profit After Tax**Jumped 467% to $18.7 million.
**Free Cash Flow**Turned positive at $5.9 million, compared to a negative $2.4 million in Q3 2024.
2. **Operational Highlights**
**Gold Production**19,106 ounces from the Blanket Mine, with an additional 437 ounces from the Bilboes oxide mine.
**Gold Sales**20,355 ounces from Blanket, with 2,861 ounces of bullion on hand sold at the start of Q4.
**On-Mine Cost**$1,228/oz sold, with an all-in sustaining cost (AISC) of $1,937/oz sold.
**Ore Production**Increased tonnes broken and hoisted, with 229.5 thousand tonnes and 208.7 thousand tonnes, respectively.
3. **Safety and Sustainability**
Reported a fatality at Blanket Mine due to a secondary blasting accident, leading to a comprehensive review of safety procedures and training.
Group Lost Time Injury Frequency Rate (LTIFR) and Total Injury Frequency Rate (TIFR) showed slight increases, with ongoing efforts to improve safety.
4. **Exploration and Development**
Continued deep exploration drilling at Blanket, targeting down-dip continuations of mineralized zones, with encouraging results.
Surface trenching at Blanket identified anomalous gold values, leading to a 5,000-metre reverse circulation drilling program.
Motapa project exploration progressed, with 17,787 metres of reverse circulation drilling and 1,763.4 metres of diamond drilling completed.
5. **Capital Expenditure and Liquidity**
Total liquidity stood at $44.3 million, supporting ongoing capital projects.
Sustaining capital expenditure totaled $5.174 million, with non-sustaining capex at $1.585 million.
Completion of the new tailings storage facility (TSF) and ongoing mine development to access new areas.
6. **Corporate Developments**
Appointed Mr. July Ndlovu as an independent non-executive director.
Approved a quarterly dividend of 14 cents per share, payable on December 5, 2025.
Bilboes feasibility study expected to be released imminently.
7. **Guidance**
Maintained 2025 gold production guidance at 75,500 to 79,500 ounces.
Revised on-mine cost guidance to $1,150 to $1,250/oz sold and AISC to $1,850 to $1,950/oz sold, reflecting higher costs and royalties.
**CEO Commentary**
Mark Learmonth, CEO, emphasized the companys focus on stable production, disciplined capital investment, and modernization of operations at Blanket. Despite the tragic fatality, the company remains committed to safety and long-term growth, with strategic investments to strengthen its foundations.
**Conclusion**
Caledonia Mining Corporation Plc demonstrated robust performance in Q3 2025, with significant improvements in revenue, profitability, and cash flow, supported by strong gold prices and operational efficiency. The company continues to invest in exploration and development to sustain long-term growth while addressing safety concerns.
Here is the HTML table code comparing the financials and debt year on year for Caledonia Mining Corporation Plc: 25.9%
MetricQ3 2025Q3 2024% Change9-Months 20259-Months 2024% Change
Revenue (US$ 000)71,44046,86852.4%192,927135,50342.4%
EBITDA (US$ 000)33,49112,756162.6%95,50242,269
Profit after tax (US$ 000)18,6543,284468.0%53,41215,538243.8%
Free cash-flow (US$ 000)5,911(2,406)345.7%48,3289,767394.8%
Total liquidity (US$ 000)44,31838,000 (approx.)16.6%44,31838,000 (approx.)16.6%
Debt (Loans and borrowings, US$ 000)1,313 (non-current) + 1,281 (current)1,500 (non-current) + 1,174 (current)-12.5% (total)1,313 (non-current) + 1,281 (current)1,500 (non-current) + 1,174 (current)-12.5% (total)

Notes:

  • Total liquidity for Q3 2024 is approximated based on the available data.
  • Debt is represented by loans and borrowings, both non-current and current.
This table provides a comparison of key financials and debt metrics for Caledonia Mining Corporation Plc between Q3 2025 and Q3 2024, as well as for the 9-month periods ending September 30, 2025, and 2024. The data is extracted from the provided text.
Open Terminal Source RNS
CNSL
CNSL Cambridge Nutritional Scien…
06:01
Market

Half-year Report

**Summary of Cambridge Nutritional Sciences PLC Half-Year Report (H1 2025)** **Financial Highlights:** - **Revenue Decline:** Revenue decreased to £3.9 million (H1 2024: £4.1 million), primarily due to slower orders in key regions lik…

**Summary of Cambridge Nutritional Sciences PLC Half-Year Report (H1 2025)**
**Financial Highlights**
**Revenue Decline** Revenue decreased to £3.9 million (H1 2024: £4.1 million), primarily due to slower orders in key regions like mainland Europe, Africa/Middle East, and the Americas.
**Gross Margin Improvement** Gross margin increased to 67.7% (H1 2024: 65.4%), driven by production efficiencies and product mix optimization.
**Adjusted EBITDA** Remained positive at £0.1 million (H1 2024: £0.2 million), despite lower sales.
**Loss Before Tax** Increased to £0.4 million (H1 2024: £0.2 million) due to lower revenue and higher operational costs.
**Cash Position** Cash balance decreased to £3.6 million (H1 2024: £4.5 million) due to working capital outflows, capital expenditures, and financing activities.
**Operational Highlights**
**Sales Restructuring** The sales and marketing teams were restructured to focus on long-term growth, separating customer service, acquisition, and success functions from sales.
**Product Performance** FoodPrint® sales declined by 7% to £2.4 million, while Food Detective® sales dropped by 23% to £0.6 million. CNS Lab sales grew by 9% to £0.9 million.
**Regional Growth** Strong growth in the UK (6%) and India (33%), offset by declines in Europe, Americas, and Africa/Middle East.
**New Product Launch** Introduced Gut Detective®, a comprehensive stool biomarker panel for gut health, targeting UK practitioners.
**Outlook**
**Full-Year Sales** Expected to be lower than the previous year due to longer sales cycles and slower commercialization in key regions.
**Strategic Focus** Emphasis on converting pipeline opportunities into orders, particularly in the USA and Europe.
**Cost Management** Aim to remain profitable at the adjusted EBITDA level through careful cost management.
**Cash Investment** Continued investment in strategic initiatives like IVDR development and new products, despite a decline in cash position.
**Management Commentary**
**Challenges** Carolyn Rand, Chair, acknowledged a frustrating first half due to underperformance in key regions, despite strong growth in the UK and India.
**Optimism** Confidence in long-term growth prospects as the restructured sales team begins to deliver, supported by improved gross margins and operational efficiencies.
**Investor Engagement**
A live investor presentation was held on 10 November 2025, led by CEO James Cooper and CFO Ajay Patel, to discuss the interim results.
**Conclusion**
Cambridge Nutritional Sciences PLC faces short-term challenges with revenue declines in key regions but remains focused on long-term growth through sales restructuring, operational efficiencies, and strategic investments. The company is well-funded to execute its strategy and expects to return to growth with a healthy gross margin.
Here is the HTML table code comparing the financials and debt year on year for Cambridge Nutritional Sciences PLC: tr>
MetricH1 2025H1 2024Change
Revenue (£'000)3,8634,134(6.6%)
Gross Margin (%)67.7%65.4%+2.3%
Adjusted EBITDA (£'000)102227(55.1%)
Loss Before Tax (£'000)(397)(196)-102.6%
Cash Balance (£'000)3,5944,520(20.5%)
Total Debt (£'000)1633,964(95.9%)

Regional Revenue Breakdown

RegionH1 2025 (£'000)H1 2024 (£'000)Change (%)
UK894840+6%
Rest of Europe707952(25.7%)
Americas737805(8.4%)
India402302+33.1%
Asia796826(3.6%)
Africa and Middle East327408(19.8%)

Product Revenue Breakdown

ProductH1 2025 (£'000)H1 2024 (£'000)Change (%)
FoodPrint®2,3802,564(7%)
Food Detective®554717(22.7%)
CNS Laboratory Service910842+8.1%
Food ELISA/Other1911+72.7%
**Notes:** * Total Debt is calculated as the sum of Short-term borrowings, Lease liabilities, and Long-term borrowings (if any). * The percentage changes are calculated based on the absolute values. * The tables provide a clear comparison of the company's financials and debt position year on year, as well as a breakdown of revenue by region and product.
Open Terminal Source RNS
RBW
RBW Rainbow Rare Earths Limited
06:01
Market

Phalaborwa Resource Update to include Yttrium

Open Terminal Source RNS
SUPR
SUPR Supermarket Income REIT PLC
06:01
Market

SUPR completes £41m of accretive acquisitions

Open Terminal Source RNS
CCEP
CCEP Coca-Cola Europacific Partn…
06:01
Market

Transactions in Own Shares

Open Terminal Source RNS
SWT
SWT Switch Metals Plc
06:01
Market

MOU signed with Xcelsior

Open Terminal Source RNS
SNT
SNT Sabien Technology Group Plc
06:01
Market

New Factoring Facility

Open Terminal Source RNS
PETS
PETS Pets at Home Group Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PLUS
PLUS Plus500 Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MERC
MERC Mercia Technologies PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
KNOS
KNOS Kainos Group PLC
06:01
Market

Interim results

**Summary of Kainos Group plc Interim Results for H1 2026** **Overview** Kainos Group plc, a UK-based IT provider specializing in Digital Services, Workday Services, and Workday Products, reported strong interim results for the six mo…

**Summary of Kainos Group plc Interim Results for H1 2026**
**Overview**
Kainos Group plc, a UK-based IT provider specializing in Digital Services, Workday Services, and Workday Products, reported strong interim results for the six months ended 30 September 2025. The company highlighted robust sales performance, revenue growth, and strategic advancements despite challenges like cost increases and investment in partnerships.
**Financial Highlights**
**Revenue**Increased by 7% to £196.1 million (H1 2025: £183.1 million), driven by organic growth and currency benefits.
**Adjusted Pre-Tax Profit**Declined by 16% to £32.0 million (H1 2025: £38.2 million) due to increased investment in the Workday partnership, National Insurance costs, and short-term use of contractors.
**Bookings**Surged by 27% to £227.9 million (H1 2025: £179.5 million), reflecting strong sales across all divisions.
**Contracted Backlog**Grew by 12% to £396.9 million (H1 2025: £354.1 million).
**Cash**Decreased by 30% to £105.5 million (H1 2025: £151.6 million) due to restructuring costs, working capital increases, and shareholder returns.
**Interim Dividend**Increased by 5% to 9.8p per share (H1 2025: 9.3p).
**Operational Highlights**
1. **Workday Products**
Revenue grew by 14% to £39.2 millionwith ARR up 19% to £77.5 million.
Achieved $100 million ARR milestone in July 2025, a significant SaaS industry benchmark.
Launched "Pay Transparency Analyzer powered by Kainos" in partnership with Workday, targeting EU compliance requirements.
2. **Digital Services**
Revenue increased by 6% to £103.5 million, driven by healthcare sector growth (33%) and North American expansion (152% revenue growth).
Secured major contracts in the UK public sector, including a £73 million deal with the DVSA.
3. **Workday Services**
Revenue grew by 4% to £53.4 million, with strong performance in North America and emerging markets like Australia and Latin America.
Bookings increased by 35% to £54.0 million.
4. **International Growth**
International revenue rose by 13% to £84.9 million, accounting for 43% of Group revenue.
5. **Customer Satisfaction**
Net Promoter Score (NPS) improved to 70 (H1 2025: 58), reflecting high customer satisfaction.
6. **Employee Engagement**
Employee retention remained strong at 92%, with engagement levels at 75%.
Recognized as one of the "50 Best Places to Work in the UK" by Glassdoor.
7. **AI Initiatives**
AI-related revenue grew by 6% to £15.3 million.
Launched Microsoft AI Centre of Excellence and developed AI solutions for Workday and other platforms.
**Strategic Developments**
Acquired Davis Pier, a Canadian consultancy, to strengthen North American presence.
Deepened Workday partnership with exclusive resell arrangements and joint product launches.
Continued investment in R&D, with expenditure rising by 12% to £8.6 million.
**Outlook**
Expects continued growth in Workday Products, Digital Services, and Workday Services in H2 2026.
Maintains full-year profit expectations in line with consensus forecasts.
Focused on long-term growth drivers, including AI adoption and digital transformation.
**Shareholder Returns**
Completed £30 million share buyback programme and announced a new £30 million programme.
**Conclusion**
Kainos demonstrated resilience and growth in H1 2026, underpinned by strong sales execution, strategic partnerships, and expansion into key markets. Despite short-term profit pressures, the company remains confident in its long-term strategy and ability to deliver shareholder value.
Here is the HTML table code comparing the financials and debt year on year for Kainos Group plc:
MetricH1 2026H1 2025Change
Revenue£196.1m£183.1m+7%
Statutory profit before tax£28.4m£34.2m-17%
Adjusted pre-tax profit£32.0m£38.2m-16%
Diluted earnings per share16.7p20.1p-17%
Adjusted diluted earnings per share18.9p22.5p-16%
Interim dividend per share9.8p9.3p+5%
Bookings£227.9m£179.5m+27%
Product annual recurring revenue (ARR)£77.5m£65.1m+19%
Contracted backlog£396.9m£354.1m+12%
Cash£105.5m£151.6m-30%

Note: Debt information is not explicitly mentioned in the provided text. However, the cash balance can be considered as a proxy for debt, with a decrease in cash potentially indicating an increase in debt or other liabilities.

Key Observations:

  • Revenue increased by 7% year-on-year, driven by strong sales performance across all divisions.
  • Profit metrics (statutory and adjusted) decreased by 16-17%, primarily due to increased costs associated with the Workday partnership, National Insurance, and contractor usage.
  • Bookings and contracted backlog increased significantly, indicating strong future revenue potential.
  • Cash balance decreased by 30%, partly due to share buybacks, acquisition of Davis Pier, and increased working capital requirements.
This table provides a clear comparison of key financial metrics between H1 2026 and H1 2025, highlighting the changes and trends in Kainos Group plc's financial performance.
Open Terminal Source RNS
CHG
CHG Chemring Group PLC
06:01
Market

Post-close and contract wins update

**Chemring Group PLC Trading Statement Summary (November 10, 2025)** Chemring Group PLC provided a post-close and contract wins update for FY25, highlighting key financial and operational developments as it enters its close period for t…

**Chemring Group PLC Trading Statement Summary (November 10, 2025)**
Chemring Group PLC provided a post-close and contract wins update for FY25, highlighting key financial and operational developments as it enters its close period for the year ended October 31, 2025.
**Financial Performance**
**FY25 adjusted operating profit** is in line with analyst expectations, with a margin of ~14.7% (up from 14.2% in FY24).
**Adjusted EPS** is expected to benefit from slightly lower finance costs.
**Net debt** as of October 312025is ~£95m.
**Order book** increased to £1.3bn (from £1.0bn in October 2024), with order intake for the year at ~£781m.
**Operational Highlights**
**Energetics segment** outperformed, driven by increased demand for propellants, energetic materials, and high-integrity devices.
**Sensors & Information segment** faced softness due to delayed UK Government orders, particularly in National Security and Defence.
**Countermeasures & Energetics** achieved ~95% order cover for FY26, while **Sensors & Information** secured ~47% cover.
**Significant Contract Wins**
1. **Energetics**
Chemring Energetic Devices (US) won a $65m sole-source framework contract for aircrew flight equipment <mark style="background-color:yellow">test</mark>er systems.
Chemring Energetics UK secured a £24m order for rocket motors and components for the Next Generation Light Anti-Tank Weapon (NLAW) system.
Chemring Nobel (Norway) won a £23m order from Nammo for HMX products.
2. **Countermeasures**
Chemring Australia won a US$35m contract for airborne countermeasures.
Chemring Countermeasures UK secured a £15m order from NATO for airborne countermeasures.
3. **Sensors & Information**
Roke won over £40m in National Security contract renewals and a £20m contract for Project ZODIAC, a critical technology program for the British Army.
**Strategic Developments**
**Landguard Group acquisition** completed in August 2025, enhancing Roke’s growth and operational synergies.
**Alloy Surfaces** (US countermeasures business) will be reported as a discontinued operation due to declining demand from the US Department of Defense. Strategic options, including a potential sale, are under consideration.
**Outlook**
Robust market conditions and increasing demand for technology-driven solutions and traditional defence capabilities are expected to sustain growth.
Full-year results for FY25 will be released on December 9, 2025.
**Directorate Change**
Fiona MacAulay, Senior Independent Director, will step down at the February 2026 AGM after completing her second three-year term.
Chemring remains focused on its niche markets, leveraging R&D investments to meet evolving customer needs in defence, security, and aerospace.
NewContract
Open Terminal Source RNS
OCI
OCI Oakley Capital Investments …
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
KIE
KIE Kier Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CRE
CRE Conduit Holdings Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HTG
HTG Hunting PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
GLV
GLV Glenveagh Properties PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
VOD
VOD Vodafone Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PSON
PSON Pearson PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
KGF
KGF Kingfisher PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ACSO
ACSO Accesso Technology Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HSX
HSX Hiscox Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BWY
BWY Bellway PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
LSEG
LSEG London Stock Exchange Group…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FSG
FSG Foresight Group Holdings Li…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
AEP
AEP Anglo-Eastern Plantations P…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
INPP
INPP International Public Partne…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
VTY
VTY Vistry Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HBR
HBR Harbour Energy PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BATS
BATS British American Tobacco PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
AO.
AO. AO.
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
GSK
GSK GSK plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CTL
CTL CleanTech Lithium plc
06:01
Market

Laguna Verde Resource Increase

Open Terminal Source RNS
HILS
HILS Hill & Smith Holdings PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IHG
IHG InterContinental Hotels Gro…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BA.
BA. BA.
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HSW
HSW Hostelworld Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SSPG
SSPG SSP Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MPE
MPE M.P.Evans Group
06:01
Market

Strong pricing during second half of 2025

Open Terminal Source RNS
WTB
WTB Whitbread PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PIN
PIN Pantheon International PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
GBG
GBG GB Group plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PTEC
PTEC Playtech Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HTWS
HTWS Helios Towers Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
UKW
UKW Greencoat UK Wind PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IGG
IGG IG Group Holdings PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ONDO
ONDO Ondo InsurTech PLC
06:01
Market

Contract Win

**Summary:** Ondo InsurTech PLC (LSE: ONDO), a leader in claims prevention technology for home insurers, announced on November 10, 2025, that Westfield Insurance has signed a contract to deploy 10,000 LeakBot devices and connected service…

**Summary**
Ondo InsurTech PLC (LSEONDO), a leader in claims prevention technology for home insurers, announced on November 10, 2025, that Westfield Insurance has signed a contract to deploy 10,000 LeakBot devices and connected services for homeowners in Ohio, Indiana, and Pennsylvania. This partnership aims to proactively prevent water damage claims, reduce loss costs, and enhance customer experience. LeakBot, a patented self-install solution, detects leaks and alerts homeowners via a mobile app, offering access to expert engineers for repairs. Independent research shows LeakBot can reduce water damage claim costs by up to 70%. Westfield’s initiative aligns with its investment in innovative technology, while Ondo continues to expand its global partnerships with 25 insurance carriers. Ondo holds the London Stock Exchange’s Green Economy Mark, underscoring its commitment to sustainable solutions. Westfield, a leading U.S. insurer founded in 1848, strengthens its position with this collaboration, further solidifying Ondo’s role as a global leader in claims prevention technology.
NewContract
Open Terminal Source RNS
HICL
HICL HICL Infrastructure Company…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
INCH
INCH Inchcape PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IWG
IWG IWG PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
RCP
RCP RIT Capital Partners
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HAS
HAS Hays plc
06:01
Market

CEO Medical Leave

Open Terminal Source RNS
CARD
CARD Card Factory PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BAB
BAB Babcock International Group…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HVPE
HVPE HarbourVest Global Private …
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PRU
PRU Prudential plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
GLEN
GLEN Glencore PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CAN
CAN Groupe Canal Plus
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CTEC
CTEC ConvaTec Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IAG
IAG International Consolidated …
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
KYGA
KYGA Kerry Group
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
RR.
RR. RR.
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CLDN
CLDN Caledonia Investments
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
INF
INF Informa PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FUTR
FUTR Future PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BTRW
BTRW Barratt Redrow plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SBRY
SBRY J Sainsbury PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IGC
IGC India Capital Growth Fund
06:01
Market

Transaction in Own Shares and Total Voting Rights

Open Terminal Source RNS
RKT
RKT Reckitt Benckiser Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SRP
SRP Serco Group
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
TRN
TRN Trainline Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SEQI
SEQI Sequoia Econ Infrastructure
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BBH
BBH Bellevue Healthcare Trust P…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
DRX
DRX Drax Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IPX
IPX Impax Asset Management Grou…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CNA
CNA Centrica PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CHRY
CHRY Chrysalis Investments Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
APTD
APTD Aptitude Software Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
TRIG
TRIG Renewables Infrastructure G…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
QQ.
QQ. QQ.
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
LSL
LSL LSL Property Services Plc
06:01
Market

Transaction in own Shares and Total Voting Rights

Open Terminal Source RNS
AHT
AHT Ashtead Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MGAM
MGAM Morgan Advanced Materials p…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
KLR
KLR Keller Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
JSG
JSG Johnson Service Group Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ABDX
ABDX Abingdon Health Plc
06:01
Market

c.US$2m multiplex diagnostic test contract win

**Summary:** Abingdon Health plc, a leading developer and manufacturer of rapid diagnostic <mark style="background-color:yellow">test</mark>s, has secured a **c.US$2 million contract** with a US-based company for the development, scale-up…

**Summary**
Abingdon Health plc, a leading developer and manufacturer of rapid diagnostic <mark style="background-color:yellow">test</mark>s, has secured a **c.US$2 million contract** with a US-based company for the development, scale-up, and technical transfer of a **semi-quantitative, multiplex lateral flow test system**. The 24-month project will be executed under a Master Service Agreement (MSA) and conducted at Abingdon Health’s Madison, Wisconsin facilities. This win highlights the strength of Abingdon Health’s **Contract Development and Manufacturing Organisation (CDMO)** services, which support customers from concept to commercial success. The contract underscores the company’s expanded U.S. manufacturing capabilities, bolstered by a recent £3.2 million fundraise, and its ability to meet growing demand from U.S.-based clients. Dr. Chris Hand, Executive Chairman, emphasized the value of Abingdon’s dual U.S. and U.K. sites and the versatility of lateral flow technology in measuring multiple analytes semi-quantitatively. The announcement reinforces Abingdon Health’s position as a comprehensive CDMO provider in the med-tech sector.
NewContract
Open Terminal Source RNS
EDIN
EDIN Edinburgh Investment Trust
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FEVR
FEVR Fevertree Drinks Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IPO
IPO IP Group
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PAY
PAY PayPoint plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MACF
MACF Macfarlane Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
WIX
WIX Wickes Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ECEL
ECEL Eurocell PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MRO
MRO Melrose Industries PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
KNOS
KNOS Kainos Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HRI
HRI Herald Investment Trust
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MTO
MTO Mitie Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
THS
THS Tharisa plc
06:01
Market

Voting Results - Karo EGM of bondholders

Open Terminal Source RNS
SE77
SE77 SE77
06:01
Market

2025 Full Year Documents and Pillar 3 Disclosure

Open Terminal Source RNS
TBCG
TBCG TBC Bank Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SE77
SE77 SE77
06:01
Market

ANZ 2025 ESG Documents

Open Terminal Source RNS
SE77
SE77 SE77
06:01
Market

ANZ 2025 Annual Report Documents

Open Terminal Source RNS
VEIL
VEIL Vietnam Enterprise Investme…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HSBK
HSBK Halyk Bank of Kazakhstan Jo…
06:01
Market

Transaction In Own Securities

Open Terminal Source RNS
VOF
VOF VinaCapital Vietnam Opportu…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
NFM
NFM NFM
06:01
Market

Drilling Campaign Approved at Harts Range Project

Open Terminal Source RNS
BOY
BOY Bodycote PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PRE
PRE Pensana Rare Earths Plc
06:01
Market

Notice of Annual General Meeting and Form of Proxy

Open Terminal Source RNS
OXIG
OXIG Oxford Instruments PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MOON
MOON Moonpig Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
THRG
THRG Throgmorton Trust Plc
06:01
Market

Total Voting Rights

Open Terminal Source RNS
BRGE
BRGE BlackRock Greater Europe In…
06:01
Market

Total Voting Rights

Open Terminal Source RNS
BRSC
BRSC Blackrock Smaller Companies…
06:01
Market

Total Voting Rights

Open Terminal Source RNS
OSB
OSB OneSavings Bank PLC
06:01
Market

OSB GROUP PLC - Transaction in Own Shares

Open Terminal Source RNS
NBPE
NBPE NB Private Equity Partners …
06:01
Market

NBPE Announces Transaction in Own Shares

Open Terminal Source RNS
PSH
PSH Pershing Square Holdings Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
0MGD
0MGD Jyske Bank A/S
05:39
Market

Share repurchase programme: Transactions of week 45 2025

Open Terminal Source RNS
0MGD
0MGD Jyske Bank A/S
05:39
Market

Aktietilbagekøb: Transaktioner i uge 45 2025

Open Terminal Source RNS

Digested News

The ticker catalyst tape is rendered as native mobile cards. Articles and ticker links stay clickable.

JCGI logo
Latest RNS 15:48
JCGI

Holding(s) in Company

JPMorgan China Growth & Income PLC

TR1 Buy
['City of London Investment Management Company Limited', '19.130000', '18.020000']
BAG logo
Latest RNS 15:45
BAG

Director/PDMR Shareholding

A.G.Barr PLC

<mark style="background-coloryellow">Purchase</mark> of shares in relation to the A.G. BARR All Employee Share Ownership Plan (AESOP) dividend reinvestment
SST logo
Latest RNS 15:42
SST

Holding(s) in Company

The Scottish Oriental Smaller Companies Trust plc

TR1 Buy
['City of London Investment Management Company Limited', '13.050000', '12.090000']
WIZZ logo
Latest RNS 15:39
WIZZ

Holding(s) in Company

Wizz Air Holdings PLC

<mark style="background-coloryellow">TR1</mark> Buy
['Barclays PLC', '0.030000', 'Below minimum threshold ']
BAG logo
Latest RNS 15:39
BAG

Director/PDMR Shareholding

A.G.Barr PLC

<mark style="background-coloryellow">Purchase</mark> of shares in relation to the A.G. BARR All Employee Share Ownership Plan (AESOP). The AESOP is an all-employee trust arrangement approved by HM Revenue and Customs, under which employees are able to buy ordinary shares in the Company of 4⅙p each, using deductions from salary in each pay period, and receive allocations of matching free ordinary shares.
IGET logo
Latest RNS 15:35
IGET

Issue of Equity

Invesco Perpetual Select Trust plc - Global Equity Income Share Portfolio

NFG logo
Latest RNS 15:31
NFG

Holding(s) in Company

Next 15 Group PLC

TR1 Buy
['Liontrust Investment Partners LLP', '9.855000', '10.977700']
RR. logo
Latest RNS 15:31
RR.

Director/PDMR Shareholding

RR.

Rolls-Royce Holdings plc (the Company) announces that the following person(s) discharging managerial responsibilities <mark style="background-color:yellow">purchase</mark>d ordinary shares of 20p each in the Company by way of a monthly share purchase plan.
GAW logo
Latest RNS 15:24
GAW

Holding(s) in Company

Games Workshop Group PLC

TR1 Buy
['Baillie Gifford & Co', '5.050000', '4.970000']
AWE logo
Latest RNS 15:02
AWE

Holding(s) in Company

Alphawave IP Group PLC

<mark style="background-coloryellow">TR1</mark> Buy
['JPMorgan Chase & Co.', 'Below minimum threshold', '1.344761']
TIDE logo
Latest RNS 14:15
TIDE

Contract Renewal with Major Global Retailer

Crimson Tide plc

**Summary**
Crimson Tide PLC, the provider of the mpro5 process management app, has secured a three-year contract extension worth £3.88 million with one of the world’s largest retailers. This renewal strengthens the company’s long-standing relationship with the retailer, which already uses mpro5 across 3,000+ locations in the UK and Ireland, with potential for further international expansion. The platform has become integral to the retailer’s in-store operations, consolidating multiple systems and driving efficiency. The agreement highlights mpro5’s role as a mission-critical tool for large enterprises and aligns with the retailer’s digital transformation strategy. CEO Jon Clarke emphasized the renewal’s significance, noting it reflects the company’s successful customer retention and growth strategy, with four of its top five revenue customers renewing contracts this financial year. This positions Crimson Tide for future growth.
NewContract
WKP logo
Latest RNS 14:09
WKP

Holding(s) in Company

Workspace Group PLC

TR1 Buy
['Jefferies Financial Group Inc', '0.996000', '1.563000']
IPF logo
Latest RNS 14:01
IPF

Form 8.3

International Personal Finance PLC

GNC logo
Latest RNS 14:01
GNC

Holding(s) in Company

Greencore Group

TR1 Buy
['UBS Group AG-Investment Bank & Global Wealth Management', '3.980700', '0.000000']
BGEU logo
Latest RNS 13:56
BGEU

Holding(s) in Company

Baillie Gifford European Growth Trust PLC

TR1 Buy
['Allspring Global Investments Holdings.', '21.031000', '20.633000']
ESP logo
Latest RNS 13:55
ESP

Form 8.3

Empiric Student Property Plc

MAB logo
Latest RNS 13:01
MAB

Director/PDMR Shareholding

Mitchells & Butlers PLC

<mark style="background-coloryellow">Purchase</mark> of partnership shares by the SIP Trustee (notified on 10 November 2025)
GAMA logo
Latest RNS 13:01
GAMA

Holding(s) in Company

Gamma Communications PLC

TR1 Buy
['Allianz Global Investors GmbH', '10.800000', '11.010000']
PCGH logo
Latest RNS 12:47
PCGH

Holding(s) in Company

Polar Capital Global Healthcare Trust plc

TR1 Buy
['Rathbones Investment Management Ltd', '13.978800', '14.003100']
DGE logo
Latest RNS 12:21
DGE

Director/PDMR Shareholding

Diageo PLC

Share <mark style="background-coloryellow">purchase</mark> under an arrangement with the Company
AMS logo
Latest RNS 11:39
AMS

Holding(s) in Company

Advanced Medical Solutions Group plc

TR1 Buy
['Richard Griffiths and controlled holdings', '0.53', '0.37']
APN logo
Latest RNS 10:51
APN

Holding(s) in Company

Applied Nutrition Plc

TR1 Buy
['UBS Group AG-Investment Bank & Global Wealth Management', '0.000000', '5.016711']
ESP logo
Latest RNS 10:24
ESP

Form 8.3

Empiric Student Property Plc

JUP logo
Latest RNS 10:16
JUP

Holding(s) in Company

Jupiter Fund Management Plc

TR1 Buy
['SILCHESTER INTERNATIONAL INVESTORS LLP', '15.970000', '16.997000']
EWI logo
Latest RNS 09:39
EWI

Holding(s) in Company

Edinburgh Worldwide Investment Trust plc

TR1 Buy
['Saba Capital Management, L.P.', '25.051939', '24.887687']
MSLH logo
Latest RNS 09:31
MSLH

Director/PDMR Shareholding

Marshalls PLC

<mark style="background-coloryellow">Purchase</mark> of shares under the Marshalls plc Employee Share Purchase Plan 2015
MSLH logo
Latest RNS 09:30
MSLH

Director/PDMR Shareholding

Marshalls PLC

<mark style="background-coloryellow">Purchase</mark> of shares under the Marshalls plc Employee Share Purchase Plan 2015
MSLH logo
Latest RNS 09:28
MSLH

Director/PDMR Shareholding

Marshalls PLC

<mark style="background-coloryellow">Purchase</mark> of shares under the Marshalls plc Employee Share Purchase Plan 2015
THRG logo
Latest RNS 09:19
THRG

Holding(s) in Company

Throgmorton Trust Plc

TR1 Buy
['Jefferies Financial Group Inc', '1.218000', '2.011000']
DOM logo
Latest RNS 09:01
DOM

Holding(s) in Company

Domino’s Pizza Group PLC

TR1 Buy
['The Capital Group Companies, Inc.', '9.730380', '10.615023']
PTSB logo
Latest RNS 09:01
PTSB

Holding(s) in Company

Permanent TSB Group Holdings PLC

TR1 Buy
['The Goldman Sachs Group, Inc.', '3.68', '3.73']
WIZZ logo
Latest RNS 08:47
WIZZ

Holding(s) in Company

Wizz Air Holdings PLC

<mark style="background-coloryellow">TR1</mark> Buy
['Barclays PLC', 'Below minimum threshold', '0.030000']
ECEL logo
Latest RNS 08:31
ECEL

Director/PDMR Shareholding

Eurocell PLC

Eurocell plc announces that, pursuant to the Non-executive Directors Share <mark style="background-color:yellow">Purchase</mark> Plan which was announced on 3 February 2023, five directors have purchased shares in the Company on 7 November 2025. As previously announced, following these trades, Will Trumans membership of the scheme has now ceased.
0RPR logo
Latest RNS 06:28
0RPR

Share buyback programme - week 45

Ringkjoebing Landbobank A/S

**Summary of Ringkjøbing Landbobank A/S Share Buyback Programme - Week 45 (10 November 2025)**
Ringkjøbing Landbobank A/S announced the progress of its share buyback programme for Week 45, part of a larger initiative running from 2 June 2025 to 30 January 2026. The programme aims to repurchase up to DKK 1,000 million worth of shares, with a maximum of 1,600,000 shares, in compliance with EU regulations (Regulation No. 596/2014 and Delegated Regulation No. 2016/1052).
**Key Highlights**
1. **Total Shares Bought Back (Week 45)** 20,500 shares.
2. **Average Purchase Price (Week 45)** DKK 1,456.89.
3. **Total Programme Expenditure (Week 45):** DKK 707,975,445.
4. **Cumulative Shares Bought Back (Since Programme Start):** 910,877 shares (3.59% of share capital).
5. **Cumulative Programme Expenditure** DKK 1,207,964,151.
**Transactions Breakdown (Week 45)**
**3 November 2025:** 3500 shares at DKK 1472.79.
**4 November 2025:** 3500 shares at DKK 1470.64.
**5 November 2025:** 3500 shares at DKK 1466.14.
**6 November 2025:** 3500 shares at DKK 1456.89.
**7 November 2025:** 5000 shares at DKK 1428.41.
The bank now holds 910,877 of its own shares, excluding trading portfolio and customer investments. Detailed transaction data is attached to the corporate announcement for transparency.
**CEO Statement**
John Fisker, CEO, confirmed adherence to regulatory requirements and provided detailed transaction records for stakeholder review.
This update reflects the bank’s ongoing commitment to its share buyback strategy, with Week 45 transactions contributing to the programme’s overall progress.
BuyBack
0A3D logo
Latest RNS 06:11
0A3D

Net Asset Value

iShares VII Public Limited Company - iShares Core S&P 500 UCITS ETF

SYM logo
Latest RNS 06:01
SYM

New product launch, South Korea

Symphony Environmental Technologies plc

**Summary**
Symphony Environmental Technologies Plc, a global leader in sustainable plastic and rubber technologies, announced that its exclusive South Korean distributor, CPST, in collaboration with PetRize Inc., won the Grand Prize (Early Startup Division) at the Gyeonggi Province Pet Startup Competition for the **Wanspapa biodegradable Dog Waste Bag**. This product incorporates Symphonys **d2w® biodegradable masterbatch**, offering a sustainable solution for pet owners without compromising performance. Key advantages of Wanspapa include ASTM D6954-24 open-air biodegradability (leaving no microplastics), easy-open design, tear strength, reduced odor, lower CO₂ emissions, and South Korean manufacturing for quality assurance.
PetRize Inc., a startup with ambitious international expansion plans, aims to target major retail chains in Korea, North America, Canada, and Australia. Symphony’s CEO, Michael Laurier, praised the achievement, highlighting the success of their technology and CPST’s efforts. This milestone underscores the commercial and environmental value of Symphony’s d2w technology in the global pet market.
The announcement is non-regulatory and does not significantly impact Symphony’s performance expectations. Symphony continues to innovate with its d2p and NbR brands, offering diverse plastic technologies globally, with products available in nearly 100 countries.
**Key Points**
**Product** Wanspapa biodegradable Dog Waste Bag using Symphony’s d2w technology.
**Award** Grand Prize at Korean Pet Startup Competition.
**Advantages:** Biodegradabilityconveniencereliabilitysustainabilityand quality.
**Expansion** PetRize targets international markets, including North America, Canada, and Australia.
**Impact** Demonstrates Symphony’s technology’s commercial and environmental value.
Launch
EYE logo
Latest RNS 06:01
EYE

Multi-year contract with North American retailer

Eagle Eye Solutions Group plc

**Summary**
Eagle Eye Solutions Group PLC, a leading SaaS and AI technology company, has secured a five-year contract with one of North Americas largest independent food retailers. The retailer, operating over 450 stores across Texas and Mexico under five brands, will utilize Eagle Eyes AIR platform for promotional capabilities within its eCommerce business. The contract, expected to go live in the first half of 2026, marks a significant opportunity for Eagle Eye to deepen its relationship with the retailer and expand its presence in the North American market.
This win underscores Eagle Eyes strategic focus on North America, the worlds largest loyalty and promotions market, and reflects early success from initiatives aimed at growing the sales pipeline and improving conversion rates. Tim Mason, Eagle Eyes CEO, emphasized the companys commitment to accelerating growth in the region through enhanced personalization and customer experience.
Eagle Eyes technology, recognized by industry leaders like Gartner and Forrester, powers over 1 billion personalized offers weekly and manages 700 million loyalty member wallets globally. The company’s growing client base includes major retailers such as Loblaws, Tesco, and Carrefour. This contract reinforces Eagle Eyes position as a key player in real-time, omnichannel, and personalized marketing solutions.
NewContract
ELCO logo
Latest RNS 06:01
ELCO

Industry Award Wins

Eleco PLC

**Summary**
Eleco plc (AIMELCO), a specialist software provider for the built environment, has been honored with two prestigious awards at the Construction Computing Awards 2025: *Company of the Year* and *Project Management Software of the Year* for the twelfth consecutive year. Jonathan Hunter, CEO of Eleco plc, expressed gratitude for the recognition, attributing the success to the company’s talented teams and their dedication to meeting customer needs in a competitive and fast-evolving industry. Eleco operates internationally through brands like Elecosoft, BestOutcome, and PEMAC, offering software solutions across the building lifecycle, from planning and design to asset and facilities management. The announcement was distributed via RNS Reach, a non-regulatory press release service of the London Stock Exchange.
Awards
GPE logo
Latest RNS 06:01
GPE

GPE gets planning approval for Whittington House

GREAT PORTLAND ESTATES PLC

**Summary**
Great Portland Estates PLC (GPE) has secured planning approval from Camden Council for the refurbishment of Whittington House, a 74,500 sq ft HQ building in Londons West End (WC1). The project, expected to complete in Q1 2027, will transform the building into a sustainable, Grade A workspace with eight floors of offices, a new rooftop terrace, and a pavilion. Located near Tottenham Court Road Elizabeth Line station, the development is part of a larger 220,000 sq ft cluster of prime office space, including the Gable Building, Courtyard Building, and 31/34 Alfred Place. Trevor Phyo, GPEs Senior Development Manager, highlighted the projects significance in preserving architectural heritage while creating a modern workplace. This approval strengthens GPEs HQ portfolio and underscores its commitment to delivering exceptional spaces in prime London locations.
Approvals
AVG logo
Latest RNS 06:01
AVG

Adaptix receives FDA 510(K) clearance

Avingtrans Plc

**Summary**
Avingtrans plc, a UK-based company specializing in critical components and systems for energy, medical, and industrial sectors, announced that its subsidiary Adaptix Limited has received FDA 510(k) clearance for its orthopaedic 3D imaging product, the Adaptix Ortho350. This compact, mobile, low-dose Digital Tomosynthesis (DT) system is designed for point-of-care use, offering fast, affordable, and high-quality 3D X-ray imaging for upper and lower extremity diagnostics. The clearance enables Adaptix to enter the U.S. human healthcare imaging market, marking a significant milestone in its mission to revolutionize radiology. The Ortho350 delivers superior image clarity compared to 2D X-ray systems while reducing radiation exposure, improving diagnostic accuracy, and enhancing patient outcomes. Adaptix has already commercialized similar technology in veterinary and industrial markets, and this FDA approval validates the technologys commercial potential. Company executives expressed excitement about the strong interest from healthcare providers and the systems potential impact on primary care, intensive care, and emergency departments.
FDA
WKP logo
Latest RNS 06:01
WKP

Holding(s) in Company

Workspace Group PLC

TR1 Buy
['Saba Capital Management, L.P.', '0.162330', '0.162330']
SEEN logo
Latest RNS 06:01
SEEN

Director dealing

SEEEN PLC

<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares into SIPP
INSG logo
Latest RNS 06:01
INSG

New contract with global advisory firm

Insig Ai PLC

**Summary**
Insig AI Plc (AIMINSG), a leader in AI-led analytics and machine-learning solutions, has secured a new contract with a global advisory firm operating in over 70 countries. This agreement marks Insig AIs entry into the global advisory sector, a market with significant growth potential. The contract is based on a monthly subscription model, with expected value increases in 2026 as the solution is implemented across the clients business.
The client will utilize Insig AIs Generative Intelligence Engine (GIE) to automate the benchmarking of corporate reporting disclosures against international standards. GIE streamlines the process by converting documents into structured data, performing targeted analyses, and delivering auditable insights and recommendations. This automation enhances speed, reduces manual effort, and improves consistency in reporting.
Insig AI CEO Richard Bernstein highlighted the significance of this agreement, emphasizing its demonstration of the platforms commercial relevance and ability to support large, multinational clients. The deal is seen as a foundation for future recurring revenue growth in the advisory sector.
**Key Points**
Insig AI secures a new contract with a global advisory firm.
Entry into the global advisory sector, a new market vertical with growth potential.
Monthly subscription model with anticipated value increase in 2026.
Client will use Insig AIs Generative Intelligence Engine (GIE) for automated benchmarking of corporate reporting disclosures.
GIE enhances speed, reduces manual effort, and improves consistency in reporting.
Agreement demonstrates Insig AIs platform relevance and ability to support large clients.
Foundation for future recurring revenue growth in the advisory sector.
NewContract
APN logo
Latest RNS 06:01
APN

Final Results

Applied Nutrition Plc

**Summary of Applied Nutrition PLCs Final Results for FY25**
Applied Nutrition PLC, a leading sports nutrition, health, and wellness brand, announced its final results for the fiscal year ended July 31, 2025 (FY25), highlighting significant growth and strategic achievements.
**Financial Highlights**
**Revenue Growth** FY25 revenue increased by 24.2% to £107.1 million, surpassing IPO guidance and market expectations.
**EBITDA and Profit** Adjusted EBITDA rose by 18.8% to £30.9 million, and unadjusted operating profit grew by 18.6% to £28.1 million.
**Cash Flow** Strong free cash flow conversion of 72.4% and net cash of £18.5 million at the period end.
**Operational and Strategic Achievements**
**Global Expansion** Deepened relationships with existing customers and expanded into new geographies, including Latin America and Asia.
**Product Innovation** Launched new products like Vimto-flavored gels, hydration products, and Sparkling Collagen Protein Water.
**Capacity Increase** Completed a factory extension in August 2024, increasing revenue capacity to approximately £200 million.
**Current Trading and Outlook**
**Continued Momentum** Strong sales growth in Q4 FY25 continued into Q1 FY26, with positive market share trends.
**Investment in Growth** Plans to invest in additional capacity and capabilities to support continued growth.
**Prudent Outlook** Despite a strong Q1 FY26, the Board maintains current market expectations for FY26 due to the early stage of the financial year.
**CEO Commentary**
Thomas Ryder, CEO, emphasized over-delivering on IPO targets, strengthening customer relationships, and expanding globally. The company aims to become the worlds most trusted and innovative sports nutrition brand.
**Key Financial Metrics**
**Revenue** £107.1 million (FY24: £86.2 million)
**Adjusted EBITDA** £30.9 million (FY24: £26.0 million)
**Operating Profit** £28.1 million (FY24: £23.7 million)
**Free Cash Flow** £16.5 million (FY24: £7.1 million)
**Strategic Focus**
**B2B Model** Leveraging a low-risk, cost-effective B2B strategy with complementary D2C growth.
**Innovation** Continuous product development to meet consumer trends and expand market share.
**Global Presence** Expanding into new markets and strengthening distributor relationships.
**Future Investments**
**Production Expansion** Investing £2.0-£2.5 million to increase capacity to £300 million in revenue.
**New Distribution Facility** Planning a new global distribution facility and head office, expected to cost £3.5-£4.0 million.
**Conclusion**
Applied Nutrition PLC demonstrated robust financial and operational performance in FY25, exceeding expectations and positioning itself for continued growth in FY26. The company remains focused on innovation, global expansion, and strengthening its market position in the sports nutrition and wellness sector.
Here is the HTML table code comparing the financials and debt year on year for Applied Nutrition PLC:
MetricFY25 (£m)FY24 (£m)Change
Revenue107.186.224.2%
Gross Profit49.341.319.4%
Adjusted EBITDA30.926.018.8%
Adjusted Profit Before Tax30.225.717.5%
Free Cash Flow16.57.1132.4%
Net Cash18.518.7(1.1%)
Lease Liabilities (Current)0.60.3100.0%
Lease Liabilities (Non-Current)2.41.560.0%
Total Lease Liabilities3.01.866.7%
**Notes:** * The table compares key financial metrics and debt (lease liabilities) for Applied Nutrition PLC between FY25 and FY24. * Net Cash is calculated as Cash and Cash Equivalents minus Total Lease Liabilities. * The percentage change is calculated as ((FY25 - FY24) / FY24) * 100. * This table provides a snapshot of the company's financial performance and debt position, highlighting areas of growth and potential concerns.
RHIM logo
Latest RNS 06:01
RHIM

Trading Update

RHI Magnesita NV

<mark style="background-coloryellow"></mark>
CMCL logo
Latest RNS 06:01
CMCL

3rd Quarter Results

Caledonia Mining Corporation Plc

**Summary of Caledonia Mining Corporation Plcs 3rd Quarter 2025 Results**
Caledonia Mining Corporation Plc reported strong financial and operational results for the third quarter of 2025, driven by higher gold prices and increased sales. Key highlights include
1. **Financial Performance**
**Revenue**Increased by 52% to $71.4 million compared to Q3 2024, due to a 40% rise in the average realized gold price and an 8.7% increase in ounces sold.
**Gross Profit**Rose to $36.9 million, up from $19.3 million in Q3 2024.
**EBITDA**Surged by 162% to $33.5 million.
**Profit After Tax**Jumped 467% to $18.7 million.
**Free Cash Flow**Turned positive at $5.9 million, compared to a negative $2.4 million in Q3 2024.
2. **Operational Highlights**
**Gold Production**19,106 ounces from the Blanket Mine, with an additional 437 ounces from the Bilboes oxide mine.
**Gold Sales**20,355 ounces from Blanket, with 2,861 ounces of bullion on hand sold at the start of Q4.
**On-Mine Cost**$1,228/oz sold, with an all-in sustaining cost (AISC) of $1,937/oz sold.
**Ore Production**Increased tonnes broken and hoisted, with 229.5 thousand tonnes and 208.7 thousand tonnes, respectively.
3. **Safety and Sustainability**
Reported a fatality at Blanket Mine due to a secondary blasting accident, leading to a comprehensive review of safety procedures and training.
Group Lost Time Injury Frequency Rate (LTIFR) and Total Injury Frequency Rate (TIFR) showed slight increases, with ongoing efforts to improve safety.
4. **Exploration and Development**
Continued deep exploration drilling at Blanket, targeting down-dip continuations of mineralized zones, with encouraging results.
Surface trenching at Blanket identified anomalous gold values, leading to a 5,000-metre reverse circulation drilling program.
Motapa project exploration progressed, with 17,787 metres of reverse circulation drilling and 1,763.4 metres of diamond drilling completed.
5. **Capital Expenditure and Liquidity**
Total liquidity stood at $44.3 million, supporting ongoing capital projects.
Sustaining capital expenditure totaled $5.174 million, with non-sustaining capex at $1.585 million.
Completion of the new tailings storage facility (TSF) and ongoing mine development to access new areas.
6. **Corporate Developments**
Appointed Mr. July Ndlovu as an independent non-executive director.
Approved a quarterly dividend of 14 cents per share, payable on December 5, 2025.
Bilboes feasibility study expected to be released imminently.
7. **Guidance**
Maintained 2025 gold production guidance at 75,500 to 79,500 ounces.
Revised on-mine cost guidance to $1,150 to $1,250/oz sold and AISC to $1,850 to $1,950/oz sold, reflecting higher costs and royalties.
**CEO Commentary**
Mark Learmonth, CEO, emphasized the companys focus on stable production, disciplined capital investment, and modernization of operations at Blanket. Despite the tragic fatality, the company remains committed to safety and long-term growth, with strategic investments to strengthen its foundations.
**Conclusion**
Caledonia Mining Corporation Plc demonstrated robust performance in Q3 2025, with significant improvements in revenue, profitability, and cash flow, supported by strong gold prices and operational efficiency. The company continues to invest in exploration and development to sustain long-term growth while addressing safety concerns.
Here is the HTML table code comparing the financials and debt year on year for Caledonia Mining Corporation Plc: 25.9%
MetricQ3 2025Q3 2024% Change9-Months 20259-Months 2024% Change
Revenue (US$ 000)71,44046,86852.4%192,927135,50342.4%
EBITDA (US$ 000)33,49112,756162.6%95,50242,269
Profit after tax (US$ 000)18,6543,284468.0%53,41215,538243.8%
Free cash-flow (US$ 000)5,911(2,406)345.7%48,3289,767394.8%
Total liquidity (US$ 000)44,31838,000 (approx.)16.6%44,31838,000 (approx.)16.6%
Debt (Loans and borrowings, US$ 000)1,313 (non-current) + 1,281 (current)1,500 (non-current) + 1,174 (current)-12.5% (total)1,313 (non-current) + 1,281 (current)1,500 (non-current) + 1,174 (current)-12.5% (total)

Notes:

  • Total liquidity for Q3 2024 is approximated based on the available data.
  • Debt is represented by loans and borrowings, both non-current and current.
This table provides a comparison of key financials and debt metrics for Caledonia Mining Corporation Plc between Q3 2025 and Q3 2024, as well as for the 9-month periods ending September 30, 2025, and 2024. The data is extracted from the provided text.
CNSL logo
Latest RNS 06:01
CNSL

Half-year Report

Cambridge Nutritional Sciences plc

**Summary of Cambridge Nutritional Sciences PLC Half-Year Report (H1 2025)**
**Financial Highlights**
**Revenue Decline** Revenue decreased to £3.9 million (H1 2024: £4.1 million), primarily due to slower orders in key regions like mainland Europe, Africa/Middle East, and the Americas.
**Gross Margin Improvement** Gross margin increased to 67.7% (H1 2024: 65.4%), driven by production efficiencies and product mix optimization.
**Adjusted EBITDA** Remained positive at £0.1 million (H1 2024: £0.2 million), despite lower sales.
**Loss Before Tax** Increased to £0.4 million (H1 2024: £0.2 million) due to lower revenue and higher operational costs.
**Cash Position** Cash balance decreased to £3.6 million (H1 2024: £4.5 million) due to working capital outflows, capital expenditures, and financing activities.
**Operational Highlights**
**Sales Restructuring** The sales and marketing teams were restructured to focus on long-term growth, separating customer service, acquisition, and success functions from sales.
**Product Performance** FoodPrint® sales declined by 7% to £2.4 million, while Food Detective® sales dropped by 23% to £0.6 million. CNS Lab sales grew by 9% to £0.9 million.
**Regional Growth** Strong growth in the UK (6%) and India (33%), offset by declines in Europe, Americas, and Africa/Middle East.
**New Product Launch** Introduced Gut Detective®, a comprehensive stool biomarker panel for gut health, targeting UK practitioners.
**Outlook**
**Full-Year Sales** Expected to be lower than the previous year due to longer sales cycles and slower commercialization in key regions.
**Strategic Focus** Emphasis on converting pipeline opportunities into orders, particularly in the USA and Europe.
**Cost Management** Aim to remain profitable at the adjusted EBITDA level through careful cost management.
**Cash Investment** Continued investment in strategic initiatives like IVDR development and new products, despite a decline in cash position.
**Management Commentary**
**Challenges** Carolyn Rand, Chair, acknowledged a frustrating first half due to underperformance in key regions, despite strong growth in the UK and India.
**Optimism** Confidence in long-term growth prospects as the restructured sales team begins to deliver, supported by improved gross margins and operational efficiencies.
**Investor Engagement**
A live investor presentation was held on 10 November 2025, led by CEO James Cooper and CFO Ajay Patel, to discuss the interim results.
**Conclusion**
Cambridge Nutritional Sciences PLC faces short-term challenges with revenue declines in key regions but remains focused on long-term growth through sales restructuring, operational efficiencies, and strategic investments. The company is well-funded to execute its strategy and expects to return to growth with a healthy gross margin.
Here is the HTML table code comparing the financials and debt year on year for Cambridge Nutritional Sciences PLC: tr>
MetricH1 2025H1 2024Change
Revenue (£'000)3,8634,134(6.6%)
Gross Margin (%)67.7%65.4%+2.3%
Adjusted EBITDA (£'000)102227(55.1%)
Loss Before Tax (£'000)(397)(196)-102.6%
Cash Balance (£'000)3,5944,520(20.5%)
Total Debt (£'000)1633,964(95.9%)

Regional Revenue Breakdown

RegionH1 2025 (£'000)H1 2024 (£'000)Change (%)
UK894840+6%
Rest of Europe707952(25.7%)
Americas737805(8.4%)
India402302+33.1%
Asia796826(3.6%)
Africa and Middle East327408(19.8%)

Product Revenue Breakdown

ProductH1 2025 (£'000)H1 2024 (£'000)Change (%)
FoodPrint®2,3802,564(7%)
Food Detective®554717(22.7%)
CNS Laboratory Service910842+8.1%
Food ELISA/Other1911+72.7%
**Notes:** * Total Debt is calculated as the sum of Short-term borrowings, Lease liabilities, and Long-term borrowings (if any). * The percentage changes are calculated based on the absolute values. * The tables provide a clear comparison of the company's financials and debt position year on year, as well as a breakdown of revenue by region and product.
KNOS logo
Latest RNS 06:01
KNOS

Interim results

Kainos Group PLC

**Summary of Kainos Group plc Interim Results for H1 2026**
**Overview**
Kainos Group plc, a UK-based IT provider specializing in Digital Services, Workday Services, and Workday Products, reported strong interim results for the six months ended 30 September 2025. The company highlighted robust sales performance, revenue growth, and strategic advancements despite challenges like cost increases and investment in partnerships.
**Financial Highlights**
**Revenue**Increased by 7% to £196.1 million (H1 2025: £183.1 million), driven by organic growth and currency benefits.
**Adjusted Pre-Tax Profit**Declined by 16% to £32.0 million (H1 2025: £38.2 million) due to increased investment in the Workday partnership, National Insurance costs, and short-term use of contractors.
**Bookings**Surged by 27% to £227.9 million (H1 2025: £179.5 million), reflecting strong sales across all divisions.
**Contracted Backlog**Grew by 12% to £396.9 million (H1 2025: £354.1 million).
**Cash**Decreased by 30% to £105.5 million (H1 2025: £151.6 million) due to restructuring costs, working capital increases, and shareholder returns.
**Interim Dividend**Increased by 5% to 9.8p per share (H1 2025: 9.3p).
**Operational Highlights**
1. **Workday Products**
Revenue grew by 14% to £39.2 millionwith ARR up 19% to £77.5 million.
Achieved $100 million ARR milestone in July 2025, a significant SaaS industry benchmark.
Launched "Pay Transparency Analyzer powered by Kainos" in partnership with Workday, targeting EU compliance requirements.
2. **Digital Services**
Revenue increased by 6% to £103.5 million, driven by healthcare sector growth (33%) and North American expansion (152% revenue growth).
Secured major contracts in the UK public sector, including a £73 million deal with the DVSA.
3. **Workday Services**
Revenue grew by 4% to £53.4 million, with strong performance in North America and emerging markets like Australia and Latin America.
Bookings increased by 35% to £54.0 million.
4. **International Growth**
International revenue rose by 13% to £84.9 million, accounting for 43% of Group revenue.
5. **Customer Satisfaction**
Net Promoter Score (NPS) improved to 70 (H1 2025: 58), reflecting high customer satisfaction.
6. **Employee Engagement**
Employee retention remained strong at 92%, with engagement levels at 75%.
Recognized as one of the "50 Best Places to Work in the UK" by Glassdoor.
7. **AI Initiatives**
AI-related revenue grew by 6% to £15.3 million.
Launched Microsoft AI Centre of Excellence and developed AI solutions for Workday and other platforms.
**Strategic Developments**
Acquired Davis Pier, a Canadian consultancy, to strengthen North American presence.
Deepened Workday partnership with exclusive resell arrangements and joint product launches.
Continued investment in R&D, with expenditure rising by 12% to £8.6 million.
**Outlook**
Expects continued growth in Workday Products, Digital Services, and Workday Services in H2 2026.
Maintains full-year profit expectations in line with consensus forecasts.
Focused on long-term growth drivers, including AI adoption and digital transformation.
**Shareholder Returns**
Completed £30 million share buyback programme and announced a new £30 million programme.
**Conclusion**
Kainos demonstrated resilience and growth in H1 2026, underpinned by strong sales execution, strategic partnerships, and expansion into key markets. Despite short-term profit pressures, the company remains confident in its long-term strategy and ability to deliver shareholder value.
Here is the HTML table code comparing the financials and debt year on year for Kainos Group plc:
MetricH1 2026H1 2025Change
Revenue£196.1m£183.1m+7%
Statutory profit before tax£28.4m£34.2m-17%
Adjusted pre-tax profit£32.0m£38.2m-16%
Diluted earnings per share16.7p20.1p-17%
Adjusted diluted earnings per share18.9p22.5p-16%
Interim dividend per share9.8p9.3p+5%
Bookings£227.9m£179.5m+27%
Product annual recurring revenue (ARR)£77.5m£65.1m+19%
Contracted backlog£396.9m£354.1m+12%
Cash£105.5m£151.6m-30%

Note: Debt information is not explicitly mentioned in the provided text. However, the cash balance can be considered as a proxy for debt, with a decrease in cash potentially indicating an increase in debt or other liabilities.

Key Observations:

  • Revenue increased by 7% year-on-year, driven by strong sales performance across all divisions.
  • Profit metrics (statutory and adjusted) decreased by 16-17%, primarily due to increased costs associated with the Workday partnership, National Insurance, and contractor usage.
  • Bookings and contracted backlog increased significantly, indicating strong future revenue potential.
  • Cash balance decreased by 30%, partly due to share buybacks, acquisition of Davis Pier, and increased working capital requirements.
This table provides a clear comparison of key financial metrics between H1 2026 and H1 2025, highlighting the changes and trends in Kainos Group plc's financial performance.
CHG logo
Latest RNS 06:01
CHG

Post-close and contract wins update

Chemring Group PLC

**Chemring Group PLC Trading Statement Summary (November 10, 2025)**
Chemring Group PLC provided a post-close and contract wins update for FY25, highlighting key financial and operational developments as it enters its close period for the year ended October 31, 2025.
**Financial Performance**
**FY25 adjusted operating profit** is in line with analyst expectations, with a margin of ~14.7% (up from 14.2% in FY24).
**Adjusted EPS** is expected to benefit from slightly lower finance costs.
**Net debt** as of October 312025is ~£95m.
**Order book** increased to £1.3bn (from £1.0bn in October 2024), with order intake for the year at ~£781m.
**Operational Highlights**
**Energetics segment** outperformed, driven by increased demand for propellants, energetic materials, and high-integrity devices.
**Sensors & Information segment** faced softness due to delayed UK Government orders, particularly in National Security and Defence.
**Countermeasures & Energetics** achieved ~95% order cover for FY26, while **Sensors & Information** secured ~47% cover.
**Significant Contract Wins**
1. **Energetics**
Chemring Energetic Devices (US) won a $65m sole-source framework contract for aircrew flight equipment <mark style="background-color:yellow">test</mark>er systems.
Chemring Energetics UK secured a £24m order for rocket motors and components for the Next Generation Light Anti-Tank Weapon (NLAW) system.
Chemring Nobel (Norway) won a £23m order from Nammo for HMX products.
2. **Countermeasures**
Chemring Australia won a US$35m contract for airborne countermeasures.
Chemring Countermeasures UK secured a £15m order from NATO for airborne countermeasures.
3. **Sensors & Information**
Roke won over £40m in National Security contract renewals and a £20m contract for Project ZODIAC, a critical technology program for the British Army.
**Strategic Developments**
**Landguard Group acquisition** completed in August 2025, enhancing Roke’s growth and operational synergies.
**Alloy Surfaces** (US countermeasures business) will be reported as a discontinued operation due to declining demand from the US Department of Defense. Strategic options, including a potential sale, are under consideration.
**Outlook**
Robust market conditions and increasing demand for technology-driven solutions and traditional defence capabilities are expected to sustain growth.
Full-year results for FY25 will be released on December 9, 2025.
**Directorate Change**
Fiona MacAulay, Senior Independent Director, will step down at the February 2026 AGM after completing her second three-year term.
Chemring remains focused on its niche markets, leveraging R&D investments to meet evolving customer needs in defence, security, and aerospace.
NewContract
ONDO logo
Latest RNS 06:01
ONDO

Contract Win

Ondo InsurTech PLC

**Summary**
Ondo InsurTech PLC (LSEONDO), a leader in claims prevention technology for home insurers, announced on November 10, 2025, that Westfield Insurance has signed a contract to deploy 10,000 LeakBot devices and connected services for homeowners in Ohio, Indiana, and Pennsylvania. This partnership aims to proactively prevent water damage claims, reduce loss costs, and enhance customer experience. LeakBot, a patented self-install solution, detects leaks and alerts homeowners via a mobile app, offering access to expert engineers for repairs. Independent research shows LeakBot can reduce water damage claim costs by up to 70%. Westfield’s initiative aligns with its investment in innovative technology, while Ondo continues to expand its global partnerships with 25 insurance carriers. Ondo holds the London Stock Exchange’s Green Economy Mark, underscoring its commitment to sustainable solutions. Westfield, a leading U.S. insurer founded in 1848, strengthens its position with this collaboration, further solidifying Ondo’s role as a global leader in claims prevention technology.
NewContract
ABDX logo
Latest RNS 06:01
ABDX

c.US$2m multiplex diagnostic test contract win

Abingdon Health Plc

**Summary**
Abingdon Health plc, a leading developer and manufacturer of rapid diagnostic <mark style="background-color:yellow">test</mark>s, has secured a **c.US$2 million contract** with a US-based company for the development, scale-up, and technical transfer of a **semi-quantitative, multiplex lateral flow test system**. The 24-month project will be executed under a Master Service Agreement (MSA) and conducted at Abingdon Health’s Madison, Wisconsin facilities. This win highlights the strength of Abingdon Health’s **Contract Development and Manufacturing Organisation (CDMO)** services, which support customers from concept to commercial success. The contract underscores the company’s expanded U.S. manufacturing capabilities, bolstered by a recent £3.2 million fundraise, and its ability to meet growing demand from U.S.-based clients. Dr. Chris Hand, Executive Chairman, emphasized the value of Abingdon’s dual U.S. and U.K. sites and the versatility of lateral flow technology in measuring multiple analytes semi-quantitatively. The announcement reinforces Abingdon Health’s position as a comprehensive CDMO provider in the med-tech sector.
NewContract
SMIF logo
AI Chartist

SMIF

Today News536
Pulse--
AI Net0
Ticker AI

SMIF

AI sentiment, signals and catalyst scoring — loaded fresh from the site engine for the selected ticker.

Market AI · 2025-11-10

LONDON MARKET CLOSE: FTSE 100 at new high amid US shutdown optimism

FTSE 100 Hits All-Time High: Reached a record closing peak of 9,787.15, up 1.1%, and set a new intra-day high of 9,800.35 on Monday, 10th Nov 2025. US Government Shutdown Progress: US Senate cleared the way for a d…

Market AI · 2025-11-10

LONDON MARKET MIDDAY: FTSE climbs as US shutdown deal nears

Date and Time: 10th Nov 2025, 12:23 London Stock Market: FTSE 100 up 1.0% at 9,780.33, nearing record levels. FTSE 250 up 1.1% at 22,021.47. AIM All-Share up 1.3% at 759.35. Cboe UK i…

Market AI · 2025-11-10

LONDON MARKET EARLY CALL: FTSE 100 seen up on hopes of US shutdown end

Here is a bullet point summary of the provided text in HTML format: html Market and Economic Summary - 10th Nov 2025 06:52 London Stocks: Set to open higher, with FTSE 100 futures up 0.9% at 9,764.17, boosted by t…

🤖
AI Intel
Sentiment scoring · good/bad/net · catalyst intensity · AI groups
Select a ticker above
Nexus Signal

Market Pulse

--pulse
Up
0
Down
0
News536
AI Net0
Movers0
📡
Nexus Signal
Price geometry · AI sentiment · short pressure · catalyst density fused into one read
Select a ticker above
Fundamentals

SMIF

MarketALL-MARKETS
RNS Today536
AI Score—
Business readCatalyst first, then balance-sheet — revenue quality, recurring income and debt maturity are the key filters after a major RNS.
Risk readWatch dilution risk, covenant headroom and customer concentration. Ask whether today's RNS changes the re-rating case.
🔭
Fundamentals
Market cap · broker target · float · valuation ratios · sector context
Select a ticker above
Financials

SMIF

Earnings lensCheck if today's RNS changes revenue timing, cash conversion or funding pressure — then confirm against historical trend.
Balance-sheet lensPrioritise net cash position, debt covenants, working capital and capex direction before acting on price momentum.
Forecast lensRevenue quarterly table, EPS, PE ratios, enterprise value multiples and analyst revisions load with the selected ticker.
📊
P&L / Financials
Revenue · income · cash flow · leverage · EPS · PE ratios
Select a ticker above
Structure DNA

SMIF

MarketALL-MARKETS
Up Count0
RNS Today536
Float structure Ownership pattern TR1 flow Re-rating potential
🧬
Structure DNA
Float · shares out · long/short interest · ownership concentration
Select a ticker above
RNS Today536
Up0
Down0
💎
Capital Radar
Broker targets · director dealing · TR1 flow · institution holders · market position
Select a ticker above
Short Data

SMIF

RNS Today536
MarketALL-MARKETS
AI Net0
Short pressure lensShort data matters most when it conflicts with fresh catalysts — high short interest plus a positive RNS is a squeeze candidate. Low short interest plus bad news has less bounce risk.
🎯
Short Data
Holder positions · % float shorted · borrow cost · squeeze candidates
Select a ticker above
Volatility Lab

SMIF

Movers0
News536
Up0
Execution lensATR defines stop width. Use it to judge whether today's RNS triggered a clean breakout or noise within the daily range.
Volume confirmsVolume expansion on catalyst day is the key signal — high volume on break through resistance confirms the move; low volume warns of fade.
⚡
Volatility Lab
ATR · realized range · volume profile · reaction zones · breakout confirmation
Select a ticker above
🧠
Ask AI
Chart context · RNS news · support/resistance · MACD · catalyst risk — all live
Target path News risk Invalidation Capital flow